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1 .  Ab b r e v i a t i o n s  
Å  angstrom 
a_b   apical to basal transport direction 
ABC   ATP-binding cassette 
ACE   angiotensin converting enzyme 
ADME   absorption, distribution, metabolism, excretion 
AF   Amentoflavone 
API  active pharmaceutical ingredient 
AQ  absorptive quotient 
b_a   basal to apical transport direction 
BCRP   breast cancer resistance protein 
BCS   biopharmaceutical classification system 
Caco-2  colon adenocarcinoma cells 
CW   molar number of occupied sites per area 
CYP  cytochrome P450 enzymes 
D   Digoxin 
ER   efflux ratio 
Fa   fraction absorbed 
FRV  final residual value scaled 
HPLC  high performance liquid chromatography 
hPepT1  human di/tri-peptide transporter 
kon   rate constant for adsorption to the surface  
koff   rate constant for desorption of the surface 
LC  liquid chromatography 
logP  partition coefficient 
MS  mass spectrometry 
MDCK  Madin-Darby canine kidney 
MRP2   multidrug resistance protein 2 
MW   molecular weight 
OATP   organic anion transporting polypeptide 
P   permeability coefficient 
Papp   apparent permeability coefficient 
P-gp   P-glycoprotein 
PSA  polar surface area 
Q   Quinidine HCl 
SHP  succus helix pomatia 
SLC   solute carrier family 
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SQ  secretory quotient 
vk   apical efflux rate / pump rate 
VP   Verapamil HCL 
W   molar number of free sites per area 
Wtot   total number of binding sites on the surface
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2 .  S u mm ar y 
Intestinal absorption is required for a sufficiently high bioavailability of drugs administered 
by the peroral route. Several molecular mechanisms are involved in intestinal absorption 
and can profoundly influence its magnitude including permeation of the mucosa by 
passive diffusion, transport across the intestinal wall by carrier mediated processes, 
chemical and enzymatic alteration of the molecule in the intestinal lumen and/or in the 
enterocyte, dissolution behaviour of the drug and interaction with food ingredients or co-
administered drugs at the dissolution and the transport level. These mechanisms 
typically act simultaneously and each depends on drug molecule and epithelium related 
chemical and biological factors whose effect is not definitely established. This makes 
intestinal absorption a rather complex process, which, despite recent advances, is 
fundamentally still poorly understood. Therefore, experimental verification of drug 
absorption remains a must in current industrial drug development practice. Prediction of 
in vivo absorption based on in vitro methodology may help reduce the volume of 
necessary clinical investigations. Cell culture techniques predominantly employing the 
Caco-2 cell line have been established in the last decade as a screening and study tool 
of intestinal absorption. This technique, although widely used in industrial and academic 
settings, still poses a number of challenges. These include artefacts like adsorption to 
container surfaces and cellular accumulation, which might lead to an erroneous 
estimation of the permeability, poor recovery, and faulty mass balance. The estimation of 
independent parameters for parallel processes (e.g. passive permeability and active 
efflux) is still not the common procedure in the analysis of permeation data and the 
usually employed apparent permeability coefficient Papp and efflux ratio (ER) are afflicted 
with limitations. 
The objective of the present work was to establish a methodology for determining the 
contribution of passive diffusion, carrier-mediated transport, enzymatic degradation and 
non-specific binding/adsorption to drug absorption measured in the Caco-2 cell system 
and investigating drug-drug interactions for absorption in this system. Transport 
experiments across the cell monolayer were conducted in bi-directional modus using 
model drug compounds (Amentoflavone, Verapamil, Digoxin and Quinidine) that are 
known to be subject to more than one of the above molecular mechanisms. In order to 
delineate the contribution of these mechanisms, a model for analysing the experimental 
data was introduced. This model encompassed quantitative expressions based on 
biophysical or physicochemical principles of the effect of all these mechanisms on 
transport and described the variation of drug concentration in the different compartments 
of the cell system as a result of the simultaneous action of these mechanisms. The 
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resulting system of differential equations was fitted to the experimental data using 
regression analysis following numerical integration and relevant parameters reflecting the 
quantitative effect of each mechanism involved in absorption were deduced. These 
parameters were the passive permeability coefficient, first and zero order carrier 
mediated transport rate, first order metabolic rate constant and binding constant. This 
was done for the above drugs used individually and for selected binary mixtures. 
Amentoflavone exhibited strongly asymmetric transport, which was almost not detectable 
in the apical to basal direction and pronounced in the basal to apical direction. This 
suggested that Amentoflavone is subject to apical efflux in the Caco-2 cells. This was 
partly reversed by GF120918 and Vinblastine which are known inhibitors of P-
glycoprotein (P-gp) and P-gp and MRP2, respectively, indicating that Amentoflavone was 
substrate of at least one of these efflux transporters. The active apical efflux was almost 
abolished at low temperature. Amentoflavone also underwent phase II metabolism in the 
Caco-2 cells. At least two glucoronides and one sulfate were detected by HPLC-MS, 
which were hydrolysable by specific enzymes. These metabolites exhibited also apical 
efflux. Finally, Amentoflavone was strongly adsorbed to the surface of the Transwell 
plates used in cell culture and transport studies. The adsorption and desorption rate 
constant and the total number of surface binding sites was determined in blank 
experiments using the plates without cells. For this, a model describing the time 
dependent concentration decrease of the drug due to adsorption was employed. These 
surface adsorption parameters were subsequently used in the model describing the 
absorption of Amentoflavone in Caco-2 cells. This procedure allowed the determination 
of absorption parameters that were not biased by non-specific binding effects. 
Amentoflavone was found to have a rather low passive cell permeability, which combined 
with its substantial apical efflux resulted in its marginal absorption in the apical to basal 
transport direction. The metabolic rate constant was smaller than the efflux rate constant 
but still sufficiently large to produce relevant amounts of metabolite in the course of the 
cell absorption experiment. 
Verapamil, Digoxin and Quinidine were studied in a wide concentration range individually 
and in binary mixtures to determine the significance of the interplay of passive diffusion 
and apical efflux on absorption and how this is affected by concomitant administration of 
a second drug. Passive permeability coefficients were independent of concentration and 
varied among the three drugs over at least a ten-fold range. The rate of apical mass 
efflux varied between the three drugs, increased with concentration and seemed to level 
off for at least one of the three drugs in the studied concentration range. The dominance 
of one mechanism over the other depended on concentration in a different pattern for the 
2. Summary 
David Blaser Page 13 of 194 University of Basel, 2007 
three compounds. Thus, the outcome of the combination of passive permeation and 
apical efflux for apical to basal absorption can only be predicted if the passive 
permeability coefficient and the concentration dependence of the carrier mediated efflux 
rate are known. All three drugs were substrates of apical efflux carriers. In binary 
mixtures, they commonly reduced the efflux rate of the concomitant compound. This 
reduction was mutual yet its extent varied between the compounds. Hence, these apical 
efflux carrier substrates may also act as inhibitors and vice versa exhibiting at least a 
partially overlapping specificity. 
In conclusion, the introduced model approach and data analysis provide a quantitative 
insight into the process of drug absorption which can be used for a better understanding 
and potentially as a means supporting the prediction of in vivo absorption based on cell 
culture data and the delineated effect of the involved mechanisms. 
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3 .  I n t r od u c t i on  an d  O bj e c t i ve s  
The oral route is generally accepted to be the most convenient for administration of 
drugs. One prerequisite for an orally administered drug to have a systemic effect is that 
there is drug uptake from the gastro-intestinal tract, i.e. the drug has to be absorbed from 
the gut lumen into the blood stream. The unchanged amount of drug that is absorbed 
determines its bioavailability and the systemic exposure of the body to the drug. The 
absorption is an important property in the determinants of the ability of a molecule to act 
as a drug. Poor absorption properties are often encountered in molecules from 
contemporary drug development programs. These are either due to poor water solubility 
or low intestinal wall permeability. The issue of solubility and permeability properties and 
their influence of the absorption have been addressed by the framework of the 
biopharmaceutic classification system (BCS) [Amidon, Kasim, Takagi]. Drugs that belong 
to class III (high solubility and low permeability) and IV (low solubility and low 
permeability) possess unfavourable permeability properties. 
The reasons for poor absorption behaviour of a molecule can be based on different 
physico-chemical and physiological properties: (1) Molecules may not have the ability to 
easily cross biological membranes by passive diffusion resulting in low permeability. The 
main properties of a drug influencing its passive permeation through biological 
membranes are lipophilicity, hydrogen-bonding capacity, charge and size / molecular 
weight [Camenisch]. Based on these properties a simple rule of thumb to assess a drug’s 
likeliness to be absorbed was defined [Lipinski]. (2) For an increasing number of 
molecules active efflux out of the cell, caused by proteins located in the apical cell 
membrane, is identified to have the potential to limit the overall permeability by pumping 
the drug molecules in the basal to apical direction. The physiological function of these 
proteins is to prevent uptake of toxic substrates or to facilitate the excretion of such 
substrates across the intestinal tract or in the liver. The relevant efflux transporters for 
drugs in clinical use belong to the ATP-binding cassette (ABC) family (e.g. P-
glycoprotein, BCRP, MRP2) [Ambudkar, Borst, Litman 2001, Schinkel]. (3) Chemical 
instability or metabolism are important factors in limiting the absorption of drugs. A drug 
molecule must withstand pH values between 1.5 and 7.0 in the gastro-intestinal fluid and 
high enzymatic activity that can both lead to degradation [Rowland]. Both the liver and 
the intestinal epithelium constitute metabolic barriers where an absorbed drug molecule 
may be metabolised. Metabolism is divided into phase I metabolism, that is the 
modification of the parent drug by oxidation reactions, e.g. by Cytochrome (CYP) P450 
enzymes, and phase II metabolism, that is the conjugation of the parent compound or its 
phase I metabolite with hydrophilic moieties as glucuronic acid, sulfate or glutathione. 
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The liver may provide the main metabolising organ of the body but also the intestine 
constitutes an appreciable metabolic barrier where a drug molecule undergoing 
absorption may be metabolised before reaching the systemic circulation. Of the phase I 
metabolising enzymes, CYP3A is the dominant subfamily in the small intestine where it 
constitutes about 70% of the total CYP protein [de Waziers, Kolars, McKinnon]. Several 
phase II enzymes are expressed in the intestine at levels that are comparable to those in 
the liver. (4) Further reasons for poor absorption can be drug-drug interactions (e.g. 
complex forming, chemical reactions, inhibition of or competition for carrier-mediated 
uptake) or interactions of drugs with food components (e.g. protein binding). 
For the assessment and prediction of absorption and permeation properties at the 
different drug administration sites of the human body and the study of the underlying 
processes many in vitro and in situ methods were developed with different levels of 
complexity and sophistication [Avdeef 2003, Bohets, Deli, Ghibellini, Hidalgo 1989 & 
2001, Kansy, Schlatter, Tavelin]. One of most frequently used and best established cell 
lines for the determination of drug permeability across intestinal membranes is the 
human colon adenocarcinoma cell line Caco-2, grown on semi-permeable filter supports 
[Artursson 1991 B, Hidalgo 1989]. Caco-2 cells spontaneously differentiate into 
enterocyte-like cells and in spite of their colonic origin, a number of active transport 
mechanisms normally found in the absorptive enterocytes of the small intestine are 
present in this cell line [Bailey]. The use of the Caco-2 cell model permits the 
investigation of simultaneous absorption routes at the same time (e.g. passive diffusion, 
active efflux, metabolism), and much insight into the different steps of absorption has 
been gained by the use of the Caco-2 cell model [Artursson 1997]. 
Some of the problems and disadvantages that are affiliated with the use of the Caco-2 
cell model are the following: (1) The Caco-2 cell model normally requires, without 
optimising the culturing conditions, culture on filters for three weeks before it can be used 
for drug transport experiments. (2) A lab-to-lab and cell batch to cell batch variability is an 
often-encountered problem with the results of in vitro permeability studies. Depending on 
the exact protocol of the culturing conditions, the results of permeability measurements 
for selected compounds may differ for different labs, passages, selected clones and 
culturing conditions [Anderle, Behrens 2003 & 2004, Briske-Anderson, Hosoya, Yu]. (3) 
Artefacts like non-specific binding to container surfaces and cellular accumulation lead to 
an erroneous estimation of the permeability of compounds as well as to poor recovery of 
the compound and faulty mass balance [Balimane 2005, Ingels]. Under in vitro conditions 
the adsorption to solid surfaces and to cells depends on the composition of the 
experimental buffer or medium, the chemical identity of the compound itself, and the type 
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of the solid surface [Grohganz, Palmgren]. (4) Up to date the estimation of independent 
parameters for parallel processes (e.g. passive permeability and active efflux) is not the 
common procedure in the analysis of permeation data derived from in vitro models. The 
usually employed apparent permeability coefficient Papp is afflicted with limitations as this 
approach uses the initial drug amount in the donor, linear drug transport with time that is 
applicable to early time points only and furthermore assumes negligible back flux and no 
mass balance problems [Tran 2004, Youdim]. Additionally, substrates for active apical 
efflux are identified by calculation of the efflux ratio (ER), and by performing transport 
experiments with inhibition of the carrier-mediated component. To identify substrates by 
calculation of the ER the estimated Papp values have to be within an optimal range. For 
substrates that have Papp values outside of this range, the identification as a substrate is 
prone to fail by using this approach [Polli]. These issues and some proposed solutions 
are addressed in literature [Balimane 2005, Bentz, Ingels, Tran 2004, Troutman 2003 B, 
Youdim]. 
Objectives 
The purpose of this PhD thesis was to establish a methodology for determining unbiased 
parameters in in vitro cell culture models describing the absorption of some model drug 
compounds in the Caco-2 cell system. For this a mathematical model had to be 
developed and evaluated describing the processes involved in this system. The aim was 
to provide a tool to investigate permeation and metabolism in the Caco-2 cells grown on 
permeable filter supports in Transwell plates and to determine the effect of non-specific 
binding to the surface of Transwell plates on the permeation. This methodology should 
result in model-derived parameters that delineate passive and carrier-mediated effects 
on permeation and allow the study of drug-drug interactions on permeation based on the 
quantification of the contribution of different concurrent transport mechanism to epithelial 
permeation. The final benefit is to gain basic understanding of drug absorption and 
provide the means for prediction. 
This model should encompass passive diffusion, carrier-mediated efflux, non-specific 
binding to the Transwell surfaces and phase II metabolism and be used for the 
quantitative analysis of model compound bi-directional transport across Caco-2 cell 
monolayers. Model drugs (Amentoflavone, Digoxin, Quinidine, Verapamil) should be 
considered to exhibit efflux, phase II metabolism and non-specific binding. To gain 
knowledge on the concentration dependent behaviour of the relevant processes and 
parameters and to study drug-drug interactions on the level of passive diffusion and 
carrier-mediated transport, experiments are conducted with single compounds and binary 
combinations of the same compounds. To assess the effect of non-specific binding to the 
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surface of Transwell plates, rate constants for adsorption and desorption are 
determined in experiments without cells and then used in the experiments with cells. 
Using this model to analyse experimental data should provide estimates of the model 
parameters of each process, including the passive permeability, the efflux rate, the 
metabolic rate constant, and the kinetic parameters for non-specific binding to the 
surface. Finally the model derived kinetic parameters are compared to the conventionally 
determined apparent permeability coefficient Papp. 
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4 .  T h e or e t i c a l  s ec t i o n  
4.1 .  Drug  absorpt ion  a f ter  ora l  appl ica t ion  
The oral route is generally accepted to be the most convenient for administration of 
drugs. Orally administrable drug formulations are preferred to their non-oral alternatives 
(e.g. intravenous injections, pulmonary and transdermal delivery) for reasons such as 
better suitability for self-medication, lower production cost, established formulation 
strategies and better patient compliance. 
In order to be efficient, drugs that are orally administered must possess properties that 
are compatible with oral administration. Several criteria must be met. For instance, the 
drug molecule must be sufficiently soluble in the gastrointestinal fluids (stomach and/or 
intestine), withstand pH values between 1.5 and 7.0 [Rowland] and high enzymatic 
activity (degradation and metabolism) and last but not least permeate to a sufficient 
degree in the epithelium of the intestinal mucosa. 
The introduction of modern drug discovery technologies, such as combinatorial chemistry 
and high-throughput screening, has resulted in huge numbers of lead compounds being 
identified. Unfortunately the compounds generated in high-throughput drug discovery 
programs are generally more lipophilic, less soluble and of higher molecular weight than 
conventional drugs [Lipinski]. These characteristics often entail unfavourable 
biopharmaceutical properties, which can lead to termination of the clinical development 
of new drugs due to the poor bioavailability after oral administration [Kennedy, 
Venkatesh]. 
There is a growing research effort aimed at developing experimental and theoretical 
methods that allow the prediction of biopharmaceutical properties earlier in development, 
ideally already based on the chemical structure. The solubility and permeability of a drug 
molecule are considered to be of the most important properties that determine absorption 
and the influence of these two properties on the extent of absorption has received 
considerable attention [Amidon]. While appropriate and advanced formulation strategies 
can modify the solubility of a drug molecule to some extent, the possibilities improve the 
membrane permeability are limited. It is therefore crucial to assess the solubility and 
permeability of new potential drug molecules as early as possible during the 
development process to enable the identification of molecules or lead structures 
possessing good solubility and membrane permeability properties and to ensure 
appropriate formulation strategies. In recent years the biopharmaceutic classification 
system (BCS) has been established and many commercialised drugs have been 
classified according to this system [Amidon, Kasim, Takagi]. The BCS points to the 
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solubility and permeability as important factors for the intestinal absorption of orally 
administered drugs. This classification divides the compounds into four classes: Class I 
substances defined as having a high permeability and high solubility; Class II ones have 
a high permeability and low solubility; Class III drugs have a low permeability and a high 
solubility and class IV is appropriate for drugs with a low permeability and a low solubility. 
The limit between having a high and low permeability has been set to a fraction absorbed 
(Fa) of 90%. For classification as a highly soluble compound, the highest dose to be 
given should be soluble in 250ml of aqueous media in the range from pH 1 to pH 7.5 
[Amidon, Lennernäs]. 
The aqueous solubility of a drug substance is an important physicochemical parameter 
that has a significant role in various physical and biological processes and serves a wide 
range of needs throughout the various phases of discovery and development. Solubility 
is used to characterise compounds belonging to a chemical series and to determine 
whether these compounds are soluble enough for structure–activity relationship screens. 
In further stages, solubility data are used to assess absorption, distribution, metabolism 
and elimination parameters and to develop formulations for safety screens, pre-clinical 
and early clinical use [Bhattachar]. Reviewing the fundamentals of solubility from the 
molecular level and the current methods used solubility measurement and prediction, is 
beyond the scope of this thesis and there is comprehensive literature available on this 
topic [Avdeef 2001, Bhattachar, Delaney]. Another essential step in modern drug 
discovery and development is the evaluation and analysis of the ADME properties in 
general, and in the framework of the BCS system especially the permeability properties. 
4.2 .  The  gas tro - intes t ina l  t rac t  and  the  in tes t ina l  
epi the l ium 
One prerequisite for an orally administered drug to have a systemic effect is that there is 
drug uptake from the gastro-intestinal tract. However, the intestine may not only be well 
suited for the absorption of nutrients but also it also protects the organism from 
potentially harmful microorganisms and xenobiotics (e.g. therapeutically used drugs). 
The first hindrance to drug absorption is the acidic environment in the stomach, which 
can degrade not only bacteria but also some drug substances. In addition the intestinal 
membrane along the intestine is covered with a tight epithelium, which contains various 
enzymes that not only degrade nutrients for uptake and can convert xenobiotics into 
hydrophilic metabolites to assist in their elimination from the body. 
Once in solution a drug molecule encounters a system of sequential barriers during its 
transport from the intestinal lumen into the blood stream. The epithelial surface in contact 
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with the content of the intestinal lumen is greatly amplified by the macroscopic valve-like 
folds (circular folds), the tiny finger-like projections called villi, and the microvilli with the 
associated glycocalyx (brush-border structure) [Daugherty]. The brush-border of the 
enterocytes presents a considerable catabolic barrier of enzymatic activities. 
Furthermore the epithelial surface of the gastro-intestinal tract is coated by mucus that is 
secreted by the goblet cells and contains mucin glycoproteins, enzymes and electrolytes. 
The functional unit of the intestinal epithelium is the crypt-villus axis. Within the axis the 
epithelium is spatially separated into proliferating and differentiating cells, with the 
functional, absorptive cells (enterocytes) situated on the villus tip [Pageot]. The intestinal 
epithelium contains three different types of cells: endocrine cells secreting digestive 
hormonal peptides, the exocrine secreting goblet cells (mucus) and the Paneth cells 
(antimicrobial peptides). The absorptive cells (enterocytes) are the most abundant of the 
epithelial cells, accounting for 80 – 90% of the total number. 
4.3 .  Mechanisms of  membrane permeat ion  
Among the different properties that determine the transfer and distribution of a drug 
molecule in the human body one property of particular importance is the ability to cross 
biological membranes. The permeability across the different membranes a drug 
encounters during its passage through the body shapes its pharmacokinetic profile, 
affecting its absorption, distribution and elimination. Permeation across the cell 
membranes takes place by three main mechanisms that are subsequently discussed: 
transcellular diffusion, paracellular diffusion and active transport (either transport into the 
cells or efflux out of the cells). The main properties of a drug influencing its permeation 
through biological membranes are lipophilicity, hydrogen-bonding capacity, charge and 
size / molecular weight [Camenisch], some of which can be described by partition 
coefficients (e.g. logPoctanol/water) or molecular surface area descriptors such as the polar 
surface area (PSA) [Goodwin, Stenberg]. 
4.4 .  Passive  t ranscel lu la r  permeat ion 
The cell membrane of epithelial cell consists in the same manner as all other mammalian 
cell membranes of a lipid bilayer with embedded proteins (e.g. ion channels, 
glycoproteins, transporters). The membrane composition (phospholipids, proteins, 
cholesterol) varies between different cell types and may therefore influence the 
membrane properties. The presence of different lipids and different embedded proteins 
provides unique properties to cell membranes throughout the body [Seydel]. The 
structure of the cell membrane has traditionally been described by the fluid mosaic model 
[Singer], and more recently been further developed by the lipid raft hypothesis [Simons]. 
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These lipid rafts are membrane microdomains that are enriched in cholesterol and 
sphingolipids. The dynamic clustering of sphingolipids and cholesterol forms rafts that 
move within the fluid bilayer and they have been implicated in processes as diverse as 
signal transduction, endocytosis and cholesterol trafficking. Although a vast number of 
publications dealing with lipid rafts exist, there is still scepticism about the real nature of 
their existence and more work is still needed to formally confirm the lipid raft hypothesis 
[Shaw]. 
Epithelial cells are polarized, meaning that they possess a distinct apical membrane 
facing the intestinal lumen and a basolateral membrane facing the sub-epithelial tissues, 
with different protein and lipid compositions, and thus different permeability properties. 
The apical membrane contains, for instance, lower levels of glycosphingolipids than the 
basolateral membrane of epithelial cells [van Meer]. The lipoid nature of the cell 
membranes restricts the transport of ions and hydrophilic molecules. Passive 
transcellular transport can be divided into several subsequent steps. The first step is the 
partitioning of the solute into the apical membrane, which is followed by diffusion through 
the cytoplasm or if the solute is very lipophilic, the transport across the cell may also 
involve lateral diffusion in the lipid bilayer of the cell membrane. Finally, the solute exits 
through the basolateral membrane. The diffusion of small solutes in the cytoplasm is 
normally a rapid process, and thus the rate of passive transcellular permeability is mainly 
determined by the rate of transport across the cell membrane. 
4.5 .  Paracel lu lar  t ranspor t  
For lager and more hydrophilic compounds (charged molecules and peptides) 
transcellular diffusion if often restricted or depending on the pKa of the molecules absent 
at physiological pH values and their molecular size. Transport of these compounds 
across the epithelial cell layer can occur via water-filled pores between the cells, a 
process known as paracellular transport. The dimensions of the paracellular space itself 
lies between 10 and 30 – 50Å [Morishita]. The adjacent epithelial cells are connected to 
each other by the tight junctions, which establish a seal between adjacent cells restricting 
solute transport by this route of absorption [Salama, Shin]. The calculated human pore 
sizes (radii) are, jejunum 6–8 Å, ileum 2.9–3.8 Å and colon less than 2.3 Å [Smith]. For 
Caco-2 cell monolayers grown in the Transwell system the effective pore radius was 
calculated to be 12.0 +/- 1.9Å [Ho]. Furthermore the surface area presented by the pores 
constitutes only a small fraction (0.01% - 0.1%) of the total intestinal membrane surface 
area [Nellans, Pappenheimer]. It is therefore unlikely that this pathway contributes 
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significantly to the overall transport of most drugs in vivo, although small molecules (MW 
<200 Da) may be exceptions [Avdeef 2001, Karlsson, J.]. 
4 . 6 .  Drug t ranspor te rs:  carr ier -media ted in f lux  and ef f lux .  
The transcellular transport in the apical to the basolateral direction is in the simplest case 
only driven by passive diffusion caused by concentration gradients across the cell 
(membrane). 
For an increasing number of molecules non-diffusion contributions to the permeation are 
discovered, which are caused by proteins, embedded in the apical or the basal cell 
membrane. The physiological function of these proteins is to either extract nutrients, 
vitamins and other compounds essential for the organism from the luminal contents [Lee 
V.H., Tsuji] or to prevent uptake of toxic substrates or to facilitate the excretion of such 
substrates across the mucosa of the intestinal tract [Ambudkar], what would explain the 
broad and sometimes overlapping substrate specificity of the efflux proteins. Carrier-
mediated influx mechanisms enhance the transcellular permeability to a limited number 
of drugs, like the β-lactam antibiotics, ACE inhibitors and phosphate analogs, all of which 
are structurally similar to the native substrates of transport proteins [Lee, V.H., Tsuji]. The 
extent of this enhancement depends on the structural similarity between the drug and the 
natural substrate of the transporter, as well as on drug concentration and physiological 
factors. Examples for influx transporter, which may play a role in drug absorption and 
distribution, are the human di/tri-peptide transporter (hPepT1) located in the apical 
membrane of the enterocytes [Daniel] and Caco-2 cells [Adibi] members of the human 
organic anion transporting polypeptide (OATP) family (solute carrier family 21A, SLC21A) 
and the organic cation transporter family (SLC22A) [Sai]. 
Contrary to the carrier-mediated influx, the efflux proteins located in the apical cell 
membrane have the potential to limit the overall permeability by pumping the drug 
molecules in the basal to apical direction. The relevant efflux transporters for drugs in 
clinical use belong to the ATP-binding cassette (ABC) family. These transporters extrude 
their substrates in an ATP-dependent manner from the cells in which they are expressed 
[Borst, Schinkel]. Efflux transporters that are present in the apical membrane of 
enterocytes include P-glycoprotein (P-gp, ABCB1), the breast cancer resistance protein 
(BCRP, ABCG2), and the multidrug resistance associated protein 2 (MRP2, ABCC2) 
[Borst, Chan, L.M.S., Schinkel]. P-gp was one of the first ABC-transporters that were 
identified to be involved in the efflux of compounds and in multidrug resistance [Juliano]. 
P-gp has a very broad substrate specificity and transports a vast number of structurally 
diverse compounds such as anticancer drugs, HIV protease inhibitors and antibiotics 
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[Hunter, Schinkel]. P-gp is binds its substrates in the cytosolic leaflet of the lipid 
membrane and flips them to the extracellular leaflet or exports them to the extracellular 
environment [Loo, Meier]. MPR2 is also located in the apical membrane of enterocytes 
and transports anionic drugs and endogenous compounds, including their glutathione-, 
glucuronide- and sulfate conjugates [Suzuki]. As phase II enzymes are present in the 
human intestine, MRP2 may be responsible for the secretion of the conjugates formed in 
the intestine. 
4.7 .  Pre -sys temic  Metabol ism 
Both the intestine and the liver constitute appreciable metabolic barriers where an 
absorbed drug molecule may be metabolised before reaching the systemic circulation. 
Metabolism is divided into phase I metabolism, that is the modification of the parent drug 
by oxidation reactions, e.g. by Cytochrome (CYP) P450 enzymes, and phase II 
metabolism, that is the conjugation of the parent compound or its phase I metabolite with 
hydrophilic moieties as glucuronic acid, sulfate or glutathione. 
The liver is the main metabolising organ and enzymes of the CYP1 – 3 families account 
for about 70% of the total liver CYP content with the CYP3A isoform constituting about 
30% of this total [Shimada]. CYP3A is also the dominant subfamily in the small intestine 
where it constitutes about 70% of the total CYP protein, which represents 50% of the 
liver content [de Waziers, Kolars, McKinnon]. Several phase II enzymes are expressed in 
the intestine at levels that are comparable to those in the liver. The conjugates formed 
through phase II metabolism are often too hydrophilic to diffuse out of the cell and 
therefore require transporters to assist their exit out of the cell (e.g. MRP2). 
Caco-2 cells lack expression of appreciable quantities of CYP3A4 and other enzymes of 
the cytochrome family, responsible for oxidative metabolism [Crespi, Cummins, 
Hochman, Schmiedlin-Ren] but differentiated Caco-2 cells express phase II enzymes 
such as UDP-glucuronosyltransferases, sulfotransferases and glutathione-S-transferases 
[Galijatovic, Meunier]. Phase II metabolic activity in Caco-2 cells has been demonstrated 
in general for a diversity of compounds and especially for several different flavonoids 
[Chen, J., Galijatovic, Hu, Liu]. 
4.8 .  In  v i t ro  assessment  o f  drug permeabi l i t y:  mode ls  
In vivo studies of the intestinal membrane permeability of compounds in humans are 
costly and, if performed with relatively unknown or hazardous compounds, potentially 
harmful for the volunteers. Therefore, in vivo permeability can only be determined for a 
small number of well-characterised drugs. In the early stages of the drug development 
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process, many compounds have to be considered and these compounds are poorly 
characterised. Such studies can be performed in experimental animals instead of 
humans, but the cost and throughput still severely restrict the capacity of these 
experiments. 
Therefore, for the rapid assessment of the ADME properties of compounds many in vitro 
and in situ methods were developed with different levels of complexity and sophistication 
[Bohets, Hidalgo 2001]. Cell free, lipid based assays like PAMPA [Avdeef 2003, Kansy] 
allow higher throughput and easier miniaturization compared to cell models that allow 
mechanistic studies. To study the drug permeability at different sites in the human body, 
cell models for intestinal permeation (e.g. Caco-2 and 2/4/A1), for the blood – brain 
barrier (primary cell culture and immortalized cell lines), for hepatic drug metabolism and 
transport and for the renal drug transport are accessible [Deli, Ghibellini, Hidalgo 1989, 
Schlatter, Tavelin]. The different models can be wild – type (Caco-2, MDCK), transfected 
(h-MDR1-MDCKII), or downregulated cell lines [Hilgendorf]. 
The use of in vitro cell permeation experiments across cell monolayers to study the 
absorption of substances is widely accepted and popular [Artursson 2001, Balimane 
2005 & 2006]. Depending on the compounds used and the experimental setting, the 
purpose of these studies can be the general assessment of the permeability of a 
compound [Artursson 2001], the development of structure – permeability relationships 
[Chen, I.J.], the development of in vitro – in vivo correlations [Artursson 1991 B, Usansky, 
Yee], the identification of transporters (influx and efflux) involved in cellular permeation 
[Maeda], the study of transporter kinetics and development of comprehensive models of 
transporter function [Tran 2005], the study of the interplay between transporters and 
metabolism [Benet], the study of drug – drug interactions [Rautio] and the study of 
formulation effects [Kapitza, LeCluyse]. 
One of most frequently used cell lines for the determination of drug permeability across 
membranes is the human colon adenocarcinoma cell line Caco-2, grown on semi-
permeable filter supports [Artursson 1991 B, Hidalgo 1989]. Caco-2 cells spontaneously 
differentiate into enterocyte-like cells with the paracellular permeability comparable to 
that of human colon. In spite of its colonic origin, a number of active transport 
mechanisms normally found in the absorptive enterocytes of the small intestine are 
present in this cell line [Bailey]. Disadvantages of cell culture models is that the cells 
must be grown on filters for up to several weeks before they can be used for drug 
transport experiments. Caco-2, for example, normally requires, without optimising the 
culturing conditions, culture on filters for three weeks before it can be used for drug 
transport experiments. Furthermore depending on the exact protocol for the culturing 
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conditions, the results of permeability measurements for selected compounds may differ 
for different labs, passages, selected clones and culturing conditions [Anderle, Behrens 
2003 & 2004, Briske-Anderson, Hosoya, Yu]. An advantage of cell culture models 
compared to liposomal systems is that they measure the transport of the drug across a 
cell membrane, rather than an interaction of the drug with the lipid bilayer. Another 
advantage is that parallel transport routes, both passive and active, can be studied and 
much insight into the different steps of absorption has been gained by the use of the 
Caco-2 cell model [Artursson 1997]. 
4.9 .  In  v i t ro  assessment  of  drug permeabi l i ty:  da ta 
analys is  
Properties that influence the ease with which a drug can be absorbed (e.g. from an oral 
dosage form) include dissolution rate and solubility (determining how fast the drug 
reaches its maximum concentration Cmax within the solution), and the permeability 
coefficient P (determining the rate at which the drug will cross the biological barrier). 
Together, these factors comprise Fick's first law, describing the flux JWall of a drug across 
the respective biological barrier: 
maxCPJ WallWall •=  
(Equation 1) 
When examining drug permeability across in vitro models it is customary to use the 
shown approximate solution for the permeability coefficient Papp: 
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(Equation 2) 
where Papp is the apparent permeability coefficient, VR the volume of the receiver 
chamber, A is the area of the permeability barrier, CD0 the initial drug concentration in the 
donor chamber, and dCR/dt the change in concentration of compound in receiver 
compartment over time. 
This approach is afflicted with limitations: The equation uses the initial drug amount in the 
donor, linear drug transport with time that is applicable to early time points only and 
furthermore assumes negligible back flux and no mass balance problems such as due to 
stability and binding to cells (cellular retention) and / or the apparatus [Tran 2004, 
Youdim]. 
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Active apical efflux [e.g. P-glycoprotein] substrates are identified by comparison of apical 
to basal and basal to apical transport namely by calculation of the efflux ratio (ER), and 
by performing transport experiments with inhibition of the carrier-mediated component. 
Involvement of a carrier-mediated efflux mechanism is indicated if the ER is > 2.0. For 
compounds with an ER close to equality, active efflux is unlikely whereas for compounds 
with ER of 1.5 to 2.0, follow-up experiments with a potent, specific inhibitor of P-gp, e.g. 
GF120918, are required to demonstrate that the compound undergoes P-gp-mediated 
efflux. 
This approach has several inherent shortcomings and disadvantages: the ER is time 
dependent, some substrates with high passive permeability (e.g. Verapamil) may not be 
detected by this approach, no direct quantification of the passive permeability and the 
apical efflux is possible, and no direct quantification of the influence of inhibitors and/or 
concurrently applied compounds can be performed. The common practice to calculate 
passive permeability for the typical P-gp substrates is to simply subtract passive 
transport curves from the active transport curves. For semiquantitative work this might be 
adequate but it neglects the reversibility of transport, which is substantial over the longer 
time courses. For basal to apical transport, at any given timepoint, active transport 
results in higher concentrations of a drug in the apical compartment than with passive 
diffusion alone. Thus, the passive backdiffusion of drug from the apical compartment will 
be greater with active transport than with just passive diffusion alone. In the opposite 
transport direction, apical to basal, the subtraction is just as inaccurate because the 
passive backdiffusion is less with active transport than with just passive diffusion alone 
[Tran 2004]. Although improvements can be made [Youdim], the usage of the 
approximate equation still requires the establishment of the linear phase of permeability 
because the equation is just the initial slope of the transport curve. To identify substrates 
for active efflux transporters like P-glycoprotein by calculation of the ER the estimated 
Papp values have to within an optimal range. For substrates that have Papp values outside 
of this range, the identification as a substrate is prone to fail by using this approach 
[Polli]. Recently it was shown that the effects of P-glycoprotein mediated efflux on the 
absorptive and secretory transport may not be symmetrical, per given donor 
concentration [Troutman 2003 A]. 
During the past few years the awareness of the necessity of more detailed and precise 
analysis of data derived from in vitro permeation experiments arose. The approaches of 
different research groups were for instance focused on modelling and determination of 
(sub-) cellular pharmacokinetics and distribution [Duvvuri, Zhang] or on the consideration 
of the influence of the aqueous boundary layer on estimated transporter kinetics from 
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overexpresion systems [Balakrishan]. Other attempts to estimate a more accurate 
permeability coefficient [Tran 2004] rely on the usage of potent efflux inhibitors like 
GF120918. Even if the inhibition is almost complete, for compounds with very poor 
permeability it might be still almost impossible to estimate permeability coefficients. As 
the P-gp-mediated efflux activity observed during absorptive and secretory transport can 
be asymmetric for certain substrates, Troutman and Thakker studied the influence of the 
transport direction on the apical active efflux and introduced two new parameters, 
absorptive quotient (AQ) and the secretory quotient (SQ), to express the functional 
activity of P-gp during absorptive and secretory transport, respectively [Troutman 2003 A 
& B]. The permeability of a P-gp substrate is determined in absorptive and secretory 
directions in absence and in presence of the potent efflux inhibitor GF120918, and the 
contribution of P-gp in attenuating the permeability calculated. The relationship between 
attenuation of absorptive transport and enhancement of secretory transport of 
compounds by P-gp is asymmetric, and different for different sets of compounds. 
An alternative approach to the use of the apparent permeability coefficient and its 
improvements is the use of biophysical modelling of the transmembrane events involving 
passive diffusion and efflux mechanisms. The intent of such modelling is to delineate and 
quantify the mass transfer mechanisms that take place during permeation. This approach 
may furthermore provide means for the evaluation of the influence of type and 
concentration of the chosen compound as well as the influence of a second substance or 
of excipients on the permeation in terms of passive diffusion and active efflux, depending 
on the exact mode of modelling. These models can provide information about critical 
parameters and the behaviour of the system if the parameters are changed. In the study 
of efflux transporters the modelling and the measurement of the kinetic characteristics of 
transport can be a powerful approach to enhancing the understanding of their function 
and mechanism or probe different hypothesis about the exact mode of efflux [Litman 
2003, Tran 2005]. Other modelling approaches including both, passive diffusion and 
active efflux focused on the use of these procedures as tools for improving the prediction 
ability of in vitro models [Rodriguez-Ibáñez]. 
4.10 .  Non-speci f ic  b ind ing /  Adsorpt ion  
Molecules adsorb on virtually all surfaces, such as packaging materials for 
pharmaceutical products [Yahya]. The amount they adsorb is roughly proportional to the 
amount of the surface [Cussler]. The degree of adsorption depends on the chemical 
nature of the adsorbent (the material that is adsorbing) and the adsorbate (the substance 
4. Theoretical section 
David Blaser Page 28 of 194 University of Basel, 2007 
being adsorbed), the surface area of the adsorbent, the temperature and the 
concentration of the adsorbate [Martin]. 
Adsorption to the container surfaces can lead to an erroneous estimation of the 
permeability of compounds or other in vitro parameters [Karlsson, M.] as well as to poor 
recovery of the compound and a low mass balance [Ingels, Balimane 2005]. Under in 
vitro conditions the adsorption to solid surfaces and to cells depends on the composition 
of the experimental buffer or medium, the chemical identity of the compound itself, and 
the type of the solid surface [Grohganz, Palmgren]. Different attempts to minimize the 
impact of the adsorption in permeability studies in Transwells have been proposed, 
including pre-treatment of the device with albumin, postexperimental washing with 
organic solvents, calculation of the permeability from the disappearance from the donor 
compartment or the addition of serum albumin or different excipients to the receiver 
compartment [Chan, O.H., Krishna, Lee, Y.-G.]. All of these proposed options have 
drawbacks like being labour-intensive or tedious, interference with analytical methods, 
the possibility to affect the membrane fluidity or transporter function or the susceptibility 
to chemical and / or metabolic degradation and cellular accumulation. 
The types of adsorption are generally recognized as physical or van der Waals’ 
adsorption, and chemical adsorption or chemisorption. Physical adsorption, associated 
with van der Waals’ forces, is reversible, the removal of the adsorbate from the 
adsorbent being known as desorption. Chemisorption, in which the adsorbate is attached 
to the adsorbent by primary chemical bonds, is irreversible [Martin]. The adsorption of 
molecules to surfaces is usually described in isotherms, in which the amount adsorbed 
on a solid is plotted depending on the solution concentration at constant temperature. 
Three commonly cited isotherms are the linear, Langmuir, and Freundlich types 
[Cussler]. The simple linear isotherm of the type “concentration in the adsorbent = 
constant ● concentration in the solution” is frequently assumed even though it rarely 
occurs. The Freundlich isotherm is given by type “concentration in the adsorbent = 
constant1 ● (concentration in the solution)constant2” where both constants are empirically 
determined. This isotherm suggests that a plot of the concentration in the absorbent 
versus the concentration in solution should be linear on log-log coordinates. The 
theoretical base for this isotherm is vague. The Langmuir isotherm is more common than 
the linear isotherm and has a clear theoretical basis. This isotherm assumes that a 
limited number of sites on the adsorbent are subject to a mass balance and these sites 
are assumed to be subject to a chemical equilibrium. Langmuir developed an equation 
based on the theory that the molecules or atoms are adsorbed on active sites of the solid 
to form a layer one molecule thick (monolayer). The fraction of centers occupied by 
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molecules at concentration C is represented by θ, and the fraction of sites not occupied is 
1 – θ. 
4.11 .  Choice  o f  model  compounds  
The naturally occurring biflavonoid Amentoflavone (Figure 1) was chosen as model 
compound as it may be expected to have poor permeability due to its molecular weight of 
538.458g/mol and the number of hydrogen bond donors (6) and acceptors (10). It is 
transported by P-gp [Gutmann 2002] and preliminary studies of the Amentoflavone 
transport in Caco-2 cell monolayers in our group indicated phase II metabolism of 
Amentoflavone during the permeation experiments [unpublished]. Phase II metabolic 
activity in Caco-2 cells has been demonstrated in general as well as for several different 
flavonoids, including Apigenin, the monomer of Amentoflavone [Chen, J., Galijatovic, Hu, 
Liu]. The preliminary studies showed poor mass balances for Amentoflavone that could 
not be fully explained by the phase II metabolism. Based on these findings and the 
demonstrated property to strongly bind to plasma membranes [Lenne-Gouverneur] and 
due to sparingly solubility and strong lipophilicity (5.753 +/- 1.0, both calculated using 
Advanced Chemistry Development (ACD) Software Solaris V4.67) Amentoflavone was 
assumed to possess a tendency for cellular accumulation and adsorption/non-specific 
binding to plastic surfaces. 
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Figure 1: Chemical structure of Amentoflavone (C30H18O10). 
Verapamil (molecular weight 454.60g/mol, logP 4.7, calculated by PubChem), Quinidine 
(molecular weight 324.42g/mol, logP 2.6, calculated by PubChem) and Digoxin 
(molecular weight 780.94g/mol, logP 2.2, calculated by PubChem) are all known to be 
substrate of P-glycoprotein [Engman, Keogh, Litman 2001, Makhey, Meier, Neuhoff 
2003, Troutman 2003 A]. Verapamil and Quinidine are ionisable compounds, with pKa 
values of 8.97 +/- 0.50 (ACD Software Solaris V8.14) for Verapamil and 9.28 +/- 0.70 
(ACD Software Solaris V8.14) for Quinidine, whereas Digoxin can be considered as 
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neutral molecule in the relevant pH range for the transport studies. Literature findings 
indicate high permeability for Verapamil and Quinidine and rather moderate to poor 
passive permeability for Digoxin [Varma]. 
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5 .  An a l ys i s  o f  Am e n t o f l a vo n e  t r an s p or t  a n d  
p h a s e  I I  m eta b o l i s m  i n  Ca c o -2  c e l l  mo n o l a ye r s  
a n d  a d s or pt i o n  t o  t h e  Tr a n sw e l l  s ur fac e  w i th  a  
m at h em at i c a l  m o d e l  fo r  d e t e r mi n i n g  d u g 
a b s or p t i on  par am et er s  
5.1 .  Abst rac t  
Purpose 
The present study’s aim was the development of a mathematical model for delineating 
the passive and carrier mediated contributions to the absorption of Amentoflavone in 
Caco-2 cell monolayers with the integration of phase II metabolism and adsorption to the 
Transwell surface to the model. 
Material and methods 
The epithelial membrane transport kinetics and phase II metabolism of Amentoflavone (2 
– 10µM) were studied using Caco-2 monolayers cultured in Transwells. Adsorption of 
Amentoflavone was studied in Transwells without cells. The system of differential 
equations of the developed mathematical model was fitted to experimental concentration 
data, and optimal values of the kinetic parameters were deduced using the software 
EASY-FIT. 
Results 
Amentoflavone showed polarised transport behaviour, while no concentration-dependent 
effect was observed. The apical efflux was significantly reduced by the addition of the 
inhibitors GF120918 and Vinblastine. Along with Amentoflavone sulfate and glucuronide 
metabolites of Amentoflavone were identified by LC/MS. Apical efflux of the phase II 
metabolites was significantly favoured compared to basolateral efflux. The addition of 
Vinblastine resulted in almost complete inhibition of the apical efflux of Amentoflavone 
and a higher cellular accumulation of Amentoflavone. Furthermore the distribution of the 
metabolites equalized between the compartments whereas the total amount remained 
unaffected. 
Kinetic parameters of the transport could be calculated with the developed model which 
included passive and carrier mediated transport, metabolism and non-specific 
adsorption.Model estimated passive permeability coefficient of Amentoflavone was 
independent of concentration. Model estimated apical efflux parameters varied for 
different situations and expressed the mass efflux rate of Amentoflavone elicited by P-
glycoprotein in Caco-2 cells. The apical efflux parameter also reflected inhibition of the 
efflux by Vinblastine. Furthermore an overall phase II metabolic rate constant in the cell 
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was estimated. By integrating surface adsorption, cellular transport was corrected for this 
distorting effect. 
Conclusions 
Transport, phase II metabolism and adsorption of the poorly permeable substance 
Amentoflavone in Caco-2 cell monolayers could be well described by the proposed 
model of cellular transport. For each of these processes kinetic parameters could be 
derived from transport experiments. 
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5.2 .  In troduct ion  
In the course of the past 15 years the assessment of permeability across Caco-2 cell 
monolayers became one of the most popular tools for mechanistic studies of absorption 
of substances in human small intestine [Ingels, Balimane 2005]. This cell model has 
been extensively characterised and found to be useful in the field of drug permeability 
studies [Hidalgo 1989, Artursson 1991A & 2001]. The Caco-2 cells undergo spontaneous 
enterocytic differentiation in culture and are polarized with well-established tight 
junctions. Of the most important transport proteins with efflux activity, several (e.g. P-
glycoprotein and MRP-2 [Hosoya, Hidaldgo 1996, Hunter, Gutmann 1999, Balimanae 
2006]) are functionally expressed in confluent Caco-2 cell monolayers. The cells lack 
expression of appreciable quantities of CYP3A4 and other enzymes of the cytochrome 
family, responsible for oxidative metabolism [Crespi, Cummins, Hochman, Schmiedlin-
Ren] but differentiated Caco-2 cells express phase II enzymes such as UDP-
glucuronosyltransferases, sulfotransferases and glutathione-S-transferases [Meunier, 
Galijatovic]. 
The in vitro assessment of the permeability of a drug has to take into account different 
mechanisms influencing the absorption, all of which have to be known and/or controlled 
in order to estimate quantitative parameters that describe the different contributions to 
the overall permeation. A compound that permeates across Caco-2 cell monolayers, 
passively diffuses along a concentration gradient, may be subject to active efflux by 
different efflux transporters, phase II metabolism and non-specific cellular accumulation. 
Further confounding or limiting factors may be poor solubility, chemical instability or 
adsorption to container surfaces. Properties that influence the ease with which a drug 
can be absorbed (e.g. from an oral dosage form) include dissolution rate and solubility 
(determining how fast the drug reaches its maximum concentration Cmax within the 
solution), and the permeability coefficient P (determining the rate at which the drug will 
cross the biological barrier). Together, these factors comprise Fick's first law (Equation 
3), describing the flux Jwall of a drug across the respective biological barrier: 
maxCPJ WallWall •=  
(Equation 3) 
When examining drug permeability across in vitro models it is customary to use the 
shown approximate solution for the permeability coefficient Papp (Equation 4): 
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where Papp is the apparent permeability coefficient, VR the volume of the receiver 
chamber, A is the area of the permeability barrier, CD0 the initial drug concentration in the 
donor chamber, and dCR/dt the change in concentration of compound in receiver 
compartment over time. The equation uses the initial drug amount in the donor, linear 
drug transport with time that is applicable to early time points only and furthermore 
assumes negligible back flux and no mass balance problems such as due to stability and 
binding to cells (cellular retention) and/or the apparatus [Youdim, Tran 2004]. Active 
apical efflux (e.g. P-glycoprotein) substrates are identified by comparison of apical to 
basal and basal to apical transport namely by calculation of the efflux ratio (ER), and by 
performing transport experiments with inhibition of the carrier-mediated component. 
Involvement of a carrier-mediated efflux mechanism is indicated if the ER is > 2.0. For 
compounds with an ER close to equality, active efflux is unlikely whereas for compounds 
with ER of 1.5 to 2.0, follow-up experiments with a potent, specific inhibitor of P-gp, e.g. 
GF120918, are required to demonstrate that the compound undergoes P-gp-mediated 
efflux. 
This approach has several inherent shortcomings and disadvantages: the ER is time 
dependent, some substrates with high passive permeability (e.g. Verapamil) may not be 
detected by this approach, no direct quantification of the passive permeability and the 
apical efflux is possible, and no direct quantification of the influence of inhibitors and/or 
concurrently applied compounds can be performed. The common practice to calculate 
passive permeability for the typical P-gp substrates is to simply subtract passive 
transport curves from the active transport curves. For semiquantitative work this might be 
adequate but it neglects the reversibility of transport, which is substantial over the longer 
time courses. For basal to apical transport, at any given timepoint, active transport 
results in higher concentrations of a drug in the apical compartment than with passive 
diffusion alone. Thus, the passive backdiffusion of drug from the apical compartment will 
be greater with active transport than with just passive diffusion alone. In the opposite 
transport direction, apical to basal, the subtraction is just as inaccurate because the 
passive backdiffusion is less with active transport than with just passive diffusion alone 
[Tran 2004]. Although improvements can be made [Youdim], the usage of the 
approximate equation still requires the establishment of the linear phase of permeability 
because the equation is just the initial slope of the transport curve. Other attempts to 
estimate a more accurate permeability coefficient [Tran 2004] rely on the usage of potent 
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efflux inhibitors like GF120918. Even if the inhibition is almost complete, for compounds 
with very poor permeability it might be still almost impossible to estimate permeability 
coefficients. As the P-gp-mediated efflux activity observed during absorptive and 
secretory transport can be asymmetric for certain substrates, Troutman and Thakker 
introduced two new parameters, absorptive quotient (AQ) and the secretory quotient 
(SQ), to express the functional activity of P-gp during absorptive and secretory transport, 
respectively [Troutman 2003 A & B]. The permeability of a P-gp substrate is determined 
in absorptive and secretory directions in absence and in presence of the potent efflux 
inhibitor GF120918, and the contribution of P-gp in attenuating the permeability 
calculated. The relationship between attenuation of absorptive transport and 
enhancement of secretory transport of compounds by P-gp is asymmetric, and different 
for different sets of compounds. 
Molecules adsorb on virtually all surfaces, such as packaging materials for 
pharmaceutical products [Yahya]. The amount they adsorb is roughly proportional to the 
amount of the surface [Cussler]. The degree of adsorption depends on the chemical 
nature of the adsorbent (the material that is adsorbing) and the adsorbate (the substance 
being adsorbed), the surface area of the adsorbent, the temperature and the 
concentration of the adsorbate [Martin]. Adsorption to the container surfaces can lead to 
an erroneous estimation of the permeability of compounds or other in vitro parameters 
[Karlsson, M.] as well as to poor recovery of the compound and a low mass balance 
[Ingels, Balimane 2005]. Under in vitro conditions the adsorption to solid surfaces and to 
cells depends on the composition of the experimental buffer or medium, the chemical 
identity of the compound itself, and the type of the solid surface [Grohganz, Palmgren]. 
Different attempts to minimize the impact of the adsorption in permeability studies in 
Transwells have been proposed, including pre-treatment of the device with albumin, 
postexperimental washing with organic solvents, the calculation of the permeability from 
the disappearance from the donor compartment or the addition of serum albumin or 
different excipients to the receiver compartment [Chan, O.H., Krishna, Lee, Y.-J.]. All 
these have drawbacks like being labour-intensive or tedious, interference with analytical 
methods, the possibility to affect the membrane fluidity or transporter function or the 
susceptibility to chemical and/or metabolic degradation and cellular accumulation. 
By reason of the shortcomings of the traditional way to treat data of transport 
experiments and to able to directly estimate the transport parameters from concentration-
time profiles, we developed a mathematical model to describe the transport of drug 
between the apical, the basal, and the cellular compartment [Kapitza]. The developed 
model took into account passive permeation described by the permeability coefficient P 
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and carrier mediated efflux described by the kinetic parameter vk. In this publication we 
present extensions to the model with inclusion of phase II metabolism and adsorption to 
the Transwell surface. A modelling approach helps to identify the system critical 
parameters and to gain information on the system behaviour when the conditions are 
modified. To test our model we needed a model compound that is poorly permeable, 
undergoes active apical efflux and phase II metabolism, is subject to non-specific binding 
to surfaces (adsorption) and shows to a certain extent cellular accumulation. The 
naturally occurring biflavonoid Amentoflavone was chosen as model compound as it may 
be expected to have poor permeability due to its molecular weight of 538.458g/mol and 
the number of hydrogen bond donors (6) and acceptors (10). It is transported by P-gp 
[Gutmann 2002] and preliminary studies of the Amentoflavone transport in Caco-2 cell 
monolayers in our group indicated phase II metabolism of Amentoflavone during the 
permeation experiments [unpublished]. Phase II metabolic activity in Caco-2 cells has 
been demonstrated in general as well as for several different flavonoids, including 
Apigenin, the monomer of Amentoflavone [Chen, J., Galijatovic, Hu, Liu]. The preliminary 
studies showed poor mass balances for Amentoflavone that could not be fully explained 
by the phase II metabolism. Based on these findings and the demonstrated property to 
strongly bind to plasma membranes [Lenne-Gouverneur] and due to sparingly solubility 
and strong lipophilicity (5.753 +/- 1.0, both calculated using Advanced Chemistry 
Development (ACD) Software Solaris V4.67) we assumed a tendency for cellular 
accumulation and adsorption. 
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5.3 .  Mater ia ls  and methods  
5.3.1.  Materials 
The human colon adenocarcinoma cell line Caco-2 was a gift of Prof. H. P. Hauri, 
Biocenter, University of Basel, and originated from the American Type Culture Collection 
(ATCC, Rockville, MD, USA). Dulbecco’s modified Eagle’s medium (DMEM) (with l-
glutamine, 4500mg/l D-glucose, without sodium pyruvate), l-glutamine 200mM (100x), 
MEM non-essential amino acids solution (100x, without l-glutamine), foetal bovine serum 
FBS, Trypsin-EDTA (10x) liquid, and Dulbecco’s Phosphate Buffered Saline (without 
Ca2+ Mg2+) were all purchased from Gibco (Gaithersburg, MD, USA). For cell culture 
DMEM was supplemented with 10% (v/v) FBS, 2mM l-glutamine, and 1% MEM. 
Transport media used for the permeation studies and the cytotoxicity experiments were 
made with Dulbecco’s modified Eagle’s medium (DMEM) base (without glucose, l-
glutamine, phenol red, sodium pyruvate and sodium bicarbonate) (SIGMA-Aldrich, Fluka 
Chemie GmbH, Buchs, Switzerland). This was dissolved in bi-distilled and autoclaved 
water and supplemented with glucose (4.5g/l), HEPES (4.76g/l), NaCl (1.987g/l) and l-
glutamine (0.876g/l), the pH was adjusted to 7.40 and the final medium was subjected to 
sterile filtration. Glucose, Hepes, NaCl and l-glutamine were all obtained from SIGMA-
Aldrich, (Fluka Chemie GmbH, Buchs, Switzerland). Petri dishes (56.7cm2), 24-well 
plates and 96-well plates were from Nunc (Roskilde, Denmark) and the 6-well Transwell 
plates were from Costar, Corning (NY, USA). Amentoflavone (HPLC grade) was from 
Extrasynthèse (Genay, France). Vinblastine sulfate and Tween 80 (polyethylensorbitan 
monooleate) were obtained from SIGMA-Aldrich (Fluka Chemie GmbH, Buchs, 
Switzerland). GF120918 was obtained from Dr. F. Hyafil, Glaxo Wellcome, (Centre de 
Recherches France, les Ulis cedex, France). Nile blue A, sodium dodecyl sulfate (SDS) 
and the thiazolyl blue tetrazolium bromide for the MTT assay were purchased from Fluka 
(Fluka Chemie GmbH, Buchs, Switzerland). All other reagents were of analytical grade. 
5.3.2.  Cel l  cul ture 
Caco-2 cells were grown in petri dishes and maintained at 37°C in an atmosphere of 8% 
CO2 and in equilibrium with distilled water using culture medium. They were passaged by 
treatment with 0.25% trypsin and 2.65mM EDTA with a splitting ratio of 1:12. The 
medium was changed every alternate day until the petri dishes reached 90% confluence. 
Cells were used in the 7h experiments at passage number 60 – 65 and in 5h 
experiments at passage 82 – 92. 
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5.3.3.  MTT-assay 
Mitochondrial activity of the cell was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) assay. This assay is based on the reduction of 
MTT by hydrogenase activity in functionally intact mitochondria [Mosmann]. The 
hydrogenase catalyses the conversion of the yellow MTT reagent to blue formazan 
crystals. Caco-2 cells were seeded on 6-well Transwell plates at a density of 
114,000cells/cm2 and used for experiments 20 – 24 days post-seeding. Medium was 
changed every other day. The effect of concentration of Amentoflavone, Vinblastine and 
GF120918 was investigated using 3 wells per group. The treatment of the cells with 
respect to the preparation steps before incubation and the incubation time was the same 
as in the transport experiments with the compound and concentration in question. After 
removing the culture medium, cells of the 6-well Transwell plates were rinsed on the 
apical side with 3.5ml and on the basal side with 4ml D-PBS (with Ca2+ und Mg2+) and 
1600µl of the transport medium was added to the apical compartment and 2800µl to the 
basal compartment of each well. The plates were then incubated for 60min in the 
incubator (Sorvall Heraeus, Heracell, Kendro, Switzerland). Then the compounds were 
added to the transport medium and the cells incubated for either 5h or 7h in the incubator 
hood (TH 15, Edmund Bühler GmbH, Tübingen & Hechingen, Germany) at 37°C in a 
water vapour saturated atmosphere and shaken at 75rpm on a compact shaker (KS 15, 
Edmund Bühler GmbH, Tübingen & Hechingen, Germany). After removing the incubation 
solutions, the cells of the 6-well Transwell plates were rinsed on the apical side with 
3.5ml and on the basal side with 4ml D-PBS (with Ca2+ und Mg2+). The inserts were then 
transferred to petri dishes and 1500µl culture medium and 150µl MTT solution (5mg/ml in 
D-PBS (without Ca2+, Mg2+)) was added to the apical compartment of each well resulting 
in a final MTT concentration of 0.45mg/ml. The cells were then incubated for another 4h 
in the incubator. Subsequently the cells of the 6-well Transwell plates were lysed and 
developed formazan crystals were dissolved by adding 1500µl lysis buffer containing 
10% SDS in 0.01 M HCl [Tada] and incubation for 15 h in the incubator. The amount of 
formazan was quantified in quadruplicate by transferring 200µl to a 96-well plate and 
measuring the absorbance at 580nm (reference wavelength 650nm) using an ELISA 
plate reader (VERSAmax, Molecular Devices, Sunnyvale, CA, USA). 10µl of ethanol 
absolutum were added to avoid foam. Mitochondrial activity was expressed relative to a 
control group treated with transport media. 
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5.3.4.  Experimental  determinat ion of  the contact  height  and 
mathematical  description of  the contact  area of  the transport 
medium with Transwell  surfaces 
A mathematical description of the course of the contact area of the transport medium 
with the Transwell surface during the transport experiments was determined form 
experimentally measured contact heights. This description is later on used in the 
calculations of Amentoflavone adsorption to the surface and the calculations the amount 
bound to the surface depending on the concentration in the solution. 
Firstly the contact height of the donor and acceptor solutions was determined in the 
Transwell apparatus without cells by colouring the Transwell surface with a solution of 
Nile Blue A 0.002g/ml (0.2% (m/v)). The Transwell plates were kept for 60min at 37°C in 
a water vapour saturated atmosphere in the incubation hood and agitated on an orbital 
compact shaker at 75min−1. The Volumes used in the apical and basal compartment 
respectively were corresponding to the volumes after a certain number of sample 
drawings of 117µl. The volumes for the specified time periods were the following: 0 – 
0.5h: apical compartment 1600µl and basal compartment 2800µl; 0.5h – 2.5h: apical 
compartment 1483µl and basal compartment 2683µl; 2.5 – 5h: apical compartment 
1366µl and basal compartment 2566µl; 5 – 7h: apical compartment 1249µl and basal 
compartment 2449µl. The polycarbonate membrane of the Transwell plates was either 
free or sealed with adhesive tape on the basal side of the membrane, to mimic the 
situation with or without cells. The contact height was determined at the following three 
points in the Transwell system: the inner surface of the insert (apical compartment), the 
outer surface of the insert (basal compartment) and the surface of the cavity / well (basal 
compartment). 
The experimentally determined contact height was plotted against the apical and basal 
volumes and a linear relationship was calculated for each compartment by linear 
regression analysis with Microsoft Excel. For calculation of the contact areas all contact 
heights were recalculated for the given volumes and used in the calculations of the 
contact areas. The contact areas with the solution were calculated as subsequently 
described. The contact area in the apical compartment is equal to the contact height of 
the solution with the Transwell insert times the circumference of the polycarbonate filter. 
The circumference of the filter was calculated from a filter area of 470mm2 as specified 
by the Transwell producer. The circumference used in the calculations was 76.852mm. 
The calculation of the total contact area in the basal compartment was done by addition 
of the contact area with the basal side of the Transwell insert and the contact area with 
the rest of the basal compartment. The contact area with the basal side of the insert is 
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the outer circumference of the insert times the contact height. The outer circumference is 
calculated from the experimentally measured outer diameter of the insert. The outer 
circumference used in the calculations was 86.08mm. The contact area with the rest of 
the basal compartment was calculated from the addition of the basal base area with the 
contact area from the contact height of solution. The base area was calculated from the 
experimentally measured area radius of 17.45mm, resulting in a base area of 
956.623mm2 and a base area circumference of 109.642mm that was multiplied with the 
contact height. 
The reduction of the contact area was modelled as a continuous reduction over time and 
not as it is in reality as a stepwise reduction at discrete times. Timepoints for certain 
areas were exactly one hour after the nominal time for sample drawing in the „free case” 
(without adhesive tape), and exactly between the time for two sample drawings for the 
„sealed case“ (with adhesive tape). The first point reflecting the area for the initial 
volumes was set after 15min. The reduction of the contact area in the apical and the 
basal compartment due to sampling as a function of time, was accounted for by 
polynomial relations (Equation 5), the parameters of which were determined empirically 
using regression analysis with EASY-FIT using the model type “explicit”, the numerical 
method “DFNLP”, a scaling of 1 and an termination tolerance of 0. The point of origin and 
the endpoint were free. 
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(Equation 5) 
5.3.5.  Permeation of Amentof lavone across Transwell  
polycarbonate membrane without Caco-2 cel l  monolayers at 4 and 
37°C 
To study the impact of adsorption on the transport behaviour of Amentoflavone, 
permeation experiments in Transwell plates without cells were performed both at 37°C 
and at 4°C. Before the experiments the Transwell pl ates without cells were incubated for 
19 – 22 days with culture medium in the incubator. The medium was not changed. The 
Transwell plates were washed on the apical side with 3.5ml and on the basal side with 
4ml D-PBS (with Ca2+ und Mg2+) 37°C and 1600 µl of the transport medium were added to 
the apical compartment and 2800µl were added to the basal compartment. The drug was 
then added in both the apical and the basal compartment. The transport direction was 
therefore apical and basal (a&b). Different concentrations of Amentoflavone (2, 5, 7.5 & 
10µM) were used in these permeation studies. Three wells were used for each 
concentration. The permeation experiments were performed over 7h and sampling and 
time points were the same as in experiments with cells. After the permeation experiment 
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the Transwell plates were once washed on the apical side with 3.5ml and on the basal 
side with 4ml D-PBS (without Ca2+ und Mg2+) 4°C and then subject to methanol 
extraction. 
5.3.6.  Extraction of  the Transwel l  plates with methanol  
The Transwell plates were extracted with methanol after the transport experiment and 
the removal of the cell monolayer to estimate the amount of substance bound to the 
surface and the filter material. In cell free experiments with Amentoflavone in Transwell 
plates the extraction was also performed. 1600µl Methanol 37°C were added to the 
apical side and 2800µl to the basal side. The plate was sealed with parafilm to avoid 
undesired evaporation. The Transwell plates were extracted for 45min at 37°C in a water 
vapour saturated atmosphere in the incubation hood and agitated on an orbital compact 
shaker at 75min−1. Subsequently 500µl were taken per compartment and in each case 
combined with 500µl water 37°C and mixed in a microtube. 234µl of this water-methanol 
extract mixture were combined with 26µl of a solution of Tween 80 0.1% (v/v), mixed and 
then analysed by HPLC. 
5.3.7.  TEER 
The transepithelial electrical resistance (TEER) of cultured cells on Transwell inserts was 
monitored before and after each permeation experiment with an EVOM epithelial 
voltohmmeter (World Precision Instruments WPI, Berlin, Germany). Before the 
experiment, Caco-2 monolayers were washed on the apical side with 3.5ml and on the 
basal side with 4ml D-PBS (containing Ca2+ und Mg2+) and 1600µl of the transport 
medium were added to the apical compartment and 2800µl to the basal compartment. 
The 6-well Transwell plates were then incubated for at least 60min in the incubator 
(Sorvall Heraeus, Heracell, Kendro, Switzerland) before the pre-experiment TEER 
measurement. Before the post-experiment TEER measurement the withdrawn sampling 
volume was replaced with transport medium. The TEER measurements were performed 
at 37°C in the Endohm-24 Chamber (World Precision I nstruments WPI, Berlin, Germany) 
containing 4.6ml transport medium. Physiologically and morphologically well-developed 
confluent Caco-2 monolayers (at least 18 days old) with TEER values above 250Ωcm2 
were used in the experiments. 
5.3.8.  Permeation of  Amentof lavone across Caco-2 cel l 
monolayers at  4 and 37°C in presence or  absence of  inhibitors of 
act ive apical  ef f lux 
Cells were seeded at a density of 114,000 cells/cm2 onto 6-well Transwell plates with an 
insert area of 4.7cm2 and a pore size of the polycarbonate membrane of 0.4µm. Culture 
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medium was changed every other day and cell monolayers were used between 18 and 
22 days post seeding for the 7h experiments and 20 – 24 days postseeding for the 5h 
experiments. 
The drug was added from a stock solution after the TEER measurement either in the 
apical or in the basal compartment with respect to the cell monolayer. The transport 
directions were therefore apical to basal (a_b) and basal to apical (b_a). Bidirectional 
transport of different concentrations of Amentoflavone alone (37°C: 2 (only b_a), 5, 7.5 & 
10µM; 4°C: 5 & 10 µM; with 5µM also an experiment with addition of Amentoflavone in 
the apical and basal compartment at same time (a&b) was performed) was investigated 
in these permeation studies. In some experiments, the efflux inhibitor Vinblastine was 
added at a concentration of 70µM to the solution in both compartments to investigate the 
effect on the overall transport and metabolism of Amentoflavone in Caco-2 cell 
monolayers. After a pre-incubation period of 30min at 37°C and 75rpm with Vinblastine, 
Amentoflavone was added at a concentration of 5µM to either the apical or basal 
compartment and the permeation was studied for 7h at 37°C. GF120918 (0.1 and 1 µM) 
and Vinblastine (3.9, 25 and 70µM) were added in both compartments at the same time 
as Amentoflavone in the basal compartment to study their impact on the b_a transport of 
Amentoflavone over 5h. Three wells were used in each group at least (concentration, 
transport direction, inhibitors and temperature). The receiver compartment contained 
transport medium with the same ethanol concentration as the drug solution (0.5% (v/v)). 
Permeation of drug across the cell monolayer was monitored by sampling the solutions in 
both compartments, at predefined time points for the duration of 7h in the case of all 
experiments with Amentoflavone alone or in experiments with Vinblastine 70µM and the 
duration of 5h for Amentoflavone 5µM in basal to apical direction alone or incubated 
together with either GF120918 0.1 or 1µM or together with Vinblastine 3.9, 25 or 70µM. 
Samples were drawn after 30, 150, 300 and 420min during the 7h experiments and after 
30, 150 and 300min during the 5h experiments. Sampling volume was 117µl for the 7h 
experiments and 200µl for the 5h experiments. In the first case 13µl of a solution of 
Tween 80 0.1% (v/v) were added to the sample. The samples were mixed with a reagent 
mixer. The withdrawn volume was not replaced. The samples were collected in 
polypropylene vials (Milian AG, Geneva, Switzerland and Agilent Technologies, USA / 
Basel, Switzerland) except for the samples of the 5h experiments that where collected in 
glass vials (Infochroma AG, Zug, Switzerland and Schmidlin Labor & Service AG, 
Sarbach, Switzerland). The starting volume of the apical solution was 1600µl and the one 
of the basal solution 2800µl. During the permeation experiment the Transwell plates were 
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kept at 4 or 37°C in a water vapour saturated atmos phere in the incubation hood and 
agitated on an orbital compact shaker at 75min−1. After the permeation experiments 
performed at 37°C the TEER values of the cell monol ayers were measured again. No 
TEER measurement was performed after the transport experiments performed at 4°C. 
After the 7h experiments the cell monolayers were furthermore subject to cell lysis and 
the Transwell plates were subject to methanol extraction. 
5.3.9.  Detect ion of  Amentof lavone phase I I  metabol ism in Caco-2 
cel l  monolayers using HPLC-MS 
Caco-2 cells of passage 60 were grown for 19 days on a petri dish. After removing the 
culture medium, cells were rinsed once with 15ml D-PBS (without Ca2+ und Mg2+) and 
25ml of the transport medium with 10µM Amentoflavone (containing 1% ethanol (v/v)) 
were added. The petri dish was kept at 37°C in a wa ter vapour saturated atmosphere in 
the incubation hood and agitated for 7h on an orbital compact shaker at 50min−1. As a 
control transport medium 10µM Amentoflavone (containing 1% ethanol (v/v)) was 
incubated in centrifuge tubes 50ml (Falcon Blue Max, in house) and proceeded the same 
way. The monolayer was checked with the inverted phase contrast microscope (Labovert 
090-122.012, Fa. Ernst Leitz Wetzlar GmbH (Leica Mikroskopie Systeme AG, Glattbrugg, 
Switzerland)) for morphological alterations. Samples were drawn after 30, 150, 300 and 
420min. The sampling volume was 117µl. 13µl of a solution of Tween 80 0.1% (v/v) were 
added to the sample and mixed with a reagent mixer. The withdrawn volume was not 
replaced. The samples were collected in polypropylene vials (Milian AG, Geneva, 
Switzerland and Agilent Technologies, USA / Basel, Switzerland). Concentration of 
Amentoflavone and the formation of new peaks were analysed by HPLC-MS. The 
spectral properties of the phase II metabolites were assumed to be the same as the ones 
of Amentoflavone itself. 
5.3.10.  Cel l  lysis 
Subsequently to the TEER measurement after the 7h transport experiments the Caco-2 
monolayers were washed on the apical side with 3.5ml and on the basal side with 4ml D-
PBS (without Ca2+ und Mg2+) 4°C. The inserts were transferred to petri dishes  and 0.3ml 
trypsin 37°C were added to each insert. The petri d ishes were incubated for 15min in the 
incubator, 1ml culture medium was added and the cells were scraped of with a cell 
scraper and collected into centrifuge tubes 15ml (Falcon Blue Max, in house). The 
suspension was spun 5min at 1000rpm (SIGMA 302-K, SIGMA Laborzentrifugen GmbH, 
Osterode am Harz, Germany) and the supernatant was discarded. The pellet was 
resuspended in 750µl water 37°C and transferred to a microtube. 
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At this stage positive controls of Amentoflavone were added to blank cell pellets to 
correct the recovery in the samples from transport experiments. The suspension was 
vortexed and frozen in the refrigerator at -80°C fo r at least 15min. The samples were 
thawed in the thermomixer (model 5436, Eppendorf / Dr. Vaudaux AG, Schönenbuch, 
Switzerland) at 37°C and supplemented with 750 µl MeOH 37°C, vortexed for 10s and put 
into an ice-water mixture for 20min. The microtubes were shaken in the thermomixer for 
10min at 37°C and 1400min -1, followed by a centrifugation in the Eppendorf centrifuge 
(5415C, Eppendorf / Dr. Vaudaux AG, Schönenbuch, Switzerland) at 14000rpm. The 
water-methanol supernatant was transferred to a microtube and stored in the refrigerator 
at 4°C. 750 µl Methanol 37°C was added to the pellet. The mixtur e was subject to 6 
pulses with the ultrasonic disintegrator (Branson Sonifier 250, Model 101-063-197, output 
control: 2 / duty cycle: 30%, SKAN AG, Basel, Switzerland) followed by 5min in the 
thermomixer at 37°C and 1400min -1 and a centrifugation in the Eppendorf centrifuge at 
14000rpm. The supernatant was transferred to a microtube and subject to evaporation by 
nitrogen. The pellet was treated again as described. As the methanol was evaporated the 
water-methanol extract was added to the residue. The microtubes were shaken for 3min 
in the thermomixer at 37°C and 1400min -1 and centrifuged in the Eppendorf centrifuge at 
14000rpm for 25min. 234µl of this water-methanol extract mixture were combined with 
26µl of a solution of Tween 80 0.1% (v/v), mixed and then analysed by HPLC-MS. 
5.3.11.  HPLC 
Drug concentration in the samples of the 7h experiments was determined by HPLC-UV-
MS (Agilent series 1100, Agilent Technologies, USA) with an isocratic pump G1310A, an 
autosampler G1313A, a variable wavelength detector G1314A, and a mass spectrometer 
detector G1946C. The MS detector employed atmospheric pressure electrospray 
ionisation and was operated in the SIM mode at negative polarity with capillary voltage 
4000V, variable fragmentor (m/z 537 120V, m/z 610 100V and m/z 720 100V), drying gas 
flow 10l/min, drying gas temperature 350°C and nebu lizer pressure 20psig. A C-8 
reversed phase column (CC 125/2 Nucleosil 100 – 5 C8ec, 5µm, Macherey-Nagel, 
Oensingen, Switzerland) and the following mobile phase was used: H2O (bi-distilled and 
filtered through 0.45µm)/MeOH/THF/acetic acid 96%(v/v) = 51.5/23 /12/13.5. 1.993g/l 
ammonium acetate was dissolved in the mobile phase. The pH-value at 25°C was 3.0 – 
3.3. The flow rate was 0.20ml/min and the injection volume 100µl. Amentoflavone was 
detected at 341nm in UV and at m/z 537 in MS, Amentoflavone glucuronidate and sulfate 
were detected at 341nm in UV and at m/z 713 and 617, respectively in MS. All ions 
correspond to the de-protonated form. Quantification was performed using the AUC 
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measured in the UV against a set of external standard solutions within the linear 
response concentration range. MS was only for identification of the peaks. 
Drug concentration in the samples of the 5h experiments was determined by HPLC-UV 
(Agilent series 1050, Agilent Technologies, USA) with an isocratic pump 79852AX, an 
autosampler 79855A and a variable wavelength detector 79853A. A C-18 reversed 
phase column (Spherisorb ODS2, 5µm, RP18, 4mm x 250mm, HP) and the following 
mobile phase was used: H2O (bi-distilled and filtered through 0.45µm)/MeOH/THF/glacial 
acetic acid = 38/45 /15/2. The flow rate was 0.8ml/min and the injection volume 50µl. 
Amentoflavone was detected at 341nm in UV. Quantification was performed against a 
set of external standard solutions within the linear response concentration range. 
5.3.12.  Calculation of  normalised f luxes <J> 
Normalised fluxes <J> into the receiver compartment were calculated for Amentoflavone 
in the apical to basal as well as in the basal to apical transport direction according to 
(Equation 6): 
0** DCSt
AJ
∆
∆
>=<  
(Equation 6) 
where ∆A is the total amount of Amentoflavone transported [nmol] (in solution and 
withdrawn) to the receiver compartment after 7h, ∆t is the change in time [s], S is the 
area of the monolayer [cm2], and CD0 is the initial concentration in the donor compartment 
at time 0. The calculation of the normalised flux <J> was preferred to the calculation of 
Papp as especially in the apical to basal transport direction only very small amounts (close 
to the limit of detection) permeated and no reliable slope (Papp) could be determined. 
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5.4 .  Theore t ica l  model l ing  
5.4.1.  Modell ing of adsorpt ion to Transwell  surfaces in 
Transwel ls without cel ls 
The types of adsorption are generally recognized as physical or van der Waals’ 
adsorption, and chemical adsorption or chemisorption. Physical adsorption, associated 
with van der Waals’ forces, is reversible, the removal of the adsorbate from the 
adsorbent being known as desorption [Martin]. The adsorption of molecules to surfaces 
is usually described in isotherms, in which the amount adsorbed on a solid is plotted 
depending on the solution concentration at constant temperature. Three commonly cited 
isotherms are the linear, Langmuir, and Freundlich types [Cussler]. The Langmuir 
isotherm assumes that a limited number of sites on the adsorbent are subject to a mass 
balance and these sites are assumed to be subject to a chemical equilibrium. Langmuir 
developed an equation based on the theory that the molecules or atoms are adsorbed on 
active sites of the solid to form a layer one molecule thick (monolayer). To describe the 
adsorption of Amentoflavone from the transport medium used in transport experiments to 
the Transwell surface, a model was developed based the assumption of a reversible 
adsorption and on Langmuir isotherms in an equilibrium situation. Assuming that the 
substance of interest binds only to the surface (forming a monolayer) and does not 
penetrate into the solid, the adsorption of a substance to a solid surface can be 
described the following way 
[ ] [ ] [ ]Wk CWC on→+  
(Equation 7) 
and 
[ ] [ ] [ ]Wk CWC off←+  
(Equation 8) 
where C is the molar concentration in the solution [mol/l], W is the molar number of free 
sites per area [nmol/cm2], CW is the molar number of occupied sites per area [nmol/cm2], 
kon is the rate constant for the adsorption to the surface and koff is the rate constant for 
the desorption of the surface. Furthermore the adsorption was modelled assuming a 
saturable process 
[ ] [ ] totW WCW =+  
(Equation 9) 
where Wtot is the total number of binding sites on the surface [nmol/cm2]. It is important to 
be aware, that kon, kon and Wtot are assumed to be concentration-independent. For 
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modelling purposes the equilibrium of the adsorption was defined in a time dependent 
manner as described in the following equations (Equation 10) - (Equation 12): 
[ ] [ ] [ ]WCk
dt
Cd
on ••−=  
(Equation 10) 
[ ] [ ]WoffW Ckdt
Cd
•−=  
(Equation 11) 
[ ] [ ] S
dt
CdV
dt
Cd W
•=•  
(Equation 12) 
where the volume V [ml] and the contact area S [cm2] are time dependent. In this time 
dependent definition of the equilibrium, the reverse reaction (koff) was defined by the 
decrease of CW and not as usually done in textbooks by the increase of C. The units of 
the rate constants according to this definition are for kon [cm2/(nmol•min)] and koff [1/min]. 
The volume and therefore the contact area with the Transwell surface change over time 
as a result of the sampling. The reduction of volume and the contact area are modelled 
as described in chapter 5.4.5.In order to determine the rate constants governing the 
adsorption to the Transwell surface at 4 and 37°C t he experiments in Transwell plates 
without cells were conducted. These transport data were analysed by the subsequently 
developed system of differential equations. The aim was to describe the change of molar 
amount depending on the time. All modelling was done under the assumption of mass 
preservation. The general description of the change of concentration in the apical 
compartment is 
A
AA
dVdt
dM
dt
dC 1
•=  
(Equation 13) 
and general description for the change of concentration of substance bound to the 
surface is 
A
WAWA
dSdt
dM
dt
dC 1
•=  
(Equation 14) 
The change in the molar amount in solution in the apical compartment was modelled as 
subsequently described. The change of the molar amount in solution in the apical 
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compartment due to adsorption from the solution to the Transwell surface over time can 
be defined by 
dt
dMVWCk AAAAon =•••−  
(Equation 15) 
The subscript “A” denotes the apical compartment, V the volume of solution [ml], P the 
permeability coefficient over the polycarbonate filter [cm/min] and SM the area of the filter 
support [cm2]. The amount desorbing from the Transwell surface into the solution is 
expressed by 
dt
dMSCk AAWAoff =••  
(Equation 16) 
in terms of the change in the molar amount in solution over time. The molar amount that 
gets lost from solution due to sampling is expressed by 
A
A C
dt
dV
•+  
(Equation 17) 
the term being with a plus sign as the change in volume itself is negative and will set the 
whole expression to negative. The change of the molar amount in solution that is caused 
by diffusion through the Transwell membrane is expressed by 
MBA SCCP •−•+ )(  
(Equation 18) 
and is generally set to plus as it is not known in which compartment the concentration is 
bigger. The whole term will be positive is there is diffusion from the apical to the basal 
compartment and negative if there is diffusion from the basal to apical compartment. As a 
result of the adsorption to the surface there may emerge concentration differences 
between the two compartments, resulting in diffusion across the Transwell membrane. 
On the other hand, if the membrane is not sealed, sampling may cause convection, 
resulting in a substance transport by the fluid flow. As there is no knowledge on the 
direction of the convection, it is neglected in the modelling. By neglecting the convection 
the estimated values for the passive permeability coefficient through the Transwell 
membrane will not reflect the true permeability across the polycarbonate membrane. In 
any case the fluid flow caused by the convection will be smaller than the volumes of the 
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sampling. Taken these different simultaneous mechanisms together, the change of the 
molar amount in solution in the apical compartment, can be described by 
MBAA
A
AWAoffAAAon
A SCCPC
dt
dVSCkVWCk
dt
dM
•−•+•+••+•••−= )(  
(Equation 19) 
The change of the molar amount adsorbed to the surface in the apical compartment, can 
be described by 
WA
A
AWAoffAAAon
WA C
dt
dSSCkVWCk
dt
dM
•+••−•••=  
(Equation 20) 
with adsorption to and desorption of the surface and 
WA
A C
dt
dS
•+  
(Equation 21) 
being the molar amount that gets lost from the surface by drying up due to sampling. The 
term is with a plus sign as the change in contact area itself is negative and will set the 
whole expression to negative. Equal equations can be defined for the basal compartment 
and the basal surface. kon and koff for the adsorption in the basal compartment are the 
same as in the apical compartment. To get an equation that describes the change of the 
molar concentration of drug in the apical solution, (Equation 13) was differentiated and 
the chain rule applied 
A
A
A
AAAA V
dt
dCC
dt
dV
dt
VdC
dt
dM
•+•=
•
=  
(Equation 22) 
The two equations (Equation 22)and (Equation 19) are set equal 
MBAA
A
AWAoffAAAonA
A
A
A SCCPC
dt
dVSCkVWCkV
dt
dCC
dt
dV
•−•+•+••+•••−=•+• )(
 
(Equation 23) 
and converted 
MBAAWAoffAAAonA
A SCCPSCkVWCkV
dt
dC
•−•+••+•••−=• )(  
(Equation 24) 
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A
M
BA
A
A
WAoffAAon
A
V
SCCP
V
SCkWCk
dt
dC
•−•+••+••−= )(  
(Equation 25) 
and as 
[ ] [ ]WAAtot CWW +=  
(Equation 26) 
is inserted, we get 
A
M
BA
A
A
WAoffWAtotAon
A
V
SCCP
V
SCkCWCk
dt
dC
•−•+••+−••−= )()(  
(Equation 27) 
The equation includes the substance in solution and the substance bound to the surface, 
resulting in the total amount of substance (mass balance). The number of free binding 
sites on the surface was eliminated from the equation, as the information we get with this 
number is not important for the transport characterisation. (Equation 14), describing the 
change of the molar concentration of drug bound to the apical surface was also 
differentiated and the chain rule applied 
A
WA
WA
AAWAWA S
dt
dCC
dt
dS
dt
SdC
dt
dM
•+•=
•
=  
(Equation 28) 
The two equations (Equation 28) and (Equation 20) are set equal 
WA
A
AWAoffAAAonA
WA
WA
A C
dt
dSSCkVWCkS
dt
dCC
dt
dS
•+••−•••=•+•  
(Equation 29) 
and converted 
AWAoffAAAonA
WA SCkVWCkS
dt
dC
••−•••=•  
(Equation 30) 
WAoff
A
A
AAon
WA Ck
S
VWCk
dt
dC
•−•••=  
(Equation 31) 
and as 
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[ ] [ ]WAAtot CWW +=  
(Equation 32) 
is inserted, we get 
WAoff
A
A
WAtotAon
WA Ck
S
VCWCk
dt
dC
•−•−••= )(  
(Equation 33) 
The same modelling with subsequent differentiation and conversion were performed for 
the equations for concentration in the basal solution depending on time and the 
concentration of the adsorbed substance to the basal surface depending on time, 
resulting in the following system of differential equations for the description of the overall 
transport and adsorption in Transwell plates without cells under the assumption of mass 
preservation. 
Concentration in the solution (Transwell without cells): 
A
M
BA
A
A
WAoffWAtotAon
A
V
SCCP
V
SCkCWCk
dt
dC
•−•+••+−••−= )()(  
(Equation 34): apical compartment solution 
( ) ( )
B
m
BA
B
B
WBoffWBtotBon
B
V
SCCP
V
SCkCWCk
dt
dC
•−•−••+−••−=  
(Equation 35): basal compartment solution 
Adsorption to the Transwell surface (Transwell without cells): 
WAoff
A
A
WAtotAon
WA Ck
S
VCWCk
dt
dC
•−•−••= )(
 
(Equation 36): apical compartment surface 
( ) WBoff
B
B
WBtotBon
WB Ck
S
VCWCk
dt
dC
•−•−••=  
(Equation 37): basal compartment surface 
The time dependent variables of this system of differential equations are CA and CB that 
are measured during the experiment and CWA and CWB. The constants in the equations 
are kon, koff, Wtot and P. These equations were used in Easy-Fit® in the fittings of the 
permeation data of Amentoflavone in Transwell plates without cells. Permeation data 
were analysed using this theoretical model for transport and adsorption in Transwell 
plates without cells. 
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5.4.2.  Mathematical  model  for  determining drug absorpt ion 
parameters in Caco-2 cel l  monolayers 
In an earlier publication our group already presented a mathematical model to describe 
the transport of drug between the apical, the basal, and the cellular compartment 
[Kapitza]. This model enables a direct estimation of the relevant transport parameters 
from concentration-time profiles. The developed model took into account passive 
permeation described by the permeability coefficient P and carrier mediated efflux 
described by the kinetic parameters vmax and K. The transport processes considered for 
modelling drug permeation in the Caco-2 cell monolayer and the relevant processes in 
the basic model are displayed in (Figure 2). Extensions to the model with inclusion of 
phase II metabolism and adsorption and the detailed derivation of the model equations 
are treated in this chapter. 
 
Figure 2: Transport processes considered for modelling drug permeation in the Caco-2 
monolayer and relevant processes 
This model was based on the following assumptions: 
1) Three different compartments are considered in which drug concentration varies with 
time, the apical, the cellular and the basal compartment. 
2) Drug may move between the apical and the cellular and the cellular and the basal 
compartment in both directions by passive diffusion. Passive diffusion through the apical 
and the basal cell membrane is symmetrical and is characterized in both cases by the 
permeability coefficient, P. No effect of electrical membrane potential on the transport is 
considered. 
3) Drug is subject to carrier mediated active efflux from the cellular to the apical 
compartment. This follows saturable kinetics that may be characterized by two 
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macroscopic kinetic parameters, vmax, the maximum transport rate and K, the mass in the 
cellular compartment for which one-half of the maximum rate is attained, often referred to 
as affinity or dissociation constant. One global set of parameters is used to describe 
carrier-mediated efflux. 
4) No two different orientations or conformations of the carrier at the two faces of the 
membrane are explicitly involved. The drug concentration in the apical compartment 
does not influence efflux transport and the entire mass of drug present in the cellular 
compartment is substrate of the transporter. 
5) The total mass of drug in the three compartments is preserved. 
5.4.3.  Modell ing of  compound permeat ion across Caco-2 cel l  
monolayers in Transwells 
In order to determine the kinetic constants governing the permeation across Caco-2 cell 
monolayers grown in Transwells the following mathematical model was developed based 
on the above mentioned assumptions. The equations describing the kinetics of cellular 
transport were defined as changes of molar amounts over time. The advantage of this 
procedure is that the different and changing volumes (cellular volume, donor and 
acceptor volume) of the three compartments don’t cause problems, as they are 
accounted for by separate equations. The situation is different from the treatment of data 
of enzyme kinetics where e.g. a substrate concentration of 1M results in a product 
concentration of 1M provided that a 1:1 conversion takes place. 
The change of concentration in the apical compartment, can be generally described by 
A
AA
Vdt
dM
dt
dC 1
•=  
(Equation 38) 
The change of the molar amount in solution in the apical compartment for the apical to 
basal transport direction was modelled as subsequently described. The change of the 
molar amount in solution in the apical compartment caused by concentration gradient 
driven diffusion across the apical cell membrane into the cellular compartment is defined 
by 
( ) ( ) SmCCP
dt
dMCCP
Smdt
dMJ CabAabAabCabAabAab •−•−=→−•−=
•
=  
(Equation 39) 
The subscript “A” denotes the apical compartment and the subscript “C” the cellular 
compartment, V the volume of solution [ml], the indices ab (lower case) denote 
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permeation in the apical to basal direction, P the permeability coefficient across the cell 
membrane [cm/min] and SM the area of the cell monolayer [cm2]. The term is set to 
minus. If the concentration in the apical compartment is bigger than in the cellular 
compartment the whole term will be negative reflecting the loss of substance in the apical 
compartment due to diffusion from the apical to the cellular compartment. 
The molar amount that being effluxed from the cellular compartment into the apical 
compartment by a carrier-mediated mechanism is described by the Michaelis-Menten 
equation 
Cab
Cab
MK
Mv
+
•
+ max
 
(Equation 40) 
The molar amount that gets lost from solution due to sampling is expressed by 
Aab
A C
dt
dV
•+  
(Equation 41) 
the term being with a plus sign as the change in volume itself is negative and will set the 
whole expression to negative. 
Taken these three different mechanisms affecting the amount of substance in the apical 
compartment together, we get an equation describing the course of the molar amount of 
substance in the apical compartment over time 
( ) AabA
Cab
Cab
CabAab
Aab C
dt
dV
MK
MvSmCCP
dt
dM
•+
+
•
+•−•−= max
 
(Equation 42) 
The change of the molar amount in solution in the basal compartment for the apical to 
basal transport direction can be described a similar manner by 
( ) AabBBabCabBab Cdt
dVSmCCP
dt
dM
•+•−•=  
(Equation 43) 
For modelling the amount of substance in the basal compartment only the change of the 
molar amount in solution caused by diffusion across the basal cell membrane and the 
molar amount that gets lost from solution due to sampling have to be taken into account. 
The processes causing a change of the molar amount in the cellular compartment for the 
apical to basal transport direction are diffusion across the apical and the basal cell 
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membrane and carrier-mediated transport across the apical membrane. The situation in 
the cellular compartment can therefore be described by 
( ) ( ) SmCCP
MK
MvSmCCP
dt
dM
BabCab
Cab
Cab
CabAab
Cab
•−•−
+
•
−•−•=
max
 
(Equation 44) 
As the modelling is done under a mass balance approach the overall change for all three 
equations together is zero. This is true for situations in which only passive diffusion and 
carrier-mediated transport is integrated to the model. Equal equations can be defined for 
the basal to apical transport direction. To describe the change in amount in the three 
different compartments there are for each transport direction three equations with 6 
variables (CA, CC, CB, MA, MC, MB). The change of the volume of solution is modelled as 
described in chapter 5.4.5. To reduce the number of variables, the molar amounts should 
be expressed in concentration or vice versa. 
To get an equation that describes the change of the molar concentration of drug in the 
apical solution, (Equation 38) was differentiated and the chain rule applied 
A
Aab
Aab
AAAabAab V
dt
dCC
dt
dV
dt
VdC
dt
dM
•+•=
•
=  
(Equation 45) 
The two equations (Equation 45) and (Equation 42) are set equal 
( ) AabA
Cab
Cab
CabAabA
Aab
Aab
A C
dt
dV
MK
MvSmCCPV
dt
dCC
dt
dV
•+
+
•
+•−•−=•+• max
 
(Equation 46) 
and converted 
( )
Cab
Cab
CabAabA
Aab
MK
MvSmCCPV
dt
dC
+
•
+•−•−=• max
 
(Equation 47) 
( )
ACab
Cab
A
CabAab
Aab
VMK
Mv
V
SmCCP
dt
dC 1max
•
+
•
+•−•−=
 
(Equation 48) 
The Michaelis-Menten term describes the efflux across a membrane (area) and the 
maximum velocity is in [nmol/(s•cm2)] and not as in enzyme kinetics where the reaction 
takes place in solution in [nmol/s]. Therefore the term has to be extended by the area of 
the monolayer Sm resulting in the following equation 
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( )
ACab
Cab
A
CabAab
Aab
V
Sm
MK
Mv
V
SmCCP
dt
dC
•
+
•
+•−•−= max
 
(Equation 49) 
The same approach was applied to the basal compartment to get an equation describing 
the change of the molar concentration of drug in the basal solution. 
The differentiated form of (Equation 38) for the basal compartment was set equal to 
(Equation 43) 
( ) BabBBabCabBBabBabB Cdt
dVSmCCPV
dt
dCC
dt
dV
•+•−•=•+•  
(Equation 50) 
and converted 
( ) SmCCPV
dt
dC
BabCabB
Bab
•−•=•  
(Equation 51) 
( )
B
BabCab
Bab
V
SmCCP
dt
dC
•−•=
 
(Equation 52) 
To equation that describes the change of the molar amount of drug in the cellular 
compartment is the following 
( ) ( )
CCC
BabCab
Cab
Cab
CabAab
Cab
VCM
with
SmCCP
MK
MvSmCCP
dt
dM
•=
•−•−
+
•
−•−•=
max
 
(Equation 53) 
This model results in the following differential equations describing the change of drug 
concentration or mass as a function of time in the three compartments during permeation 
in both directions if the relevant processes are passive diffusion and carrier-mediated 
transport. 
transport direction apical to basal: 
( )
ACab
Cab
A
CabAab
Aab
V
Sm
MK
Mv
V
SmCCP
dt
dC
•
+
•
+•−•−= max
 
(Equation 54): apical compartment 
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B
BabCab
Bab
V
SmCCP
dt
dC
•−•= )(  
(Equation 55): basal compartment 
SmCCPSm
MK
MvSmCCP
dt
dM
BabCab
Cab
Cab
CabAab
Cab
•−•−•
+
•
−•−•= )()( max
 
(Equation 56): cellular compartment 
 
transport direction basal to apical: 
ACba
Cba
A
AbaCba
Aba
V
Sm
MK
Mv
V
SmCCP
dt
dC
•
+
•
+•−•= max)(
 
(Equation 57): apical compartment 
B
CbaBba
Bba
V
SmCCP
dt
dC
•−•−= )(  
(Equation 58): basal compartment 
Sm
MK
MvSmCCPSmCCP
dt
dM
Cba
Cba
AbaCbaCbaBba
Cba
•
+
•
−•−•−•−•=
max)()(
 
(Equation 59): cellular compartment 
C is the molar concentration [µM], M is the molar amount of substance [nmol], the indices 
A, B, and C (upper case) denote the apical, basal and cellular compartment, respectively, 
the indices ab and ba (lower case) denote permeation in the apical to basal and the 
basal to apical direction, respectively, Sm is the surface area of the monolayer [cm2] and 
V is volume of solution in each compartment [ml]. 
5.4.4.  Mathematical  model  for  determining drug absorpt ion 
parameters in Caco-2 cel l  monolayers with inclusion of  phase I I  
metabol ism and adsorpt ion to the Transwell  surface 
In a next step adsorption and phase II metabolism were integrated to the model by 
extension of the system of differential equations described in chapter 5.4.3 to fully 
describe all the relevant processes taking place during the absorption of Amentoflavone 
in Caco-2 cell monolayers grown in Transwell plates. Adsorption was modelled as 
described in chapter 5.4.1 as a saturable process dependent on the concentration of 
Amentoflavone in solution and the contact area of the solution with the Transwell surface. 
The parameters describing the adsorption are the following: kon is the rate constant for 
the adsorption to the surface [cm2/(mol●min)], koff is the rate constant for desorption of 
the surface [1/min], and Wtot is the total number of binding sites on the surface 
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[nmol/cm2]. The values of the parameters kon, koff and Wtot of Amentoflavone were first 
estimated in cell-free experiments in the Transwell apparatus as described in chapter 
5.4.6 and later on used in the fits for Amentoflavone with cell monolayers. The phase II 
metabolism was modelled as a first-order process. The formed amount of metabolites 
depends on the amount of Amentoflavone in the cellular compartment and the rate 
constant kM [1/min]. The transport behaviour of the metabolites itself was neglected for 
modelling purposes. The combined amount of the detected sulfates and glucuronidates 
was quantified at each time point and used in the fitting. The cellular compartment was 
treated as a sink for the metabolites. The transport processes included in the extended 
version of the transport model are displayed in Figure 3. 
 
Figure 3: Transport processes considered for modelling drug permeation in the Caco-2 
monolayer and relevant processes including phase II metabolism and adsorption. 
To consider the adsorption to and the desorption of the surface, the expressions already 
developed for the transport experiments without cell monolayers ((Equation 34) - 
(Equation 37)) were integrated to (Equation 54), (Equation 55), (Equation 57) and 
(Equation 58)) and the system of differential equations describing the change of drug 
concentration or mass as a function of time in the three compartments during permeation 
in both directions was extended by the equations for the amounts bound to the surface in 
the apical and basal compartment. The phase II metabolism was modelled as a first-
order process with the formed amount of metabolites depending on the amount of 
Amentoflavone in the cellular compartment and the rate constant kM [1/min]. This 
extension was integrated to the equation for the cellular compartment. An equation for 
the formed amount of metabolites had to be added for each transport direction. The 
modelling resulted in the following system of differential equations. The equations are 
displayed in the full version. 
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transport direction apical to basal: 
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(Equation 60): apical compartment solution 
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(Equation 62): cellular compartment 
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transport direction basal to apical: 
( )
A
A
WAbaoffWAbatotAbaon
ACba
Cba
A
CbaAba
Aba
V
SCkCWCk
V
Sm
MK
Mv
V
SmCCP
dt
dC
••+−••−•
+
•
+•−•−= )(max
 
(Equation 66): apical compartment solution 
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(Equation 67): basal compartment solution 
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(Equation 68): cellular compartment 
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(Equation 69): phase II metabolism 
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(Equation 71): Transwell basal surface 
5.4.5.  Analysis of  the permeation data 
Modelling of the reduction of the volume of solution 
The reduction of the volume of solution in the apical and the basal compartment due to 
sampling as a function of time was accounted for by polynomial relations describing this 
reduction. The reduction was modelled as a continuous reduction over time and not as it 
is in reality as a stepwise reduction at discrete times. Two cases had to be distinguished 
for the modelling of the reduction of the volume in Transwells, the first one being 
Transwells with cells or sealing of the membrane (“sealed case”) and the second one 
with no cell monolayer or any other sealing on the membrane (“free case”). 
For the modelling of the reduction of the volume in the sealed case, timepoints for certain 
volumes were exactly between the times for two sample drawings. The first point 
reflecting the initial volumes was set after 15min. The parameters of the polynomial 
relations were determined empirically using regression analysis with EASY-FIT using 
the model type “explicit”, the numerical method “DFNLP”, a scaling of 1 and a termination 
tolerance of 0.00000001. The point of origin and the endpoint were free for the fitting. 
The values
 for the different parameters, Vapical,0,calculated and Vbasal,0,calculated were determined 
for the transport experiments over 7h with sampling volumes of 117µl and sampling after 
30, 150, 300 and 420 minutes. The determined relations were later on used in the fittings 
of the data of transport experiments. For a sampling volume of 117µl regression analysis 
yielded in the following polynomial relations for the reduction of the volume in the sealed 
case
 
32 70000000095.00000064596.00021457.0630764.1)( ttttVapical •−•+•−=  
(Equation 72)
 
32 70000000095.00000064597.00021457.083076424.2)( ttttVbasal •−•+•−=  
(Equation 73) 
These relations are only valid if there is no fluid flow between the apical and basal 
compartment. This is the case if there is an intact cell monolayer on the membrane of the 
Transwell or if the membrane is sealed in any other way. If the membrane is not sealed 
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sample drawings in the apical and basal compartment without replacement of the 
withdrawn solution may result in fluid flow, thus possibly equalizing an imbalance in liquid 
level in the two compartments. For these reasons the reduction in volume for 
experiments without cells cannot be described with the same relations even if the sample 
volume is the same. For the calculation of the contact area the contact height of the 
solution with the Transwell surface was also experimentally measured for the case 
without any sealing of the membrane (see chapter 5.3.4). The reduction of the contact 
height of the solution in the apical compartment due to sampling as a function of time 
was calculated by the following polynomial relations, the parameters of which were 
determined empirically using regression analysis with EASY-FIT with the same settings 
as in the sealed case. Only experiments over 7h and with a sampling volume of 117µl 
were performed with a free membrane. For these conditions the regression analysis 
yielded in the following polynomial relations for the height of contact in the apical 
compartment in the free case. 
32 17170.00000000070.00000132 0.00052770.56601380)( ttttHeightapical •−•+•−=  
(Equation 74)
 
This polynomial relation is applied to describe to the course of the apical volume resulting 
in the decrease of volume (starting volume 1.6ml). After estimation of the apical volumes 
for different time points, the basal volume is calculated based on the assumption of 
conservation of volume in the two compartments. The total initial volume is known (1.6 + 
2.8ml) as well as the volume withdrawn as samples (0.117ml) and the calculated apical 
volumes. With these data the basal volume can be calculated. The reduction of the 
volume of solution in the free case was accounted for by the same polynomial relations 
as in the sealed case (see (Equation 72 and (Equation 73). The parameters were 
determined the same way as described above. The regression analysis yielded in the 
following polynomial relations for the reduction of the volume in the free case. 
32 5170.0000000150.000010890.00338151.64832392)( ttttVapical •−•+•−=  
(Equation 75)
 
32 19650.00000000370.000000730.00067782.81033228)( ttttVbasal •−•+•−=  
(Equation 76) 
5.4.6.  Est imat ion of  adsorpt ion parameters in t ranswells without  
cel ls 
The concentration variables defined by the system of differential equations, (Equation 34) 
to (Equation 37), were fitted to the experimental concentration data. Concentration data 
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of both compartments obtained from concomitant incubation in the apical and the basal 
compartment were fitted at the same time. Numerical solution of the equations and least 
squares fit were performed using the software Easy-Fit and optimal values of the kinetic 
parameters kon, koff, Wtot and P were deduced. 
The regression analysis with EASY-FIT was performed using the model type “ODE” 
(ordinary differential equations), the numerical method “DFNLP”, a scaling of 0, an initial 
stepsize of 0.000001 to 0.00000001 and a final accuracy (absolute and relative) of 
0.000001 to 0.00000001. Data obtained from transport experiments at 37°C and at 4°C 
were analysed separately. The transport parameters were determined for every single 
concentration and temperature. The reduction of the volume of solution over time was 
accounted for by the already mentioned polynomial equations. The reduction of the 
contact area over time was accounted for by the experimentally determined polynomial 
relations shown in chapter 5.5.2. 
Two attempts were differentiated for the parameter estimation with Easy-Fit. The first 
way of fitting the experimental data was to only include the measured concentrations at 
the defined time points and obtain CAa&b(0) and CBa&b(0) from the model simulation 
(“Model without CDonora&b(0)”). Doing so we assumed that already the donor concentration 
is affected by adsorption (to pipettes and other materials used in the preparation of the 
donor solutions) and most probably lower than the expected respectively the intended 
donor concentrations. The second way of fitting the experimental data was to assume 
that CAa&b(0) and CBa&b(0) were close to the expected respectively the intended donor 
concentrations (“Model with CDonora&b(0)”). Doing so, we integrated the not experimentally 
measured donor concentrations to the fitting along with the measured concentrations at 
the defined time points. With this attempt we also obtained from the model simulation 
values for CAa&b(0) and CBa&b(0) that best fit with the rest of the data. If all parameters to 
be estimated were free in the fittings, in most instances a strong correlation between kon, 
koff, Wtot and P occurred in the regression analysis, which meant that these parameters 
could not be deduced individually from each other. Therefore all fittings were performed 
using step-by-step procedure, beginning with all parameters. After the first fitting the 
parameters estimated for all concentrations used at the same temperature were 
compared, and the parameter (kon, koff or Wtot) with the most consistent values estimated 
was set as a constant in the next fitting. Again comparison and selection of the 
parameters was performed and a second parameter (kon, koff or Wtot) was set as a 
constant in the next fitting. After the third round of fitting the data the last left parameter 
(kon, koff or Wtot) could be determined. The regression analysis resulted in values for kon, 
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koff, Wtot and P. Furthermore the course of CWA and CWB dependent on the time was 
obtained from model simulation. 
5.4.7.  Analysis of  Amentof lavone permeation across Caco-2 cel l  
monolayers 
Permeation data were analysed using this theoretical model for the kinetics of cellular 
transport. The concentration variables defined by the system of differential equations 
were fitted to the experimental concentration data. Concentration data of both 
compartments obtained from the apical to basal and the basal to apical direction of 
permeation were simultaneously fitted. This provided a more stable regression analysis 
compared to the separate evaluation of each permeation direction. Previous work using 
the transport model [Kapitza] showed that in most instances a strong correlation between 
vmax and K occurred in the regression analysis, which meant that these parameters could 
not be deduced individually from each other. Therefore all fittings in the present work 
were performed using the approximation of first order kinetics for the carrier-mediated 
efflux (MC << K) for the estimation of the transport parameters 
Cxy
Cxy
Cxy Mvk
MK
Mv
•=
+
•max
 
(Equation 77) 
This approximation yielded in all situations better results as estimated by the final 
residual values of the fittings than the approximation of zero order kinetics for the carrier-
mediated efflux (MC >> K) that was previously used. The reduction of the volume of 
solution over time was accounted for by the already mentioned polynomial equations. 
The reduction of the contact area over time was accounted for by the experimentally 
determined polynomial relations shown in chapter 5.5.2. The non-specific binding to 
Transwell surface was calculated by the kinetic parameters estimated in chapter 5.5.3. 
Numerical solution of the equations and least squares fit were performed using the 
software Easy-Fit and optimal values of the kinetic parameters P, vk, and kM applicable 
to the different experimental conditions were deduced. The regression analysis with 
EASY-FIT was performed using the model type “ODE” (ordinary differential equations), 
the numerical method “DFNLP”, a scaling of 1, an initial stepsize of 0.00000001 and a 
final accuracy (absolute and relative) of 0.00000001. The transport data obtained by the 
methods described in chapter 5.3.8 was used in the fittings. Transport parameters were 
determined for every single concentration (only data from 7h experiments). A cell 
monolayer volume of 0.0094ml was used based on a monolayer thickness of 20µm and a 
monolayer area of 4.70cm2. The regression analysis resulted in values for the passive 
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permeability coefficient P, the rate constant vk, which expresses the apical efflux rate in 
nmol/(cm2●s) and the rate constant kM which describes the formation of the metabolites 
[1/min]. Furthermore the drug concentrations at time zero, CAab(0) and CBba(0) and the 
drug mass in the cellular compartment were obtained from model simulation. 
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5.5 .  Resul ts  and  d iscussion  
5.5.1.  Cel l  toxici ty of  the dif ferent  compounds 
The possibility of adverse effects elicited by the different compounds and combinations 
used on cultured Caco-2 cell monolayers was evaluated by determining the 
mitochondrial dehydrogenase activity of the cells by using the MTT assay. This is an 
established method addressing one aspect of cell functionality and is widely used as a 
criterion of cytotoxicity. The MTT assay detects specifically mitochondrial metabolic 
activity and the ability of the cells for proliferation. The results of the MTT assay are 
shown in (Figure 4) and (Figure 5). For the 7h incubation with Amentoflavone and 
Vinblastine and combinations of the two compounds, mitochondrial activity values of the 
cells were in the range between 89.51% (Amentoflavone 5µM b_a) and 101.59% 
(Vinblastine 70µM a&b & Amentoflavone 5µM a_b) of the control. None of these values 
was statistically significant different from the control as determined by the Student’s t-test 
at p < 0.05. 
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Figure 4: Mitochondrial dehydrogenase activity of the cells determined by the MTT assay 
following 7h incubation in 6-well Transwell plates. Results are expressed in percent of 
control obtained with transport medium + 0.5% Ethanol (v/v) and given as mean and 
standard deviation with n = 4. Column: 1 transport medium + 0.5% EtOH (v/v), 2 
Amentoflavone 5µM a_b, 3 Amentoflavone 5µM b_a, 4 Vinblastine 70µM a&b, 5 Vinblastine 
70µM a&b & Amentoflavone 5µM a_b, 6 Vinblastine 70µM a&b & Amentoflavone 5µM b_a. 
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Figure 5: Mitochondrial dehydrogenase activity of the cells determined by the MTT assay 
following 5h incubation in 6-well Transwell plates (passage 82 - 92, 20 – 24 days post 
seeding). Results are expressed in percent of control obtained with transport medium + 
0.5% Ethanol (v/v) and Amentoflavone 5µM a_b and given as mean and standard deviation 
with n = 3. Columns: 1, 3, 5, 7 and 9 transport medium + 0.5% EtOH (v/v)) and 
Amentoflavone 5µM a_b, 2 GF120918 0.1µM a&b and Amentoflavone 5µM a_b, 4 GF120918 
1µM a&b and Amentoflavone 5µM a_b, 6 Vinblastine 3.9µM a&b & Amentoflavone 5µM a_b, 
8 Vinblastine 25µM a&b & Amentoflavone 5µM a_b, 10 Vinblastine 70µM a&b & 
Amentoflavone 5µM a_b. * denotes results that are statistically significant from the control 
at p < 0.05. 
For the 5h incubation with Amentoflavone and varying concentrations of Vinblastine and 
GF120918, mitochondrial activity values of the cells were in the range between 87.15% 
(GF120918 0.1µM a&b) and 125.17% (Vinblastine 70µM a&b) of the control. The effects 
of two combinations, the reduction of GF120918 0.1µM a&b and Amentoflavone 5µM 
a_b to 90.31% and the increase of Vinblastine 70µM a&b & Amentoflavone 5µM a_b to 
125.17%, were statistically significant (Student’s t-test) at p < 0.05. No positive 
correlation between concentration of GF120918 or Vinblastine and the effect on the 
mitochondrial activity in the studied concentration range was observed. Taken together 
the employed compounds and concentrations had overall no significant cytotoxic effect 
on the cells. The statistically significant effects observed in a two instances in the MTT 
assay in the 6-well Transwell plates were not consistent between the two incubation 
times (Vinblastine) or within the series of applied concentrations (both Vinblastine and 
GF120918. Hence, they do not appear to be systematic. The test in the Transwell plates 
corresponds exactly to the experimental setup used in the permeation studies except for 
the fact, that no samples were drawn. A masking of cytotoxicity of the compounds by an 
interaction of the MTT assay with high concentrations of some P-glycoprotein and MRP 
substrates leading to false cell viability values during concomitant incubation [Vellonen] 
cannot be ruled out. 
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5.5.2.  Determination of the contact  height  and mathematical  
description of  the contact area of  the transport  medium with 
Transwel l  surfaces (Transwel ls without  cel ls)  
The contact height and based on the height the contact area of different volumes of 
transport medium with the Transwell surface during the transport experiments was 
determined by colouring the surface with a solution of Nile Blue A. The volumes 
corresponded to the volumes for certain time points during the transport experiments. 
The polycarbonate membrane of the Transwell was either free or sealed to mimic the 
situation with or without cells. The solution in the apical compartment is in contact with 
the inner surface of the Transwell insert, the solution in the basal compartment is in 
contact with the outer surface of the Transwell insert and the surface of the Transwell 
cavity. The experimentally determined height of contact was plotted against the apical 
and basal volumes and linear relationships were calculated by linear regression in 
Microsoft Excel. The relations describing the course of the contact height are displayed 
in (Table 1). These relations describe the contact height for experiments with donor 
volumes of 1600µl (apical compartment) and 2800µl (basal compartment), sampling 
volumes of 117µl and sampling after 30, 150, 300 and 420min. 
Table 1: Equations describing the course of the height of contact between the solution and 
the different parts of the Transwell plates. 
 
contact height [mm] 
free membrane 
contact height [mm] 
sealed membrane 
apical compartment: 
inner surface insert 
H = 0.0026 • volume [µl] + 1.4239 
R2 = 0.9614 
H = 0.0045 • volume [µl] – 1.2153 
R2 = 0.9197 
basal compartment: 
outer surface insert 
H = 0.0043 • volume [µl] – 4.7878 
R2 = 0.9486 
H = 0.0041 • volume [µl] – 3.4003 
R2 = 0.9926 
basal compartment: 
surface cavity 
H = 0.0038 • volume [µl] – 2.3064 
R2 = 0.9868 
H = 0.004 • volume [µl] – 1.9699 
R2 = 0.9581 
 
The relations describing the contact height for all the different parts of the Transwell 
plates show good linear correlation as evaluated by the correlation coefficient. Therefore 
the assumption that there is a linear connection between the volume and contact height 
and the resulting contact area, appears to be correct. Based on the contact height the 
contact area for the different time points was calculated as described in chapter 5.3.4. 
The reduction of the contact area was then modelled as a continuous reduction 
described by polynomial relations and the regression analysis performed with Easy-Fit 
yielded in the following relations for the contact area in the free case (with possible fluid 
flow between the two compartments) 
32 320.0000000120.00001015 0.00405564.34994077)( ttttSapical •−•+•−=  
(Equation 78)
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32 1210.0000000550.000039510.015891925.1737344)( ttttSbasal •−•+•−=  
(Equation 79) 
and in the sealed case 
32 310.0000000310.00002234 0.00742064.70576080)( ttttSapical •−•+•−=  
(Equation 80) 
32 5630.0000000700.000051570.016970626.8842921)( ttttSbasal •−•+•−=  
(Equation 81) 
with S being the contact area in [cm2] and t being the time in [min]. These descriptions of 
the contact area were used in the fittings of Amentoflavone data of transport experiments 
with or without cells. 
5.5.3.  Adsorpt ion of  Amentof lavone to Transwell  surfaces at  4°C 
and 37°C (Transwel ls without  cel ls,) :  Est imation of  the adsorpt ion 
parameters and representative f i ts of  the Amentof lavone transport 
and adsorption in Transwel ls without cel ls 
Transport experiments with Amentoflavone in Transwell plates without cells were 
performed as described in chapter 5.3.5, at 4°C and  at 37°C. The concentration-time 
profiles of these experiments with concomitant incubation of Amentoflavone in the apical 
and basal compartment were used to determine the adsorption parameters kon, koff, Wtot 
of Amentoflavone to the Transwell surface and calculate the amount of Amentoflavone 
adsorbed to the surface, CWA and CWB, at the two different temperatures. The 
experimental permeation data were analysed using the theoretical model for transport 
and adsorption in Transwell plates without cells consisting of (Equation 34) to (Equation 
37), and the fitting software Easy-Fit®. 
Two attempts were differentiated for the parameter estimation with Easy-Fit. The first 
attempt was to include only the measured concentrations at the defined time points for 
the parameter estimation. Values for the donor concentrations CAa&b(0) and CBa&b(0) were 
obtained from the model simulation (“Model without CDonora&b(0)”). For the second attempt 
we assumed that CAa&b(0) and CBa&b(0) were close to the intended donor concentrations 
(“Model with CDonora&b(0)”). The values for the intended donor concentrations CAa&b(0) and 
CBa&b(0) were included in the fittings for the parameter estimation. Still values for CAa&b(0) 
and CBa&b(0) fitting better to the experimentally observed concentration profiles were 
obtained from the model simulation. As in most instances a strong correlation between 
kon, koff, Wtot and P occurred in the regression analysis and these parameters could not 
be deduced individually from each other all fittings were performed using step-by-step 
procedure and one parameter after the other was estimated. This procedure used for the 
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parameter estimation for the two assumptions and the two temperatures resulted in the 
values shown in (Table 2). 
Table 2: Estimated values for Wtot, kon and koff for the two assumptions for calculating the 
adsorption to Transwell plates without cells. 
model without CDonor a&b(0) model with CDonor a&b(0) 
 
37°C 4°C 37°C 4°C 
Wtot [nmol/cm2] 0.5 1.3 0.65 1.7 
kon [cm2/(nmol • min)] 0.001565 0.000601 0.03 0.0165 
koff [1/min] 0.00085 3.75 • 10-35 0.0165 0.0195 
 
One has to be aware, that the estimation of the adsorption parameters was performed 
under the assumption of concentration independency of the kon, koff & Wtot, be it for 
different experiments or during one defined experiment. The non-specific binding can be 
described by these parameters at each time point during the experiment. The estimated 
parameters differed for the two temperatures (4°C a nd 37°C) as well as for the two 
models (model with CDonora&b(0) and model without CDonora&b(0)). Wtot was in both models 
bigger for the lower temperature, indicating a higher binding capacity of the surface at 
4°C. If this finding demonstrates a real higher cap acity of if the higher number is just 
artefact of the model and fitting procedure reflecting therefore rather a virtual binding 
capacity, is uncertain, as at 4°C the model encount ers stronger adsorption. The model 
with CDonora&b(0) shows slightly higher values for Wtot than the model without CDonora&b(0). 
Again this may be due to the fact that there is more Amentoflavone in the system that 
adsorbs (see chapter 5.5.4) and therefore the higher value results. Further inspection 
shows that the values for kon and koff are at both temperatures higher for the model with 
CDonora&b(0) than for the model without CDonora&b(0). Surprisingly these values are generally 
lower at 4°C than at 37°C, indicating that the valu es for Wtot has a stronger impact on the 
total amount adsorbed than kon and koff. In one case the value for koff is even higher than 
the one for kon, further complicating any systematic interpretation of these parameters. 
Taken together there is strong evidence that the estimated adsorption parameters are 
rather descriptive values than reflecting real processes taking place in the Transwell 
plates. (Figure 6) and (Figure 7) show representative fits for Amentoflavone permeation 
after simultaneous addition in the apical and basal compartment. The fitting was done 
with the model with CDonora&b(0) and with the model without CDonora&b(0). The experimental 
data used for the fittings in (Figure 6) and (Figure 7) were the same. (Figure 8) and 
(Figure 9) show representative calculated courses of CWA and CWB (amounts bound to 
the surface) depending on time that were obtained from model simulation for the fits of 
the experimental data used in (Figure 6) and (Figure 7) with the respective models. 
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Figure 6: Representative fit of Amentoflavone 2µM apical and basal in Transwell plates 
without cells at 37°C. The fitting was done with th e model with CDonora&b(0). 
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Figure 7: Representative fit of Amentoflavone 2µM apical and basal in Transwell plates 
without cells at 37°C. The fitting was done with th e model without CDonora&b(0). 
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Figure 8: Representative calculated course of the adsorption of Amentoflavone 2µM apical 
and basal in Transwell plates without cells at 37°C . The fitting was done with the model 
with CDonora&b(0). 
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Figure 9: Representative calculated course of the adsorption of Amentoflavone 2µM apical 
and basal in Transwell plates without cells at 37°C . The fitting was done with the model 
without CDonora&b(0). 
The model with CDonora&b(0), taking into account the aspired donor concentration in the 
fitting, results in concentration-time fits, that do describe all the measured concentrations 
as well as the fits with the model without CDonora&b(0). The first model shows strong initial 
adsorption (during the first 60min) as displayed by the initial drop in concentration (Figure 
6) and by the model calculated amounts bound to the surface (Figure 8). After this first 
phase of adsorption the concentration as well as the amount bound to the surface 
remains more or less constant. The model without CDonora&b(0) results in fits that don’t 
show an initial drop in concentration (Figure 7). This model describes the adsorption as a 
continuous process, taking place over the whole incubation period as displayed by the 
calculated amounts bound to the surface (Figure 9). The way the adsorption is modelled 
assumes that over the whole incubation time the driving force for the non-specific binding 
remains the same and that the adsorption can be described as a whole by the estimated 
set of adsorption parameters. In case of the likely situation that the adsorption is in reality 
more complex than our simple model (e.g. binding is a two step process or there is an 
initial and a steady-state phase with different adsorption parameters), we would fail in a 
complete description of the adsorption. The main focus of the model with CDonora&b(0) is 
the initial decrease in concentration due to non-specific binding whereas the model 
without CDonora&b(0) is good in delineating the decrease in concentration in the second 
part of the concentration-time profile, describing the adsorption as a continuous process 
taking place over the whole period of the experiment whereas. 
5.5.4.  Comparison of  the two di fferent  models for  adsorption 
(Transwells without  cel ls,  4°C and 37°C)  
Measured and calculated amount of Amentoflavone adsorbed to the Transwell 
surface 
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After each transport experiment the Transwell plates were extracted with methanol to 
estimate the amount of Amentoflavone bound to the surface during the incubation. (Table 
3) shows the experimentally determined amount of Amentoflavone bound to the surface 
as well as the model-derived total amounts (model without CDonora&b(0) and model with 
CDonora&b(0)) adsorbed the surface after incubation in Transwells without cells. 
Table 3: Amounts of Amentoflavone (AF) extracted from the Transwell plates without cells 
after concomitant incubation in the apical and basal compartment for 7h at 4°C and 37°C 
compared to the calculated amounts of Amentoflavone adsorbed to the Transwell surface 
with the model without CDonora&b(0) and with the model with CDonora&b(0). Experimental 
results are given as mean and standard error of the mean with n = 3. E = experimental 
values, C = calculated with the model without CDonora&b(0), C0 = calculated with the model 
with CDonora&b(0). 
amount extracted 37°C [nmol]  amount extracted 4°C [nmol] AF conc. 
[µM] E C C0  E C C0 
2 2.473 +/- 0.136 1.526 3.829  3.074 +/- 0.145 1.311 4.386 
5 5.587 +/- 0.368 2.356 7.323  9.387 +/- 0.217 3.677 10.159 
7.5 6.826 +/- 0.225 2.810 9.432  14.200 +/- 0.762 4.556 14.933 
10 11.258 +/- 0.605 6.692 11.187  20.691 +/- 0.898 6.324 22.722 
 
The experimentally determined amounts of Amentoflavone extracted from the surface 
after concomitant incubation in the apical and basal compartment for 7h at 37°C were for 
2µM 28.1% +/- 1.5, for 5µM 25.4% +/- 1.7, for 7.5µM 20.7% +/- 0.7, and for 10µM 25.6% 
+/- 1.4 of the initial amount at the start of the experiment. The same experiments 
performed at 4°C yielded in the following extractio n rates: 2µM 34.9% +/- 1.6, for 5µM 
42.7% +/- 1.0, for 7.5µM 43.0% +/- 2.3, and for 10µM 47.0% +/- 2.0 of the initial amount 
at the start of the experiment. These results are not indicating a saturation effect in the 
concentration range tested, neither for experiments performed at 4°C nor for experiments 
performed at 37°C. Regarding these results the assu mption of a linear relationship for 
the amount adsorbed and the concentration in the solution as used in the theoretical 
modelling is reasonable. Furthermore a strong dependency of the adsorption on the 
temperature is demonstrated by the results. 
The model with CDonora&b(0) yields generally in higher amounts bound to the surface 
compared to the experimentally measured values, whereas the model without CDonora&b(0) 
yields in lower amounts compared to the experimentally measured values. For 
experiments performed at 4°C the amounts calculated  with the model with CDonora&b(0) 
were closer to the experimentally measured amounts than ones calculated with the 
model without CDonora&b(0), having deviations of +42.7%, +8.2%, +5.2%, and +9.8% 
compared to deviations of –57.4%, -60.8%, -67.9%, and -69.4%. For experiments 
performed at 37°C the amounts calculated with the m odel with CDonora&b(0) were with one 
exception closer to the experimentally measured amounts than ones calculated with the 
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model without CDonora&b(0), but the deviations were bigger than the ones for the 
calculations for experiments at 4°C, having deviati ons of +54.9%, +31.1%, +38.2%, and -
0.6% compared to deviations of -38.3%, -57.8%, -58.8%, and -40.6%. By assumption of 
correctly estimated experimentally values for the amount of Amentoflavone adsorbed to 
the surface, the model with CDonora&b(0) is generally better in predicting the adsorption, 
resulting in most cases in a overestimation of the amount adsorbed to the surface. One 
other option would be an experimental underestimation of the amount adsorbed to the 
surface. The possibility of overestimation of the adsorbed amounts by the experiment 
cannot be ruled out, but would imply a systematic error in the extraction procedure used, 
as we are not aware of any inconsistencies in the estimated values, neither in the 
concentration series nor between the two different temperatures. 
Model estimated donor amounts 
The fittings of the experimental concentration data with either the model with CDonora&b(0) 
or model without CDonora&b(0) yielded in calculated donor concentrations fitting best to the 
observed concentration profiles, based on which donor amounts were calculated to be 
compared to the intended donor amounts (Table 4). 
Table 4: Estimated donor amounts for transport experiments in Transwell without cells at 
4°C and 37°C with model with C Donora&b(0) and model without CDonora&b(0). 
 model without CDonora&b(0) model with CDonora&b(0) 
Amentoflavone 
concentration 
[µM] 
2 5 7.5 10 2 5 7.5 10 
donor amount 
calculated 
37°C [nmol] 
6.28 16.88 26.06 34.08 8.91 22.35 33.40 44.23 
37°C: calc. % 
of intended 71.32 76.70 78.98 77.46 101.28 101.59 101.21 100.53 
donor amount 
calculated 4°C 
[nmol] 
5.51 14.88 21.93 26.53 8.90 22.30 33.45 44.60 
4°C: calc. % of 
intended 62.61 67.62 66.46 60.30 101.14 101.36 101.35 101.36 
 
The most striking difference between the two models was, that with the model with 
CDonora&b(0) the resulting donor amounts were almost identical to the intended ones, with 
no difference between the two temperatures, whereas for the model without CDonora&b(0) 
donor amounts between 60 – 80% of the intended was resulted, with slightly worse 
results for experiments performed at 4°C. The resul ts of the first model imply that the 
permeation experiments were performed with concentrations that corresponded to the 
intention whereas the results of the latter model imply a substantial divergence from the 
intention. The divergence would be especially problematic for the data treatment of 
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experiments with cells in which more parallel processes take place than in the simple 
system of Transwell plates without cells. 
Mass balances of Amentoflavone transport in Transwells without 
Mass balances were calculated for all permeation experiments without cells by addition 
of the amount in solution after 7h, the amount withdrawn during the experiment and the 
amount extracted with methanol from the Transwell surface. The intended donor amount 
provided the reference for calculation. (Table 5) shows the mass balances for both the 
experiments at 4°C and at 37°C. 
Table 5: Mass balances of Amentoflavone after concomitant incubation in the apical and 
basal compartment in Transwell plates without cells for 7h at 4°C and 37°C. 
recovery [%] AF conc. 
[µM] 37°C 4°C 
2 a&b 81.08 +/- 2.42 82.73 +/- 0.32 
5 a&b 89.89 +/- 2.13 92.61 +/- 0.71 
7.5 a&b 89.99 +/- 2.0 95.07 +/- 1.66 
10 a&b 83.69 +/- 4.93 91.59 +/- 3.58 
 
At 37°C between 81% and 90% of the initial amount w ere experimentally detected, 
whereas at 4°C even higher recoveries resulted (83%  – 95%). If the experimentally 
detected amounts in solution and withdrawn are seen as true values, the only values that 
may be imprecise and can be better estimated by the model are the amount bound to the 
surface and the initial donor amounts. If the experimental amounts (including the 
extracted amounts) are set into relation with the calculated donor amounts for the model 
with CDonora&b(0) the recovery is slightly lower, as the calculated donor concentrations are 
higher for the model than the intended ones. By integration of the calculated amount 
adsorbed to the surface, the recovery results between 94% and 96.5%. If the 
experimental amounts (including the extracted amounts) are set into relation with the 
calculated donor amounts for the model without CDonora&b(0) the recovery is dramatically 
higher, as the calculated donor concentrations are lower for the model than the intended 
ones. At 37°C the resulting recovery is between 107 % and 117% whereas at 4°C the 
recovery is between 132% and 151%. By integration of the calculated amount adsorbed 
to the surface, the recovery results between 94% and 100%. Again, the comparison 
between the experimentally determined amounts and mass balances compared to the 
model derived values are more consistent with the model with CDonora&b(0). 
5.5.5.  Choice of  the model  for  adsorpt ion for  analysis of  
Amentof lavone transport  in Transwells with cel ls 
The non-specific binding/adsorption taking place in Transwell plates during incubation 
with Amentoflavone, was found to be temperature- and concentration dependent and not 
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saturated in the concentration range of the performed experiments. To describe this 
adsorption a mathematical description of the adsorption was developed. 
For the derivation of the kinetic parameters describing the adsorption two different 
models were compared. For both models the set of kinetic parameters was derived from 
fittings of experimental data of concomitant incubation of different concentrations of 
Amentoflavone at two distinct temperatures in Transwell plates without cells. The kinetic 
parameters describing the adsorption, kon, koff & Wtot, were found to be concentration-
independent. With these parameters and the relations derived in the theoretical section, 
the adsorption over the whole incubation time can be described. The fitting of the 
experimental concentration data for the derivation of the adsorption parameters with the 
first model was performed taking into account only experimentally measured 
concentration values ("model without CDonora&b(0)”). For the second model the assumption 
of a donor concentration close to the expected one was taken and this values were 
integrated to the fitting (“model with CDonora&b(0)”). The main focus of the model with 
CDonora&b(0) is the initial decrease in concentration due to non-specific binding whereas 
the model without CDonora&b(0) describes the adsorption as a continuous process taking 
place over the whole period of the experiment whereas. 
The fittings with both models were almost equally well as estimated by the final residual 
values of the fittings (data not shown). As the model with CDonora&b(0) generally better 
predicted the experimentally measured adsorption and the values estimated with this 
model were found to be more consistent than with the model without CDonora&b(0), the set 
of kinetic parameters of the first model was chosen for the fittings of Amentoflavone 
transport in Transwell plates with cells, modelling the adsorption as almost exclusively 
initial event and not a continuous process. 
5.5.6.  Asymmetr ic transport  of  Amentof lavone across Caco-2 cel l  
monolayers as measured by the normal ised f luxes <J> 
For the analysis of the transport data of Amentoflavone no apparent permeability 
coefficient Papp was calculated as in the apical to basal permeation direction 
Amentoflavone showed only poor permeability. Therefore we used an normalised flux 
value <J> to compare different concentrations and experimental settings, as this value 
takes into account the whole permeated substance at the end of the experiment. 
Amentoflavone showed strong asymmetrical transport behaviour in confluent monolayers 
of Caco-2 cells (Table 6) indicating the involvement of an active efflux in the apical cell 
membrane during Amentoflavone transport. No concentration dependency of 
Amentoflavone transport was detected, neither in the apical to basal nor in the basal to 
apical direction. No saturation effect of Amentoflavone transport appears to happen in 
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the analysed concentration range. Low temperature (4°C) reduced the normalised flux 
<J> in the basal to apical transport direction about 50 fold, most probably by abolishing 
almost all of the efflux activity. The normalised flux in the apical to basal transport 
direction was reduced to non-detectable or inaccurate values. 
Table 6: The concentration dependent normalised fluxes <J> of the Amentoflavone in the 
apical to basal (a_b) and basal to apical (b_a) transport direction after 7h incubation at 4 & 
37°C and in presence of Vinblastine 70 µM a&b (Vb). Data are presented as mean and 
standard error of the mean of 3 – 6 monolayers. NP = not performed. 
 a_b  b_a 
 5µM 7.5µM 10µM  2µM 5µM 7.5µM 10µM 
<J> 37°C 
[cm/s ● 106] 
0.0080 
+/- 
0.0025 
 
0.0266 
+/- 
0.0024 
(Vb) 
0.0038 
+/- 
0.0002 
0.0043 
+/- 
0.0002 
 
0.6967 
+/- 
0.0207 
0.5403 
+/- 
0.0596 
 
0.2140 
+/- 
0.0051 
(Vb) 
0.5599 
+/- 
0.0764 
0.5374 
+/- 
0.0611 
<J> 4°C  
[cm/s ● 106] 
not 
detectable NP 
0.0005 
+/- 
0.0005 
 NP 
0.0092 
+/- 
0.0011 
NP 
0.0091 
+/- 
0.0005 
 
The addition of inhibitors of apical active efflux, Vinblastine and GF120918, to the apical 
and basal solution during Amentoflavone transport, resulted in a concentration 
dependent reduction of the normalised fluxes of Amentoflavone 5µM in the basal to 
apical direction (Table 7). 
Table 7: The concentration dependent normalised fluxes <J> of the Amentoflavone in the 
basal to apical (b_a) transport direction after 5h incubation at 37°C and in presence of 
different concentrations of Vinblastine or GF120918. Data are presented as mean and 
standard error of the mean of 3 – 15 monolayers. No permeation of Amentoflavone in the 
apical to basal transport direction was detected in these experiments. 
 GF120918 a&b [µM]  Vinblastine a&b [µM] 
 - 0.1µM 1µM  - 3.9µM 25µM 70µM 
<J> b_a AF 
5µM 37°C 
[cm/s ● 106] 
5.196 
+/- 
0.209 
3.797 
+/- 
0.132 
2.039 
+/- 
0.102 
 
5.307 
+/- 
0.410 
3.235 
+/- 
0.072 
3.569 
+/- 
0.344 
0.357 
+/- 
0.023 
 
The addition of GF120918 to the transport medium resulted in a clear concentration-
dependent inhibitory effect on the apical efflux, as displayed by the normalised flux <J> 
of Amentoflavone in the b_a direction, where 1µM resulted in a decrease of the 
normalised flux <J> to 39.24% compared to the normalised flux <J> without inhibition. 
For Vinblastine also a concentration-dependent inhibitory effect on the apical efflux was 
observed. The inhibitory effect of Vinblastine 3.9µM and 25µM was similar, whereas the 
addition of Vinblastine 70µM resulted in a decrease of the normalised flux <J> in the b_a 
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direction to 6.73% compared to the normalised flux <J> without inhibition. The effects of 
GF120918 and Vinblastine on the normalised flux <J> of Amentoflavone are indicative 
for an involvement of P-glycoprotein in the apical efflux in Caco-2 cell monolayers. This 
would be in agreement with literature [Gutmann 2002], where Amentoflavone was 
identified as P-gp substrate. The inhibitory effect of GF120918 1µM is not complete. 
Concentrations of 1 – 2µM of GF120918 are usually used for complete inhibition in 
studies on P-gp mediated transport [Troutman 2003 B, Tran 2004]. Vinblastine in a 
concentration of 70µM resulted in an almost complete inhibition of the efflux activity in 
Caco-2 cell monolayers of passage 82 – 92 at culture days 20 – 24. If the more complete 
inhibitory effect of Vinblastine, a known combined inhibitor of P-gp and MRP-2, indicates 
an involvement of another efflux transporter than P-gp in the basal to apical transport of 
Amentoflavone is uncertain. The same Vinblastine concentration resulted in a decrease 
of the normalised flux <J> in the b_a direction to 39.61% compared to the normalised flux 
<J> without inhibition if Caco-2 cell monolayer of passage 60 – 64 were used at culture 
days 20 – 22. The Caco-2 cells showed a higher efflux activity at passages 82 – 92 as 
measured by the normalised flux <J>. The normalised flux in the basal to apical direction 
was almost 10 fold higher at higher passages. 
5.5.7.  Cel lular  accumulation of Amentof lavone /  apparent  volume 
of  distribution 
For the analysis of the cellular accumulation of Amentoflavone, at the end of the 
transport experiment, the apparent volumes of distribution VD [ml] (Table 8) were 
compared. The volume of distribution was calculated by dividing the molar amount found 
in the cell by the donor concentration. 
Table 8: The apparent volume of distribution VD of Amentoflavone in the cellular 
compartment after 7h incubation at 4°C or 37°C and in presence of Vinblastine 70µM a&b 
(Vb). Data are presented in % of donor amounts as mean and standard error of the mean of 
3 – 6 monolayers. NP = not performed. 
 a_b  b_a  a&b 
 5µM 7.5µM 10µM  2µM 5µM 7.5µM 10µM   
VD 37°C 
[ml] 
0.0152 
+/- 
0.0007 
 
0.2497 
+/- 
0.0132 
(Vb) 
0.0163 
+/- 
0.0023 
0.0153 
+/- 
0.0006 
 
0.0182 
+/- 
0.0019 
0.0229 
+/- 
0.0030 
 
0.4708 
+/- 
0.0194 
(Vb) 
0.0265 
+/- 
0.0048 
0.0350 
+/- 
0.0040 
 NP 
VD 4°C 
[ml] 
0.0361 
+/- 
0.0007 
NP 
0.0218 
+/- 
0.0016 
 NP 
0.0604 
+/- 
0.0012 
NP 
0.0394 
+/- 
0.0046 
 
0.0878 
+/- 
0.0096 
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The apparent volume of distribution VD of Amentoflavone after 7h transport was 
depending of the transport direction. For equal concentrations in the basal to apical 
direction bigger amounts were detected compared to the apical to basal direction. Low 
temperature (4°C) resulted in a stronger accumulati on of Amentoflavone in the cellular 
compartment compared to 37°C. The effect was more p ronounced for donor 
concentrations of 5µM than for 10µM. Again the accumulation was bigger for the basal to 
apical transport direction. The use the apical efflux inhibitor Vinblastine 70µM resulted in 
a 16.4 times higher accumulation in the a_b direction and a 20.6 times higher 
accumulation in the b_a direction for Amentoflavone 5µM. The tendency for accumulation 
is lower in the case of 4°C than for the use of Vin blastine 70µM. Only for the experiments 
at 37°C in the basal to apical transport direction a tendency for accumulation could be 
observed. For 37°C a_b and 4°C no evident tendency is observable. Taken together, 
Amentoflavone accumulates in the Caco-2 cell monolayers during the transport. The 
accumulation is stronger during inhibition of apical efflux transporters and at 4°C than for 
uninhibited experiments at 37°C. For basal to apica l transport the accumulation is 
stronger whereas no clear-cut concentration dependency is observable. 
5.5.8.  Detect ion of  Amentof lavone phase I I  metabol ism in Caco-2 
cel l  monolayers using HPLC – MS 
Caco-2 cell monolayers grown on petri dishes were incubated with Amentoflavone and 
samples were taken after 30, 150, 300 and 420min and subsequently analysed by 
HPLC-MS as described. In addition to Amentoflavone with retention of approximately 
10min, new peaks were detected in UV at 341nm with retention between 4 – 6min 
(Figure 10). The peaks were not resolved by the method used and had at least 3 
maxima. The AUC of these peaks was increasing with time (not shown). No new peaks 
were detected in the control samples consisting of Amentoflavone at the same 
concentration incubated in centrifuge tubes 50ml (chromatogram not shown). Therefore 
it’s not likely that these peaks are degradation products of Amentoflavone. 
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Figure 10: Representative UV chromatogram with the peaks of the Amentoflavone 
metabolites between 4 and 6min and Amentoflavone with retention of 9.7min. 
Using negative ion mass spectra single ion mode (SIM) Amentoflavone (molecular 
weight 538.46g/mol) could be detected at m/z = 537. In the timeframe of the newly 
detected UV peaks, using negative ion mass spectra SIM two different new ions, m/z = 
617 and m/z = 713 could be detected ((Figure 11) and (Figure 12)). m/z = 617 is 
indicative for the conjugation of a sulfuric acid moiety (80g/mol) to Amentoflavone 
whereas m/z = 713 is indicative for the conjugation of a glucuronic acid moiety 
(176g/mol) to Amentoflavone. Furthermore m/z = 537 was also detected at retention of 
the newly developed peaks while there was no unchanged Amentoflavone is present in 
UV. The peak of m/z 537 has more or less the same shape as newly developed peaks in 
UV (not shown). This may be due to cleavage of the conjugates in the mass detector 
because of the fragmentor voltage used for ionisation. 
 
Figure 11: Chromatogram of m/z = 617 corresponding to the sulfate conjugates of 
Amentoflavone. 
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Figure 12: Chromatogram of m/z = 713 corresponding to the glucuronide conjugates of 
Amentoflavone. 
To further concentrate evidences for phase II metabolism of Amentoflavone enzymatical 
cleavage of the metabolites was performed with succus helix pomatia (SHP, from 
BioSepra, France, a kind gift of Rodolfo Gasser, Hoffmann-La Roche, Ltd., Basel, 
Switzerland; data not shown), which contains both, sulfatase and β-glucuronidase. Each 
step of the cleavage procedure was monitored by HPLC-MS and concentrations and 
chromatograms of the samples with Amentoflavone and the Amentoflavone conjugates 
were compared to blank samples with a defined amount of Amentoflavone or just 
transport medium. Samples were treated either with SHP or water. After the incubation 
with SHP in samples with Amentoflavone conjugates neither the glucuronide metabolite 
nor the sulfate metabolite were detectable as monitored with m/z = 617 & m/z = 713 
whereas in samples treated with water metabolite peaks were still detectable in MS. The 
possibility of protein binding masking the metabolites was ruled out by mass balance 
calculations and comparison to the peaks of samples without metabolites treated with 
SHP. 
The quantification of the metabolites in UV was based on the following assumptions. No 
differentiation between the two different types of Amentoflavone conjugates was done. 
They were quantified together as one pool of metabolites as with the methods used the 
sulfate and glucuronidate conjugates could not be separated from each other. It was 
assumed that the metabolites had the same molar absorption coefficient as the parent 
compound. The UV spectral properties of the metabolites were determined with a UV 
scan during the analysis of samples containing metabolites (not shown). The course of 
the measured spectrum for the metabolites was the same as for Amentoflavone. The 
maxima for both curves are at approximately 270nm und 341nm. The quantification of 
the metabolites was therefore performed against a set of external standard solutions of 
Amentoflavone within the linear response concentration range. Taken all these results 
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together it’s likely that Amentoflavone undergoes phase II metabolism in Caco-2 cell 
monolayers resulting in Amentoflavone sulfate and Amentoflavone glucuronide. These 
metabolites have the same spectral properties in UV as the parent compound and can 
therefore be quantified by using standard curves of Amentoflavone. With the HPLC 
methods used the metabolites cannot be separated and are quantified together. At least 
3 different maxima of Amentoflavone conjugates could be detected indicating that there 
is not only one distinct sulfate or glucuronide but also different ways of conjugating the 
new group to Amentoflavone. Amentoflavone contains several hydroxyl groups to which 
the conjugation may be performed. This was also described for other substances 
[Galijatovic]. As the position of the conjugation to Amentoflavone was not the main focus 
of the present work, no further effort was taken to elucidate the exact number and 
structure of the different sulfates and glucuronides. The amounts of conjugates quantified 
together as we were only interested in the total amount of conjugates. Quantification of 
the conjugates was always performed with the UV chromatograms. The MS 
chromatograms were only used for assurance of the identity of the UV peaks in different 
samples. 
5.5.9.  Transport  behaviour of  the phase I I  metabol ites:  formation, 
ef f lux and cel lular  accumulat ion of Amentoflavone metabol ites 
The Amentoflavone metabolites were formed in every transport experiment performed at 
37°C, whereas at 4°C no metabolites could be detect ed. The metabolites started to 
emerge in both compartments after 30min incubation time and the total amounts formed 
increased in an almost linear manner over time (Figure 16). 
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Figure 13: The concentration dependent efflux of the Amentoflavone metabolites into the 
apical and basolateral compartment and the accumulation of the Amentoflavone 
metabolites in the cellular compartment after 7h incubation at 37°C. Data are presented as 
mean and standard error of the mean of 3 – 6 monolayers. 
In each experiment the concentrations detected in the apical compartment were higher 
than in the basal compartment (not shown), indicating polarised transport behaviour of 
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the metabolites. (Figure 13) displays the inequality in the distribution of the cumulative 
amounts of Amentoflavone metabolites formed after 7h incubation of Amentoflavone 
solely at 37°C. The amount found in the apical comp artment was almost twice as much 
as in the basal compartment, independent of the transport direction and donor 
concentration. The polarity of the distribution was almost completely abolished by the 
addition of Vinblastine 70µM in the apical and basal compartment, indicating the 
involvement of an apical efflux transporter in the transport of the metabolites. The 
sensitivity to Vinblastine is indicative for MRP-2, as Vinblastine is a known inhibitor of this 
efflux transporter [Chan, L.M.S.]. It is furthermore generally accepted that phase II 
metabolites are substrates for MRPs [Jia, Konig, O’Leary, Vaidyanathan]. The inhibition 
of the active efflux results in an enhanced cellular accumulation of the phase II 
metabolites compared to the situation without Vinblastine. In the basal to apical transport 
direction the total amount of the metabolites formed after 7h is higher than in the apical to 
basal direction for the same donor concentrations of Amentoflavone. No clear-cut 
concentration dependency on the total amounts of metabolites formed is observable in 
the concentration range used in the transport studies. The presence of Vinblastine in the 
incubation medium results in slightly higher total amounts of metabolites in the apical to 
basal transport direction whereas in the basal to apical transport direction no such 
tendency was observed. 
5.5.10.  Analysis of  Amentof lavone transport  across Caco-2 cel l 
monolayers grown in Transwel ls based on the transport  parameters 
for  passive di ffusion and carr ier  mediated eff lux 
Permeation data were analysed using the theoretical model for the kinetics of cellular 
transport presented in chapter 5.4.4. The concentration variables defined by the system 
of differential (Equation 60) to (Equation 71) were fitted to the experimental concentration 
data and optimal values of the parameters P, vk and kM applicable to the different 
experimental conditions were deduced. Adsorption was integrated to the model 
equations and described by the set of kinetic parameters derived with the model with 
CDonora&b (0). Numerical solution of the equations and least squares fit were performed 
using the software EASY-FIT (Prof. K. Schittkowski, University of Bayreuth, Germany). 
Concentration data of both compartments obtained from the apical to basal and the basal 
to apical direction of permeation were used simultaneously in the fitting. This provided a 
more stable regression analysis compared to the separate evaluation of each permeation 
direction. The drawn lines in Figure 14 to Figure 16 represent the representative best fits 
of Amentoflavone permeation and phase II metabolism. This is considered in all cases to 
be satisfactory. 
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Figure 14: Representative fit of Amentoflavone 5µM apical to basal transport across Caco-2 
cell monolayers at 37°C. Experimental points and mo del-based fitted curves. (◊) Apical 
concentration. (∗) Basal concentration. 
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Figure 15: Representative fit of Amentoflavone 5µM basal to apical transport across Caco-2 
cell monolayers at 37°C. Experimental points and mo del-based fitted curves. (◊) Apical 
concentration. (∗) Basal concentration. 
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Figure 16: Representative fit of the total amount of Amentoflavone phase II metabolites 
formed during Amentoflavone 5µM apical to basal and basal to apical transport across 
Caco-2 cell monolayers at 37°C. Experimental points  and model-based fitted curves. (◊) a_b 
transport. (∗) b_a transport. 
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For proper fitting of the transport data of experiments performed at 37°C, small 
adjustments of the model equations had to be done. (Equation 69), describing the 
formation of the phase II in the basal to apical transport direction, was changed to  
CbaM
MCba Mk
dt
dM
••= 2  
(Equation 82) 
as the experimentally detected formed total amount of metabolites was twice as much as 
in the apical to basal direction. This adjustment was not done for the fittings of 
experimental data in presence of Vinblastine or of experiments performed at 4°C as the 
formed amounts of metabolites were either equal in both transport directions or no 
metabolites at all were formed. To simulate a lag time in the formation and excretion of 
the metabolites in the fitting of data from experiments performed at 37°C (Amentoflavone 
alone or in presence of Vinblastine), the values of MMCab(0) and MMCba(0), the total 
amounts of metabolites formed at the start of the experiment, were integrated to the 
fitting as parameters to be estimated, resulting in negative values. This is in contradiction 
to reality with the amounts being zero at the start of the experiment, but is a 
straightforward way to model the delay in the formation and detection of the metabolites. 
This provided more stable fits than setting the initial values of MMCab(0) and MMCba(0) to 
zero or manually to negative values. For the fitting of the data of experiments performed 
at 4°C, the initial values of M MCab(0) and MMCba(0) were set to zero. We generally 
assumed, for experiments at 37°C with Amentoflavone  alone or in presence of 
Vinblastine, the amounts of metabolites in the cellular compartment but not being 
detected due to concentrations below the limit of detection of the analytical method, to be 
6.5% of the total measured amounts of metabolites. This value was also integrated to the 
fitting (MmCab_fit = 0.935 • MmCab). An estimate of the goodness of the fits is the final 
residual value (FRV). The FRVs for fits of experimental data performed at 4°C and 37°C 
were all in the same range (37°C: 5 µM 0.0694, 7.5µM1st experiment 0.133, 7.5µM 2nd 
experiment 0.234, 10µM1st experiment 0.146, 10µM 2nd experiment 0.234 / 4°C: 5 µM 
0.0679, 10µM 0.839 / Vb: 5µM 0.15), indicating the estimated values among the different 
experiments are of equal quality. 
5.5.11.  Model  derived kinetic parameters for  Amentof lavone 
absorpt ion in Caco-2 cel l  monolayers 
The estimated transport parameters for Amentoflavone alone at 37°C are given in (Table 
9). (Table 10) displays the transport parameters for Amentoflavone at 4°C or at 37°C in 
presence of Vinblastine 70µM. 
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Table 9: Kinetic parameters of Amentoflavone for transport (a_b and b_a) across Caco-2 
cell monolayers for 7h at 37°C estimated by regress ion analysis with Easy-Fit. Active efflux 
was modelled as first order process and adsorption was calculated with the model with 
CDonora&b(0). 
CDonor(0) [µM] 5 7.5 1st 7.5 2nd 10 1st 10 2nd 
C(0) a_b [µM] 4.83 5.55 6.26 6.87 8.02 
C(0) b_a [µM] 4.80 5.48 5.77 7.65 7.64 
P ● 106 [cm/s] 38.1 29.5 42.0 23.1 33.6 
vk [1/(s●cm2)] 0.218 0.352 0.829 0.197 0.497 
kM [1/s] 0.0558 0.143 0.0842 0.0729 0.0528 
 
Table 10: Kinetic parameters of Amentoflavone for transport (a_b and b_a) across Caco-2 
cell monolayers for 7h at 4°C or at 37°C in presenc e of Vinblastine 70µM a&b (Vb) 
estimated by regression analysis with Easy-Fit. Active efflux was modelled as first order 
process and adsorption was calculated with the model with CDonora&b(0). 
CDonor(0) [µM] 5 / 4°C 10 / 4°C 5 / Vb 
C(0) a_b [µM] 4.71 10.32 3.80 
C(0) b_a [µM] 3.46 6.42 4.79 
P ● 106 [cm/s] 0.926 0.649 14.056 
vk [1/(s●cm2)] 0.0001 0.0045 0.0151 
kM [1/s] 0 0 0.0293 
 
Consistent values of the passive permeability coefficient were always obtained. For the 
range tested no concentration dependency of the passive permeability was observed. 
The passive permeability was slightly lower than the model estimated permeability for 
Indinavir (53 * 10-6 cm/s) and Saquinavir (89 * 10-6 cm/s) [Kapitza]. As for Amentoflavone 
only calculated lipophilicity values (logP) are available no distinct interpretation is 
possible. The calculated values differ based on the source (5.753 +/- 1.0, for ACD 
Software Solaris V4.67, 3.102 +/- 0.829, for ACD Software Solaris V8.14 and 2.2, value 
calculated by PubChem) making it impossible to compare and discuss the findings based 
on the lipophilicity of Amentoflavone. 
The passive permeability coefficient of Amentoflavone did depend on the temperature at 
which the transport experiments were performed. The estimated values for 4°C were 
about 40 fold lower than the values for 37°C. This is in agreement with diffusion theory 
and validates the model. The reason why the permeability coefficient calculated for the 
presence of Vinblastine in only about half of that without inhibition could not be 
anticipated on theoretical grounds and, being marginal in magnitude, cannot be further 
discussed unless rigorously reproduced. One reason might be due to an underestimation 
of the amount present in the cellular compartment (chapter 5.5.12). 
Preliminary studies with Amentoflavone showed a high level correlation (r = 1) between 
vmax and K in the regression analysis (correlation matrices not shown), which meant that 
these parameters could not be deduced individually from each of these experiments. The 
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best fit was obtained when (Equation 77) was used to describe carrier-mediated 
transport i.e., for a transporter mediated efflux rate dependent of drug mass in the 
cellular compartment. The model estimated values varied for the different concentrations 
but were all in the same range, not showing a clear concentration effect. Again the 
effects of temperature and inhibition were well reflected by the model. Low temperature 
(4°C) lead to an almost complete abolishment of the  apical carrier-mediated transport, 
represented by 100 – 1000 times lower values for vk. The addition of Vinblastine as 
inhibitor of carrier-mediated transport resulted in a 10-fold reduction of the estimated 
values for vk compared to no inhibition, demonstrating the ability of the model to display 
inhibition. As no value of vmax was established, no values for K could be deduced for the 
different experimental settings. The deduced kinetic parameter of apical efflux is global in 
the sense that it does not differentiate between different transporters that may be 
involved. This is sufficient for the delineation of the contributions of passive and carrier 
mediated transport processes, which was one of the objectives of the present work. For 
Amentoflavone up to now only P-glycoprotein was identified as a transporter involved in 
its transport across cell monolayers. Therefore the parameters vk can be regarded as an 
estimate of the mass efflux rate elicited by P-glycoprotein in Caco-2 cells. Distinguishing 
between parameters for individual transporters in the employed Caco-2 experimental 
model entails the availability and use of high specificity, high affinity inhibitors for the 
transporters. 
For Amentoflavone transport at a concentration of 5µM, out of the efflux rate (vk = 0.218 
1/(s●cm2)) and the average amount in the cellular compartment (MCaverage = 
0.00055nmol) an average mass efflux rate of 0.0001199 nmol/(s●cm2) corresponding to 
0.303 ng/s was calculated. The value is about 100 fold lower than the one calculated for 
Saquinavir and Indinavir (vmax = 0.0175µg/s) [Kapitza]. 
The model estimated rate constants for total phase II metabolism, kM, are concentration 
independent. The effect of low temperature, with no experimental determinable phase II 
metabolism, is well reflected by rate constants of zero. For the presence of Vinblastine 
the estimated rate constant is slightly smaller than without inhibition, whereas 
experimental total amounts remained unaffected. This might be explained by slightly 
higher calculated amounts of Amentoflavone in the cellular compartment in presence of 
Vinblastine (chapter 5.5.12), while the total amounts are equal, resulting in a smaller 
estimated value for kM, as the metabolism is modelled as first order process. 
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5.5.12.  Comparison between the measured and calculated amount 
of  Amentof lavone in the cel lular  compartment 
A representative fit of the calculated amount of Amentoflavone in the cellular 
compartment during a_b and b_a transport is shown in (Figure 17). 
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Figure 17: Calculated amounts of Amentoflavone in the cellular compartment during 
Amentoflavone 5µM apical to basal or basal to apical in Transwell plates with cells at 37°C. 
The fitting was done with the model with CDonora&b(0) and the active efflux was modelled as 
a first order process. 
In the simulation, Amentoflavone shows fast distribution into the cellular compartment 
within the first 10min of transport. After this initial binding the amount in the cellular 
compartment remains approximately constant. It is noteworthy that for a certain donor 
concentration both directions of transport result in similar time-profile and the final 
amounts of substance in the cellular compartment. The drug amounts in the cellular 
compartment obtained from model simulation and the comparison with the 
experimentally measured cell associated amounts are shown in (Table 11). 
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Table 11: The calculated amounts of Amentoflavone accumulated in the cellular 
compartment after 7h are compared to the experimental amounts. Vb = Vinblastine 70µM in 
the apical and basal compartment. Active efflux was modelled as first order process and 
adsorption was calculated with the model with CDonora&b(0). NP = not performed. 
amount cell 37°C [nmol]  amount cell 4°C [nmol] AF conc. 
[µM] calculated experimental  calculated experimental 
5 a_b 0.0003 0.0759 +/- 0.0036  0.0076 
0.1804 +/- 
0.0037 
5 a_b & Vb 0.0011 1.2485 +/- 0.0662  NP  
7.5 a_b 0.0002 0.1221 +/- 0.0173  NP  
10 a_b 0.0004 0.1528 +/- 0.0061  0.0010 
0.2183 +/- 
0.0157 
5 b_a 0.0004 0.1145 +/- 0.0150  0.0048 
0.3019 +/- 
0.0058 
5 b_a & Vb 0.0016 2.3539 +/- 0.0972  NP  
7.5 b_a 0.0003 0.1987 +/- 0.0359  NP  
10 b_a 0.0005 0.3504 +/- 0.0396  0.0004 
0.3935 +/- 
0.0457 
 
The model obtained values didn’t show a clear-cut concentration dependency, neither at 
4°C nor at 37°C. For the simulation of the 37°C the  basal to apical direction resulted in 
slightly higher calculated amounts whereas for 4°C the opposite is true. The simulations 
for low temperature resulted in most cases in slightly higher cellular amounts compared 
to 37°C. The model estimated effect of Vinblastine addition is an enhancement of the 
cellular accumulation of Amentoflavone. Contradictory to former findings [Kapitza] the 
calculated values were about two orders of magnitude lower than the experimental 
values found by extracting the cell monolayer. This may be explained by the fact that in 
their study also adsorption appeared but was not integrated to the fittings, and as the 
model is based on mass preservation the loss of drug was accounted to the cell 
compartment. 
The results indicated the necessity to integrate the possibility of the cellular compartment 
acting as a sink for at least parts of the drug permeating through this compartment in 
case of experimentally measured cellular accumulation, mimicking thereby binding to cell 
membranes, accumulation in subcellular compartments or binding to the cytoskeleton. 
Assuming a total geometrical cellular volume of 0.0094ml (chapter 5.4.7), the estimated 
volumes of distribution (chapter 5.5.7) of the experimentally measured cellular amounts 
are in the same range whereas the model-derived volumes of distribution differ by a 
factor of about 100 from the experimental values. It is a fact, that the model-estimated 
amounts are lower than the experimental values, the model doesn’t need higher amounts 
of substance in the cellular compartment for good fittings. In the steady-state there is 
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apical efflux and phase II metabolism that diminish the cell-associated amounts. The 
cellular compartment is modelled as one homogeneous compartment. The concentration 
of drug in the compartment CC is integrated to all the equations describing the processes 
in the cell (diffusion across the apical and basal membrane, apical efflux, phase II 
metabolism). The way the modelling is done assumes that all substance present in the 
cell takes part in these processes, whereas in reality only parts of the substance present 
in the cell is subject to these processes. The cell is an inhomogeneous compartment and 
the substance can distribute into a diversity of subcellular compartments or bind to 
membranes etc. To conclude, for the steady-state situation model estimated cellular 
amounts are lower than the experimentally determined amounts and lower than the 
respective donor concentrations. 
5.5.13.  Adsorpt ion of  Amentof lavone to Transwell  surfaces during 
the transport  across Caco-2 cel l  monolayers 
After the transport experiments with cells, the Transwell plates were extracted with 
methanol to estimate the amount of Amentoflavone bound to the surface during the 
incubation. (Figure 18) shows the experimentally determined amount of Amentoflavone 
bound to the surface as well as the model derived total amounts (model with CDonora&b(0)) 
adsorbed the surface after incubation in Transwells without cells. 
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Figure 18: Amounts of Amentoflavone (AF) extracted from the Transwell plates after apical 
to basal (a_b) and basal to apical (b_a) transport across Caco-2 cell monolayers for 7h at 
37°C. The experimental amounts are compared to the calculated amounts of 
Amentoflavone adsorbed to the Transwell surface. Active efflux was modelled as first 
order process and adsorption was calculated with the model with CDonora&b(0). Experimental 
results are given as mean and standard error of the mean with n = 3 – 6. The light blue 
column indicates a_b transport and the orange column b_a transport. Vb = addition of 
Vinblastine 70µM in the apical and basal compartment. 
The experimentally determined amounts of Amentoflavone extracted from the surface 
after apical to basal transport for 7h at 37°C were  for 5µM 6.7% +/- 0.4, for 5µM + Vb 
9.0% +/- 0.9, for 7.5µM 11.2% +/- 1.1, and for 10µM 10.8% +/- 1.3 of the initial amount at 
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the start of the experiment. The same experiments performed in the basal to apical 
transport direction yielded in the following extraction rates: 5µM 17.5% +/- 1.2, for 5µM + 
Vb 22.4% +/- 0.6, for 7.5µM 20.4% +/- 1.4, and for 10µM 21.2% +/- 0.8 of the initial 
amount at the start of the experiment. The results are not indicating a saturation effect in 
the concentration range tested. The basal to apical transport resulted in much higher 
amounts adsorbed to the Transwell surface, for the absolute amounts as well as the 
percentage value. This may be explained by the bigger contact area in the basal 
compartment and the better distribution of Amentoflavone between the two 
compartments during basal to apical transport, whereas in the apical to basal transport 
direction almost no Amentoflavone permeates. Representative calculated concentrations 
of Amentoflavone bound to the surface of the apical and basal compartment during a_b 
and b_a transport are shown in (Figure 19) and (Figure 20). 
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Figure 19: Calculated amounts of Amentoflavone adsorbed to the apical or basal Transwell 
surface during Amentoflavone 5µM apical to basal in Transwell plates with cells at 37°C. 
The fitting was done with the model with CDonora&b(0) and the active efflux was modelled as 
a first order process. 
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Figure 20: Calculated amounts of Amentoflavone adsorbed to the apical or basal Transwell 
surface during Amentoflavone 5µM basal to apical in Transwell plates with cells at 37°C. 
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The fitting was done with the model with CDonora&b(0) and the active efflux was modelled as 
a first order process. 
For both transport directions, in the donor compartment a fast initial binding of 
Amentoflavone to the surface with a maximum concentration bound after 60min is 
observable. In the a_b direction the concentration of substance bound to the surface 
remains roughly constant, as the decrease in the solution concentration after 60min is 
small. The strong decrease in the solution concentration (as the determinant factor in 
adsorption) in the basal compartment during b_a transport results in desorption of 
substance after the maximum concentration bound to the surface is reached. In the a_b 
direction only small amounts permeate to the basal compartment, resulting in almost 
negligible surface concentrations. Contrarily, in the b_a direction there is a constant flux 
to the apical compartment, resulting in an adsorption profile comparable to the solution 
concentration profile. 
The adsorbed amounts calculated by the model are generally higher compared to the 
experimentally measured values, with the deviations in the basal to apical direction being 
smaller than in the apical to basal direction. Likewise the deviations were smaller for 
higher donor concentrations. For basal to apical transport direction the amounts 
calculated with the model with deviated from the experimentally measured by +78.6%, 
+75.5%, +25.4%, and +18.5% compared to apical to basal transport direction with 
deviations of +259.0%, +151.1%, +63.9%, and +39.2%. The reason for the better 
consistence of the calculated values for the basal to apical transport with the 
experimental values than for the apical to basal transport is ambiguous. 
One reason for the high values of the calculated amounts bound to the surface may be 
the fact that the model estimated amounts for Amentoflavone associated with the cellular 
compartment are too low (chapter 5.5.12). The model equations may attribute some of 
the Amentoflavone present in the system to the surface rather than to the cellular 
compartment. But this may only explain part of the difference between the experimental 
and the calculated amounts. Another option would be an experimental underestimation of 
the amount adsorbed to the surface as discussed for the situation without cells (chapter 
5.5.4). The effect of the addition of Vinblastine on the adsorption of Amentoflavone is 
unclear, as we only used one concentration combination of the two compounds. The 
experimentally determined amounts bound to the surface are higher after the addition of 
Vinblastine, whereas the calculated amounts are in the same range for both experimental 
settings. Further exploration of different concentration combinations would be needed to 
gain more insight into the effect of Vinblastine on Amentoflavone adsorption in 
Transwells. 
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The experimental amounts extracted for experiments performed at 4°C exhibited a 
contradictorily behaviour. For the apical to basal transport smaller amounts were 
extracted than for the experiments performed at 37°C (for 5µM 0.4862nmol +/- 0.0425 
vs. 0.5328nmol +/- 0.0317 and for 10µM 1.2022nmol +/- 0.0609 vs. 1.7199nmol +/- 
0.2126) whereas in the basal to apical direction the expected higher amounts bound to 
the surface were found for the lower temperature (for 5µM 5.6654nmol +/- 0.1452 vs. 
2.4488nmol +/- 0.1618 and for 10µM 11.4381nmol +/- 1.0478 vs. 5.9362nmol +/- 
0.2149). These experimentally determined amounts reflected in the apical to basal 
transport direction for 5µM 6.1% +/- 0.5 and for 10µM 15.0% +/- 0.8 and in the basal to 
apical transport direction for 5µM 27.0% +/- 0.7 and for 10µM 40.9% +/- 3.7of the initial 
amount at the start of the experiment. The deviations of the calculated amounts from the 
experimentally determined ones were extreme for the apical to basal direction (for 5µM 
+607.6% and for 10µM +343.1%) whereas the basal to apical direction was well 
described by the model (for 5µM -6.2% and for 10µM -17.8%). Taken together these 
values indicated, the model cannot precisely describe in all cases the adsorption in the 
situation with cell monolayers present in the Transwell. For the basal to apical transport 
direction the model yields nevertheless in quite reasonable estimates of the adsorption. 
For a more accurate description of the adsorption during apical to basal transport further 
exploration of the adsorption behaviour would be necessary. As the model for adsorption 
only included the plastic surface of the surface and the polycarbonate membrane of the 
Transwell was neglected, the possible influence of the filter support on the adsorption 
should be evaluated. 
5 .5 .14 .  Model  est imated donor amounts/concentrat ions for 
Amentof lavone transport  in Transwells with cel ls  
The drug concentrations at time zero, CA(0) and CB(0), obtained from the best fit were 
smaller than the theoretical concentrations of the prepared aqueous solutions despite the 
integration of the adsorption to the model equations. The donor concentrations obtained 
for the apical to basal transport at 4°C were in be tter agreement with the intended ones 
(88 – 103%) than for the basal to apical transport (64 – 78%), again indicating the vital 
role of the basal compartment with its larger surface in the adsorption and that the model 
is an approximation of the reality with the adsorption parameters being descriptive for 
both compartments together and not for one compartment alone. The donor 
concentrations obtained for transport at 37°C yield ed in better concordance for the apical 
to basal and the basal to apical transport direction, with no tendency for one direction 
resulting generally in higher donor concentrations. The estimated donor concentrations 
were in the range of 68.7 – 96.6% of the intended donor concentrations with the majority 
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of the values in the range of 75 – 85%. The lower calculated donor concentrations is to 
be attributed to some loss of drug during preparation as the time from the preparation of 
the solutions until the addition to cells was longer than during the experiments without 
cells. A second possible reason could be an initial binding of the drug to the cells 
resulting in lower solution concentrations than in Transwells without cells but with the 
same donor amounts, and therefore leading to lower calculated donor concentrations. 
5 .5 .15 .  Mass balances of Amentof lavone transport  in Transwel ls 
with cel ls  
Mass balances were calculated for the permeation experiments by addition of the 
amount in solution after 7h, the amount withdrawn during the experiment, the amount 
metabolised and the amount extracted with methanol from the Transwell surface. The 
intended donor amount provided the reference for calculation. The mass balances for 
experiments performed at 37°C yielded in the apical  to basal direction recovery rates of 
55.6 – 74.6% and in the basal to apical direction 61.4 – 77.7% if only experimental 
values were regarded. If the measured amounts were set into relation with the model 
derived donor concentrations recovery rates were in the a_b direction between 71.5 and 
96.4% and in the b_a direction between 75.2 and 99.9%. By replacing the experimentally 
measured amounts adsorbed by the model derived values recovery rates in the a_b 
direction were mainly between 85.4 and 95% with two outliners of 77.1 and 113.9%. In 
the b_a direction recovery rates with the calculated amounts adsorbed were all between 
88.3 and 103.4%. The mass balances for experiments performed at 4°C yielded in the 
apical to basal direction recovery rates of 57.3 and 75.4% and in the basal to apical 
direction 65.7 and 66.9% if only experimental values were regarded. If the measured 
amounts were set into relation with the model derived donor concentrations recovery 
rates were in the a_b direction 59.7 and 75.6% and in the b_a direction between 95.5 
and 101.2%. By replacing the experimentally measured amounts adsorbed by the model 
derived values recovery rates in the a_b direction were 98.1 and 96.1% and in the b_a 
direction 92.0 and 90.0%. 
5.5.16.  Conclusion 
In the present study the transport of Amentoflavone in the Caco-2 model was studied. 
Amentoflavone showed polarised transport behaviour elicited by P-glycoprotein, was 
subject to glucuronidation and sulfatation by the cells and strongly adsorbed to the 
Transwell apparatus. We employed mathematical modelling encompassing passive 
diffusion, carrier-mediated transport, carrier inhibition, phase II metabolism and non-
specific binding in order to describe the processes taking place in the transport and to 
estimate unbiased transport parameters that are characteristic for the drug and the cell 
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culture system in use. The quantitative assessment of kinetic phenomena taking place in 
the cell culture system used in the drug absorption studies could be well described by the 
proposed model of cellular transport. The model-based evaluation of the experimental 
results of this study shows that the developed model for describing the kinetics of 
permeation in the Caco-2 cell monolayer makes it possible to distinguish in a quantitative 
fashion between the contribution of passive permeation and carrier-mediated efflux to 
drug transport in this system. Reasonable values for the passive permeability coefficient 
and for the carrier-mediated transport, were obtained by the model. The influence of 
temperature and inhibition was well reflected by the two parameters. The estimated 
kinetic constants for metabolism and adsorption are not a complete description of the 
processes taking place in reality but are useful tools to describe the transport. The 
inclusion of adsorption and phase II metabolism to the model allowed us in the first place 
to analyse Amentoflavone transport, as the cellular transport could be corrected for this 
distorting effects. This analysis is proposed as a tool for independently determining the 
contribution of the individual transport processes to the overall cellular permeation. 
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6 .  I n d i v i d ua l l y  s t u d i e d  a b s or p t i o n  o f  D i go x i n ,  
Q u i n i d i n e ,  a nd  V er a pam i l  ac r os s  Ca c o- 2  c e l l s  a n d 
t h e  i n f l ue n ce  o f  b i n ar y c o m bi n a t i o n s  on  p a ss i ve  
d i f f u s i o n  a nd  a c t i ve  e f f l u x ,  a n a l ys e d  w i t h  a  
m at h em at i c a l  m o d e l  f o r  d e t e r mi n a t i o n  o f  d r u g 
a b s or p t i on  par am et er s .  
6.1 .  Abst rac t  
Purpose 
The present study’s aim was the further evaluation of a mathematical model for 
delineating the passive and carrier mediated contributions to the absorption of some 
apical efflux substrates in Caco-2 cell monolayers. Special respect was given to the 
effect of concentration and binary combinations of substances, on permeation in terms of 
these two contributing factors, passive diffusion and active apical efflux and the 
comparison with the conventional approach to analyse data from transport experiments, 
the calculation of the apparent permeability Papp. 
Material and methods 
The epithelial membrane transport kinetics of the P-glycoprotein substrates Digoxin (0.5 
– 100µM), Quinidine (1 – 200µM) and Verapamil (5 – 1000µM) alone and during 
concomitant incubation of different combinations were studied using Caco-2 monolayers 
cultured in the Transwell system. The system of differential equations of the developed 
mathematical model was fitted to experimental concentration data, and optimal values of 
the kinetic parameters were deduced using the software EASY-FIT. Kinetic analysis of 
the carrier-mediated transport and the passive permeability was performed with respect 
to concentrations-dependency of these and parameters and the influence of concomitant 
transport. 
Results 
All compounds used showed asymmetrical transport across Caco-2 cell monolayers, the 
extent of which depended on the compound and the concentration used. The Papp values 
for all three compounds were compared to previously reported ones and found to be 
comparable. Consistent values for the model estimated passive permeability coefficients 
were obtained with Verapamil possessing the highest and Digoxin the lowest passive 
permeability. No concentration dependency of the passive permeability was observed in 
the range tested. The parameter for the carrier-mediated efflux rate, vk, was different for 
each compound and concentration, reflecting the different propensity of the drugs to be 
apically effluxed and allowing quantitative assessment of the efflux. Only for Quinidine 
saturation of the apical efflux was observed. Comparison of the Papp with the model 
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estimated kinetic parameters demonstrated the sensibility of its values to small 
deviations in the mode of calculation and the necessity of sink-conditions for the 
calculation of accurate values of Papp. The contributions and the interplay of passive 
diffusion and active efflux to the net mass flux across the Caco-2 cells were different for 
all three compounds and changed in a concentrations-dependent manner. The model-
derived parameters from transport experiments with concomitant incubation of two 
compounds, demonstrated different levels and potencies of interactions between the 
compounds. Depending on the combination and the concentrations used, both reduction 
and enhancement of the apical efflux rate and the passive permeability were observed. 
Conclusions 
The present study demonstrates the utility of the proposed mathematical model for 
kinetic analysis of transport phenomena in confluent monolayers of Caco-2 cells cultured 
in the Transwell system. The model-derived parameters are less susceptible to distorting 
effects like non-sink conditions and allow their determination by simple fitting of 
concentration-time profiles. It was demonstrated, that consistent values for passive 
permeability and efflux rates are calculable by the model and that interactions between 
compounds are well reflected by the kinetic parameters. 
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6.2 .  In troduct ion  
One essential step in modern drug discovery and development is the evaluation and 
analysis of the ADME properties of a new active pharmaceutical ingredient (API). For the 
rapid assessment of these properties many in vitro and in situ methods were developed 
with different levels of complexity and sophistication [Bohets, Hidalgo 2001]. Cell free, 
lipid based assays like PAMPA [Avdeef 2003, Kansy] allow higher throughput and easier 
miniaturization compared to cell models that allow mechanistic studies. In order to probe 
the mechanistic aspects of solute transport, simplified models of the respective cellular 
barrier have been developed in recent years. In many cases, the cells that comprise 
these barriers, or cells that serve to mimic the barrier of interest, can be maintained in 
culture [Ho]. To study the drug permeability at different sites in the human body cell 
models for intestinal permeation (e.g. Caco-2 and 2/4/A1), for the blood – brain barrier 
(primary cell culture and immortalized cell lines), for hepatic drug metabolism and 
transport and for the renal drug transport are accessible [Deli, Ghibellini, Hidalgo 1989, 
Schlatter, Tavelin]. The different models can be wild – type (Caco-2, MDCK), transfected 
(h-MDR1-MDCKII), or downregulated [Hilgendorf] cell lines. 
The use of in vitro cell permeation experiments across cell monolayers to study the 
absorption of substances is widely accepted and popular [Artursson 2001, Balimane 
2005]. Depending on the compounds used and the experimental setting, the purpose of 
these studies can be the general assessment of the permeability of a compound 
[Artursson 2001], the development of structure – permeability relationships [Chen 2006], 
the development of in vitro – in vivo correlations [Artursson 1991 B, Usansky, Yee], to 
identify transporters (influx and efflux) involved in cellular permeation [Maeda], the study 
of transporter kinetics and development of comprehensive models of transporter function 
[Tran 2005], the study of the interplay between transporters and metabolism [Benet], the 
study of drug – drug interactions [Rautio] and the study of formulation effects [Kapitza, 
LeCluyse]. 
In the recent past years the awareness of the necessity of detailed and precise analysis 
of data derived from in vitro permeation experiments arose. The approaches of different 
research groups can be focused on modelling and experimental determination of (sub-) 
cellular pharmacokinetics and distribution [Duvvuri, Zhang], more exact estimations of 
the passive permeability coefficient [Tran 2004], the influence of the transport direction 
on the apical active efflux [Troutman 2003 A], consideration of the influence of the 
aqueous boundary layer on estimated transporter kinetics from overexpresion systems 
[Balakrishnan]. 
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When examining drug permeability and the influence of carrier-mediated transport in vitro 
models it is customary to use an approximate solution for the permeability coefficient Papp 
and based on that the calculation of the efflux ratio under sink conditions. This approach 
is afflicted with limitations [Youdim, Tran 2004]. To identify substrates for active efflux 
transporters like P-glycoprotein by calculation of the ER the estimated Papp values have 
to within an optimal range. For substrates that have Papp values outside of this range, the 
identification as a substrate is prone to fail by using this approach [Polli]. Recently it was 
shown that the effects of P-glycoprotein mediated efflux on the absorptive and secretory 
transport may not be symmetrical, per given donor concentration [Troutman 2003 A]. 
An alternative approach to the use of the apparent permeability coefficient and its 
improvements is the use of biophysical modelling of the transmembrane events involving 
passive diffusion and efflux mechanisms. The intent of such modelling is to delineate and 
quantify the mass transfer mechanisms that take place during permeation. This approach 
may furthermore provide means for the evaluation of the influence of type and 
concentration of the chosen compound as well as the influence of a second substance or 
of excipients on the permeation in terms of passive diffusion and active efflux, depending 
on the exact mode of modelling. These models can provide information about critical 
parameters and the behaviour of the system if the parameters are changed. In the study 
of efflux transporters the modelling and the measurement of the kinetic characteristics of 
transport can be a powerful approach to enhancing the understanding of their function 
and mechanism or probe different hypothesis about the exact mode of efflux [Litman 
2003, Tran 2005]. Other modelling approaches including both, passive diffusion and 
active efflux focus on the use of these procedures as tools for improving the prediction 
ability of in vitro models [Rodriguez-Ibáñez]. 
Our group recently published a mathematical model to describe the transport of drug 
between the apical, the basal, and the cellular compartment [Kapitza], which enables the 
direct estimation of the transport parameters from concentration-time profiles of 
permeation experiments. The developed model took into account passive permeation 
described by the permeability coefficient P and carrier mediated efflux described by the 
kinetic parameter vk. In another publication [Blaser] we presented extensions to the 
model with inclusion of phase II metabolism and adsorption to the Transwell surface. In 
the present publication with used the mathematical model for delineation of cell 
permeation kinetics of Digoxin, Quinidine, and Verapamil. All three compounds are well 
known to be P-glycoprotein substrates and inhibitors. The focus was the concentration-
dependent assessment of the contributions of passive diffusion and carrier-mediated 
transport to the overall permeation characteristics. The model derived kinetic parameters 
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were then compared to the conventional Papp values. A second part of the publication 
deals with the effect of concomitant incubation of two different compounds on the passive 
permeability and the efflux rate of the two compounds. 
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6.3 .  Mater ia ls  and methods  
6.3.1.  Materials 
The human colon adenocarcinoma cell line Caco-2 was a gift of Prof. H. P. Hauri, 
Biocenter, University of Basel, and originated from the American Type Culture Collection 
(ATCC, Rockville, MD, USA). Dulbecco’s modified Eagle’s medium (DMEM) (with l-
glutamine, 4500mg/l D-glucose, without sodium pyruvate), l-glutamine 200mM (100x), 
MEM non-essential amino acids solution (100x, without l-glutamine), foetal bovine serum 
FBS, Trypsin-EDTA (10x) liquid, and Dulbecco’s Phosphate Buffered Saline (without 
Ca2+ Mg2+) were all purchased from Gibco (Gaithersburg, MD, USA). For cell culture 
DMEM was supplemented with 10% (v/v) FBS, 2mM l-glutamine, and 1% MEM. 
Transport media used for the permeation studies and the cytotoxicity experiments were 
made with Dulbecco’s modified Eagle’s medium (DMEM) base (without glucose, l-
glutamine, phenol red, sodium pyruvate and sodium bicarbonate) (SIGMA-Aldrich, Fluka 
Chemie GmbH, Buchs, Switzerland). This was dissolved in bi-distilled and autoclaved 
water and supplemented with glucose (4.5g/l), HEPES (4.76g/l), NaCl (1.987g/l) and l-
glutamine (0.876g/l), the pH was adjusted to 7.40 and the final medium was subjected to 
sterile filtration. Glucose, Hepes, NaCl and l-glutamine were all obtained from SIGMA-
Aldrich, (Fluka Chemie GmbH, Buchs, Switzerland). Petri dishes (56.7cm2), 24-well 
plates and 96-well plates were from Nunc (Roskilde, Denmark) and the 6-well Transwell 
plates were from Costar, Corning (NY, USA). Quinidine Hydrochloride Monohydrate 
(Dihydroquinidine content 11%) and (+/-)-Verapamil Hydrochlorid (minimum 99.0% 
titration) were obtained from SIGMA-Aldrich (Fluka Chemie GmbH, Buchs, Switzerland). 
Digoxin (purum; >95.0% (HPLC)), dimethylsulfoxid (DMSO), sodium dodecyl sulfate 
(SDS) and the thiazolyl blue tetrazolium bromide for the MTT assay were purchased from 
Fluka (Fluka Chemie GmbH, Buchs, Switzerland). All other reagents were of analytical 
grade. 
6.3.2.  Cel l  cul ture 
Caco-2 cells were grown in petri dishes and maintained at 37°C in an atmosphere of 8% 
CO2 and in equilibrium with distilled water using culture medium. They were passaged by 
treatment with 0.25% trypsin and 2.65mM EDTA with a splitting ratio of 1:12. The 
medium was changed every alternate day until the petri dishes reached 90% confluence. 
Cells were used at passage number 60 – 65. 
6.3.3.  MTT-assay 
Mitochondrial activity of the cell was evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT) assay. This assay is based on the reduction of 
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MTT by hydrogenase activity in functionally intact mitochondria [Mosmann]. The 
hydrogenase catalyses the conversion of the yellow MTT reagent to blue formazan 
crystals. Caco-2 cells were seeded on 24-well plates or 6-well Transwell plates at a 
density of 114,000cells/cm2 and used for experiments 9 days postseeding (24-well 
plates) or 22 days post-seeding (6-well Transwell). Medium was changed every other 
day. The effect of concentration of Digoxin, Quinidine and Verapamil and combinations of 
these compounds was investigated using 3 wells per group. The treatment of the cells 
with respect to the preparation steps before incubation and the incubation time was the 
same as in the transport experiments with the compound and concentration in question. 
After removing the culture medium, cells of the 24-well plates were rinsed once with 
1.5ml D-PBS (with Ca2+ und Mg2+) and 1000µl of the transport medium were added to 
each well. The cells of the 6-well Transwell plates were rinsed on the apical side with 
3.5ml and on the basal side with 4ml D-PBS (with Ca2+ und Mg2+) and 1600µl of the 
transport medium was added to the apical compartment and 2800µl of the transport 
medium was added to the basal compartment of each well. The plates were then 
incubated for 60min in the incubator (Sorvall Heraeus, Heracell, Kendro, Switzerland). 
Then the compounds were added to the transport medium and the cells incubated for 3h 
in the incubator hood (TH 15, Edmund Bühler GmbH, Tübingen & Hechingen, Germany) 
at 37°C in a water vapour saturated atmosphere and shaken at 75rpm on a compact 
shaker (KS 15, Edmund Bühler GmbH, Tübingen & Hechingen, Germany). After 
removing the incubation solutions, the cells of the 24-well plates were rinsed with 1ml D-
PBS (with Ca2+ und Mg2+) and 800µl culture medium and 80µl MTT solution (5mg/ml in 
D-PBS (without Ca2+, Mg2+)) was added to each well resulting in a final MTT 
concentration of 0.45mg/ml. The cells were then incubated for another 4h in the 
incubator. The cells of the 6-well Transwell plates were rinsed on the apical side with 
3.5ml and on the basal side with 4ml D-PBS (with Ca2+ und Mg2+). The inserts were then 
transferred to petri dishes and 1500µl culture medium and 150µl MTT solution (5mg/ml in 
D-PBS (without Ca2+, Mg2+)) was added to the apical compartment of each well resulting 
in a final MTT concentration of 0.45mg/ml. The cells were then incubated for another 4h 
in the incubator. Subsequently the cells of the 24-well plates were lysed and developed 
formazan crystals were dissolved by adding 800µl lysis buffer containing 10% SDS in 
0.01 M HCl [Tada] and incubation for 15 h in the incubator. In the case of the 6-well 
Transwell plates 1500µl lysis buffer were added. The amount of formazan was quantified 
in quadruplicate by transferring 200µl to a 96-well plate and measuring the absorbance at 
580nm (reference wavelength 650nm) using an ELISA plate reader (VERSAmax, 
Molecular Devices, Sunnyvale, CA, USA). 10µl of ethanol absolutum were added to 
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avoid foam. Mitochondrial activity was expressed relative to a control group treated with 
transport media. 
6.3.4.  TEER 
The transepithelial electrical resistance (TEER) of cultured cells on Transwell inserts was 
monitored before and after each permeation experiment with an EVOM epithelial 
voltohmmeter (World Precision Instruments WPI, Berlin, Germany). Before the 
experiment, Caco-2 monolayers were washed on the apical side with 3.5ml and on the 
basal side with 4ml D-PBS (containing Ca2+ und Mg2+) and 1600µl of the transport 
medium were added to the apical compartment and 2800µl to the basal compartment. 
The 6-well Transwell plates were then incubated for at least 60min in the incubator 
before the pre-experiment TEER measurement. Before the post-experiment TEER 
measurement the withdrawn sampling volume was replaced with transport medium. The 
TEER measurements were performed at 37°C in the End ohm-24 Chamber (World 
Precision Instruments WPI, Berlin, Germany) containing 4.6ml transport medium. 
Physiologically and morphologically well-developed confluent Caco-2 monolayers (at 
least 18 days old) with TEER values above 250Ωcm2 were used in the experiments. 
6.3.5.  Individual permeation of Digoxin,  Quinidine and Verapamil  
across Caco-2 cel l  monolayers at  37°C 
Cells were seeded at a density of 114,000 cells/cm2 onto 6-well Transwell plates with an 
insert area of 4.7cm2 and a pore size of the polycarbonate membrane of 0.4µm. Culture 
medium was changed every other day and cell monolayers were used between 18 and 
22 days post seeding. The drug was added from a stock solution after the TEER 
measurement either in the apical or in the basal compartment with respect to the cell 
monolayer. The transport directions were therefore apical to basal (a_b) and basal to 
apical (b_a). Bidirectional transport of different concentrations of Digoxin (0.5, 1, 2.5, 5, 
10, 20, 35, 50, 65, 80 & 100µM), Quinidine HCl (1, 2.5, 5, 7.5, 10, 20, 30, 40, 50, 65, 80, 
100, 150 & 200µM), Verapamil HCl (5, 7.5, 12.5, 25, 50, 75, 100, 150, 200, 250, 500, 750 
& 1000µM) alone was investigated in these permeation studies. Three wells were used in 
each group (concentration and transport direction). Permeation of drug across the cell 
monolayer was monitored by sampling the solutions in both compartments, at predefined 
time points for the duration of 3h. Samples of 54µl were drawn after 15, 30, 45, 60, 90, 
120 and 180min. 6µl of a solution of Tween 80 0.1% (v/v) were added to the sample. The 
samples were mixed with a reagent mixer. The withdrawn volume was not replaced. The 
samples were collected in glass vials (Infochroma AG, Zug, Switzerland and Schmidlin 
Labor & Service AG, Sarbach, Switzerland) except for all experiments including Digoxin 
in which polypropylene vials (Milian AG, Geneva, Sw
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USA / Basel, Switzerland) were used. The starting volume of the apical solution was 
1600µl and the one of the basal solution 2800µl. During the permeation experiment the 
Transwell plates were kept at 37°C in a water vapou r saturated atmosphere in the 
incubation hood and agitated on an orbital compact shaker at 75min−1. After the 
permeation experiment the TEER values of the cell monolayers were measured again. 
Only data derived from experiments with final TEER values exceeding 80% of the initial 
values was used. 
6.3.6.  Drug permeation of  binary combinat ions of  compounds 
across Caco-2 cel l  monolayers at  37°C 
Caco-2 cells were grown on 6-well Transwell plates as previously described. The drugs 
were added together after the TEER measurement either in the apical or in the basal 
compartment with respect to the cell monolayer. Bidirectional transport of different 
combinations of compounds and concentrations were studied in these permeation 
studies (Table 12 to Table 14). Three wells were used in each group (compound 
combination, concentration and transport direction). Permeation of drugs across the cell 
monolayer was monitored as described before. After the permeation experiment the 
TEER values of the cell monolayers were measured again. Only data derived from 
experiments with final TEER values exceeding 80% of the initial values was used. 
Table 12: Combinations of Digoxin and Quinidine used to study concomitant transport in 
Caco-2 cell monolayers. 
combination 
number  Digoxin [µM]  Quinidine [µM] 
1  1  250 
2  1  250 
3  10  250 
4  10  250 
5  50  5 
6  50  50 
7  50  250 
8  100  1 
9  100  10 
10  100  50 
11  100  100 
12  100  250 
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Table 13: Combinations of Quinidine and Verapamil used to study concomitant transport in 
Caco-2 cell monolayers. 
combination 
number  Quinidine [µM]  Verapamil [µM] 
1  1  500 
2  10  25 
3  10  100 
4  10  250 
5  10  500 
6  20  250 
7  20  500 
8  50  50 
9  100  25 
10  100  50 
11  100  100 
12  250  5 
13  250  25 
 
Table 14: Combinations of Digoxin and Verapamil used to study concomitant transport in 
Caco-2 cell monolayers. 
combination 
number  Digoxin [µM]  Verapamil [µM] 
1  100  5 
2  100  25 
 
6.3.7.  HPLC 
Drug concentration in the samples of the Digoxin experiments was determined by 
capillary HPLC (Agilent series 1100, Agilent Technologies, USA) with a capillary pump 
G1376A, an autosampler G1377A µWPS and a variable wavelength detector G1314A. A 
C-8 reversed phase column (MB 125/1 Nucleosil 100-5 C8ec, Macherey-Nagel, 
Oensingen, Switzerland) and the following mobile phase was used: H2O (bi-distilled and 
filtered through 0.45µm)/MeOH/THF/acetic acid 96% (v/v) = 52/38/9/1. 5g/l ammonium 
acetate was dissolved in the mobile phase. pH-value at 25°C was 4.92. An isocratic 
method was used for quantification. The flow rate was 50µl/min, the injection volume 
40µl and the runtime 8min. Digoxin was detected at 220nm in UV. Using this method the 
retention of Digoxin was approximately 4.5min. Quantification was performed against a 
set of external standard solutions within the linear response concentration range. 
Drug concentration in the samples of the Quinidine experiments was determined by 
capillary HPLC with the same column, mobile phase and injection volume as Digoxin. An 
isocratic method was used for quantification. The flow rate was 50µl/min, the injection 
volume 40µl and the runtime 6min. Quinidine was detected at 250nm in UV. Using this 
method the retention of Quinidine was approximately 3min. Quantification was performed 
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against a set of external standard solutions within the linear response concentration 
range. 
Drug concentration in the samples of the Verapamil experiments was determined by 
capillary HPLC with the same column, mobile phase and injection volume as Digoxin. An 
isocratic method was used for quantification. The flow rate was 50µl/min, the injection 
volume 40µl and the runtime 6min. Verapamil was detected at 280nm in UV. Using this 
method the retention of Verapamil was approximately 3.5min. Quantification was 
performed against a set of external standard solutions within the linear response 
concentration range. Alternatively, drug concentration in the samples of the Verapamil 
experiments was determined by capillary HPLC with the same column as Digoxin but a 
gradient method and the following mobile phases. Mobile phase A: H2O (bi-distilled and 
filtered through 0.45µm)/MeOH/THF/acetic acid 96% (v/v) = 59/19/11/11. 1.994g/l 
ammonium acetate was dissolved in the mobile phase. Mobile phase B: H2O (bi-distilled 
and filtered through 0.45µm)/MeOH/THF/acetic acid 96% (v/v) = 10/65/12/13. 1.994g/l 
ammonium acetate was dissolved in the mobile phase. The flow rate was 50µl/min, the 
injection volume 40µl and the runtime 15min. The gradient method started with 100% of 
A. From 0 to 9min the composition of the mobile phase was changed to 100% of B and 
then until the 10.min back to 100% of A. Verapamil was detected at 280nm in UV. Using 
this method the retention of Verapamil was approximately 4min. Quantification was 
performed against a set of external standard solutions within the linear response 
concentration range. 
Drug concentration in the samples of experiments of Digoxin in combination with 
Quinidine was determined by capillary HPLC with the same column and mobile phase as 
Digoxin alone. An isocratic method was used for quantification. The flow rate was 
50µl/min, the injection volume 40, 20 or 10µl, depending on the concentrations used and 
the runtime was 8 or 11min. Digoxin was detected at 220 or 240nm in UV and Quinidine 
at 250nm in UV. Using this method the retention of Quinidine was approximately 3min 
and the retention of Digoxin was approximately 4.5min. The method could be used within 
a concentration range of 1µM-100µM for Digoxin and 1µM-250µM for Quinidine. 
Quantification was performed against a set of external standard solutions within the 
linear response concentration range. 
Drug concentration in the samples of experiments of Digoxin in combination with 
Verapamil was determined by capillary HPLC with the same column as Digoxin alone 
and the following mobile phase was used: H2O (bi-distilled and filtered through 
0.45µm)/MeOH/THF/acetic acid 96% (v/v) = 62.4/28/9/0.6. 5g/l ammonium acetate was 
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dissolved in the mobile phase. pH-value at 25°C was  4.93. An isocratic method was used 
for quantification. The flow rate was 50µl/min, the injection volume 40µl and the runtime 
15min. Digoxin was detected at 240nm in UV and Verapamil at 280nm in UV. Using this 
method the retention of Verapamil was approximately 6min and the retention of Digoxin 
was approximately 12min. Quantification was performed against a set of external 
standard solutions within the linear response concentration range. 
Drug concentration in the samples of experiments of Quinidine in combination with 
Verapamil was determined by capillary HPLC with the same method as Digoxin in 
combination with Verapamil. An isocratic method was used for quantification. The flow 
rate was 50µl/min, the injection volume 20µl and the runtime 10min. Quinidine was 
detected at 250nm in UV and Verapamil at 280nm in UV. Using this method the retention 
of Quinidine was approximately 4min and the retention of Verapamil was approximately 
6min. Quantification was performed against a set of external standard solutions within 
the linear response concentration range. The method could be used up to a 
concentration 500µM for Quinidine and 500µM Verapamil at the same time. 
6.3.8.  Calculation of  the apparent  permeabi l i ty coeff icient  and 
the ef f lux rat io 
For all compounds used, the apparent permeability coefficient (Papp) in the apical to basal 
as well as in the basal to apical transport direction and the efflux ratio (ER) were 
calculated after 15min. The Papp was calculated using the following relation: 
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(Equation 83) 
where VR is the volume of the receiver compartment [ml], ∆CR is the change in 
concentration in the receiver compartment [µM], ∆t is the change in time [s], S is the area 
of the monolayer [cm2], A is the amount of drug transported [nmol], and CD0 is the initial 
concentration in the donor compartment. The efflux ratio (ER) was calculated using the 
following relation. The apparent permeability coefficient in the basal to apical transport 
direction is divided by the apparent permeability coefficient in the apical to basal 
transport direction: 
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(Equation 84) 
The apparent permeability coefficients as well as the efflux ratio are displayed depending 
on the initial concentration used in the donor compartment. 
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6.3.9.  Mathematical  model  for  determining drug absorpt ion 
parameters in Caco-2 cel l  monolayers 
In an earlier publication our group presented a mathematical model to describe the 
transport of drug between the apical, the basal, and the cellular compartment [Kapitza]. 
This model enables a direct estimation of the relevant transport parameters from 
concentration-time profiles. The developed model took into account passive permeation 
and carrier mediated efflux. The transport processes considered for modelling drug 
permeation in the Caco-2 cell monolayer and the relevant processes in the basic model 
are passive diffusion and carrier-mediated efflux at the apical membrane. For the 
detailed derivation of the model equations and extensions to the model with inclusion of 
phase II metabolism and adsorption the reader is referenced to [Blaser]. The present 
publication only uses the basic model with passive permeation and carrier-mediated 
efflux, as in preliminary experiments with all three compounds used in this study neither 
adsorption nor phase II metabolism was detected. Briefly, this model was based on the 
following assumptions: 
1) Three different compartments are considered in which drug concentration varies with 
time, the apical, the cellular and the basal compartment. 
2) Drug may move between the apical and the cellular and the cellular and the basal 
compartment in both directions by passive diffusion. Passive diffusion through the apical 
and the basal cell membrane is symmetrical and is characterized in both cases by the 
permeability coefficient, P. No effect of electrical membrane potential on the transport is 
considered. 
3) Drug is subject to carrier mediated active efflux from the cellular to the apical 
compartment that is described by the parameter vk, the apical efflux rate. 
4) No two different orientations or conformations of the carrier at the two faces of the 
membrane are explicitly involved. The drug concentration in the apical compartment 
does not influence efflux transport and the entire mass of drug present in the cellular 
compartment is substrate of the transporter. 
5) The total mass of drug in the three compartments is preserved.  
The differential equations describing the change of drug concentration or mass as a 
function of time in the three compartments during permeation in both directions if the 
relevant processes are passive diffusion and carrier-mediated transport are the following: 
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transport direction apical to basal: 
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(Equation 87): cellular compartment 
transport direction basal to apical: 
AA
AbaCba
Aba
V
Sm
vk
V
SmCCP
dt
dC
•+•−•= )(
 
(Equation 88): apical compartment 
B
CbaBba
Bba
V
SmCCP
dt
dC
•−•−= )(  
(Equation 89): basal compartment 
CCC
AbaCbaCbaBba
Cba
VCM
with
SmvkSmCCPSmCCP
dt
dM
•=
•−•−•−•−•= )()(
 
(Equation 90): cellular compartment 
C is the molar concentration [µM], M is the molar amount of substance [nmol], P the 
permeability coefficient [cm/s], vk the apical efflux rate [nmol/(cm2●s)], the indices A, B, 
and C (upper case) denote the apical, basal and cellular compartment, respectively, the 
indices ab and ba (lower case) denote permeation in the apical to basal and the basal to 
apical direction, respectively, Sm is the surface area of the monolayer [cm2] and V is 
volume of solution in each compartment [ml]. 
6.3.10.  Modell ing of the reduct ion of the volume of  solution 
The reduction of the volume of solution in the apical and the basal compartment due to 
sampling as a function of time was accounted for by polynomial relations describing this 
reduction. The reduction was modelled as a continuous reduction over time and not as it 
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is in reality as a stepwise reduction at discrete times. For the modelling of the reduction 
of the volume, timepoints for certain volumes were exactly between the times for two 
sample drawings. The first point reflecting the initial volumes was set after 15min. The 
parameters of the polynomial relations were determined empirically using regression 
analysis with EASY-FIT using the model type “explicit”, the numerical method “DFNLP”, 
a scaling of 1 and a termination tolerance of 0.00000001. The point of origin and the 
endpoint were free for the fitting. The values
 for the different parameters, Vapical,0,calculated 
and Vbasal,0,calculated were determined for the transport experiments over 3h with sampling 
volumes of 54µl and sampling after 15, 30, 45, 60, 90, 120 and 180 minutes. The 
determined relations were later on used in the fittings of the data of transport 
experiments. For a sampling volume of 54µl regression analysis yielded in the following 
polynomial relations for the reduction of the volume.
 
32 80000000225.0000017685.00045391.063560489.1)( ttttVapical •−•+•−=  
(Equation 91) 
32 30000000225.0000017673.00045382.083560998.2)( ttttVbasal •−•+•−=  
(Equation 92) 
6.3.11.  Analysis of  compound permeation across Caco-2 cel l 
monolayers 
Permeation data were analysed using this theoretical model for the kinetics of cellular 
transport. The concentration variables defined by the system of differential equations 
were fitted to the experimental concentration data. Concentration data of both 
compartments obtained from the apical to basal and the basal to apical direction of 
permeation were simultaneously fitted. This provided a more stable regression analysis 
compared to the separate evaluation of each permeation direction. In previous work the 
carrier-mediated transport was modelled by Michaelis-Menten kinetics [Kapitza], but in 
most instances a strong correlation between vmax and K occurred in the regression 
analysis, which meant that these parameters could not be deduced individually from 
each other. Therefore all fittings in the present work were performed describing the 
carrier-mediated efflux by the global efflux rate vk, which describes the amount of 
substance pumped out of the cell per time and area. The reduction of the volume of 
solution over time was accounted for by the already mentioned polynomial equations. 
Numerical solution of the equations and least squares fit were performed using the 
software Easy-Fit and optimal values of the kinetic parameters P and vk applicable to 
the different experimental conditions were deduced. The regression analysis with EASY-
FIT was performed using the model type “ODE” (ordinary differential equations), the 
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numerical method “DFNLP”, a scaling of 1, an initial stepsize of 0.00000001 and a final 
accuracy (absolute and relative) of 0.00000001. The transport data obtained by the 
methods described in chapter 6.3.5 and 6.3.6 was used in the fittings. Transport 
parameters were determined for every single compounds and every combination 
experiment. A cell monolayer volume of 0.0094ml was used based on a monolayer 
thickness of 20µm and a monolayer area of 4.70cm2. The regression analysis resulted in 
values for the passive permeability coefficient P in cm/s and the rate constant vk, which 
expresses the apical mass efflux rate of the drugs elicited by P-glycoprotein in Caco-2 
cells in nmol/(cm2●s). Furthermore the drug concentrations at time zero, CAab(0) and 
CBba(0) and the drug mass in the cellular compartment were obtained from model 
simulation. 
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6.4 .  Resul ts  and  d iscussion  
6.4.1.  Cel l  toxici ty of  the dif ferent  compounds and combinat ions 
The possibility of adverse effects elicited by the different compounds and combinations 
used on cultured Caco-2 cell monolayers was evaluated by determining the 
mitochondrial dehydrogenase activity of the cells by using the MTT assay. This is an 
established method addressing one aspect of cell functionality and is widely used as a 
criterion of cytotoxicity. The MTT assay detects specifically mitochondrial metabolic 
activity and the ability of the cells for proliferation. 
After 3h incubation with Quinidine alone, the mitochondiral activities as reported by the 
MTT assay, were for 5µM 104.23% +/- 5.38, for 50µM 107.32% +/- 3.54, for 100µM 
98.84% +/- 3.58 and for 250µM 94.05% +/- 3.01 of the control. Only the value for 50µM 
was statistically significant higher from the control as determined by the Student’s t-test 
at p < 0.05. After 3h incubation with Digoxin alone, the mitochondiral activities were for 
1µM 94.94% +/- 3.56, for 5µM 95.01% +/- 3.14, for 50µM 91.85% +/- 2.78 and for 100µM 
86.60% +/- 2.76 of the control. The values for 50µM and 100µM were statistically 
significant lower from the control as determined by the Student’s t-test at p < 0.05. After 
3h incubation with Verapamil alone, the mitochondiral activities were for 5µM 98.57% +/- 
2.19, for 50µM 95.37% +/- 2.02, for 100µM 98.02% +/- 3.83, for 250µM 100.28% +/- 4.65 
and for 1000µM 115.50% +/- 4.85 of the control. Only the value for 1000µM was 
statistically significant higher from the control as determined by the Student’s t-test at p < 
0.05. 
Taken together the employed concentrations of Quinidine and Verapamil alone didn’t 
show a concentration – activity trend and had overall no significant cytotoxic effect on the 
cells. The statistically significant effects observed in each case were not consistent within 
the series of applied concentrations (both Quinidine and Verapamil). Hence, they do not 
appear to be systematic and there are not harmful effects of Quinidine and Verapamil 
alone in the concentration range and incubation time used. For Digoxin we observed a 
concentration dependent decrease in the mitochondrial activity with the activities for the 
highest Digoxin concentration used being statistically significant lower compared to the 
control. Therefore we have to take care, if there are no confounding effects caused by 
this slightly cytotoxic effect, on the permeation in terms of the passive permeability and 
the carrier-mediated transport. The results of the MTT assay for combinations of the 
different compounds are shown in (Figure 21) to (Figure 23). 
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Figure 21: Mitochondrial dehydrogenase activity of the cells determined by the MTT assay 
following 3h incubation in 24 well plates. Results are expressed in percent of control 
obtained with transport medium and given as mean and standard deviation with n = 3. D = 
Digoxin, Q = Quinidine, concentrations are given in µM. 
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Figure 22: Mitochondrial dehydrogenase activity of the cells determined by the MTT assay 
following 3h incubation in 24 well plates. Results are expressed in percent of control 
obtained with transport medium and given as mean and standard deviation with n = 3. D = 
Digoxin, VP = Verapamil, concentrations are given in µM. * denotes results that are 
statistically significant from the control at p < 0.05. 
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Figure 23: Mitochondrial dehydrogenase activity of the cells determined by the MTT ay 
following 3h incubation in 24 well plates. Results are expressed in percent of control 
obtained with transport medium and given as mean and standard deviation with n = 3. Q = 
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Quinidine, VP = Verapamil, concentrations are given in µM. * denotes results that are 
statistically significant from the control at p < 0.05. 
For the 3h incubation with combinations of Digoxin and Quinidine, mitochondrial activity 
values of the cells were in the range between 93.44% +/- 3.13 (Digoxin 100µM & 
Quinidine 250µM) and 104.64% +/- 2.25 (Digoxin 5µM & Quinidine 250µM) of the control. 
None of these values was statistically significant different from the control as determined 
by the Student’s t-test at p < 0.05. 
For the 3h incubation with combinations of Digoxin and Verapamil, mitochondrial activity 
values of the cells for the low Verapamil concentrations (10µM & 100µM) were 93.32% 
+/- 3.58 and 98.23% +/- 4.67. These values was statistically significant different from the 
control as determined by the Student’s t-test at p < 0.05. On the other hand, 
mitochondrial activity values of the cells for the high Verapamil concentrations were in 
the range between 117.08% +/- 3.06 (Digoxin 5µM & Verapamil 500µM) and 121.90% +/- 
5.88 (Digoxin 100µM & Verapamil 500µM) of the control and all statistically significant 
different from the control as determined by the Student’s t-test at p < 0.05. 
For the 3h incubation with combinations of Quinidine and Verapamil, mitochondrial 
activity values were always higher for those combinations with a set Quinidine 
concentration in which the higher Verapamil concentration was used. No other trends 
could be observed. Overall the activity values of the cells were in the range between 
83.60% +/- 4.08 (Quinidine 5µM & Verapamil 10µM) and 115.73% +/- 4.17 (Quinidine 
250µM & Verapamil 500µM) of the control. These two outer extremes were the only 
values that were statistically significant different from the control as determined by the 
Student’s t-test at p < 0.05. 
Taken together the employed combinations and concentrations had overall no significant 
cytotoxic effect on the cells. While in single substance experiments statistically significant 
reductions of the activity caused by Digoxin were measured, this toxicity not only 
disappeared if Digoxin was used in combinations, but for the highest concentration 
combinations with Verapamil even statistically significant higher activities were 
measured. Aside from the finding of higher mitochondrial activities for higher 
concentrations during concomitant incubations, no other systematically effects were 
observed, especially no toxic effects. The observed increase might be possibly explained 
by the reported masking of cytotoxicity of compounds by an interaction of the MTT assay 
with high concentrations of some P-glycoprotein and MRP substrates leading to false cell 
viability values during concomitant incubation [Vellonen]. Therefore care has to be taken 
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in interpretation of the estimated passive permeability coefficients and the parameters of 
the carrier-mediated transport for combinations with high concentrations used. 
6.4.2.  Cel l  permeat ion of individual drugs 
Measurement of drug permeation in the Caco-2 model was possible for Verapamil at all 
the employed drug concentrations (5 – 1000µM) in both transport directions. In the apical 
to basal direction substantial amounts of Verapamil permeated and the concentrations in 
the two compartments aligned with time, but with none of the concentrations used, an 
equilibration between the two compartments was reached. Typically after 60 – 90min the 
concentration difference remained constant (Figure 31). Generally, for all concentrations 
used, in the basal to apical direction the apical concentration exceeded the basal 
concentration after approximately 40 – 80min, with the higher concentrations resulting in 
later points in time. The apical concentrations further increased and after approximately 
90min the concentration difference remained constant (Figure 32). 
Quinidine was generally well permeable in the basal to apical transport direction. No 
permeation was measured in the apical to basal direction at 1 and 2.5µM, whereas all 
other concentrations (5 – 200µM) resulted in measurable permeation in both directions. 
In the apical to basal the permeation behaviour was typically bi-phasic, after an initial 
decrease in the donor concentrations up to approximately 90min and the appearance of 
Quinidine in the acceptor compartment, the concentration difference between the two 
compartments remained constant (Figure 29). With lower concentrations the initial 
decrease was rather abrupt and fast and for higher concentrations more gradual. 
Generally for all concentrations used, in the basal to apical direction the apical 
concentration exceeded the basal concentration after approximately 30 – 60min, with the 
higher concentrations resulting in later points in time. The apical concentrations further 
increased and for lower concentrations only few amounts of Quinidine remained in the 
donor concentrations (for 1µM after 3h Quinidine is not anymore detectable in the basal 
compartment, for 5µM the remaining concentration was about 15% and for 10µM about 
30% of the initial concentration). For higher donor concentrations (> 20µM) the remaining 
percentages in the basal compartment were bigger and anyway after approximately 
120min the concentration difference remained constant (Figure 30). 
Digoxin was the least permeable compound of the selected series. For Digoxin only the 
higher concentrations (20 – 100µM) resulted in a detectable, permeation in both transport 
directions. For lower concentrations (0.5 – 10µM) no transport in the apical to basal 
direction was detectable and transport in the basal to apical direction was rather limited. 
Generally for all concentrations the apical to basal transport direction resulted in only 
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small amounts of Digoxin appearing the receiver compartment. The concentrations in the 
apical donor compartment were fluctuating around the donor concentration by 
approximately +/-10%. In the basal to apical direction the apical concentration exceeded 
the basal concentration not until approximately 150 – 180min, independent of the donor 
concentration ((Figure 27) and (Figure 28)). 
In our experiments, to a certain degree all of three chosen substances showed 
asymmetric transport across the Caco-2 cells indicating that the drugs are subject to 
active apical efflux by at least P-gp, what is present in these cells [Gutmann 1999, 
Hidalgo 1996]. Especially Quinidine and Digoxin showed a profound asymmetry in the 
transport. From literature all three substances are known to be substrate of P-
glycoprotein [Engman, Keogh, Litman, Makhey, Meier, Neuhoff 2003, Troutman 2003 A]. 
For Quinidine transport strong concentration dependent effects on the permeation 
behaviour through Caco-2 monolayers were observed. The efflux ratio for all 
concentrations lower than 50µM, was bigger than 2, with a steep increase to higher ER 
for concentrations below 20µM. The highest ER was calculated for 5µM (~26), but as for 
lower donor concentrations in the apical to basal direction no transport could be 
detected, the ER for these concentrations might have even been bigger. As the ER for 
donor concentrations above 50µM is for all experiments with some variation around 1.5, 
there is most probably a saturation effect of the efflux transporter affecting the overall 
permeation of Quinidine. For concentrations above 50µM the Papp in the basal to apical 
direction was in the range of 90 ● 10-6 cm/s, with a trend for the values getting gradually 
higher for lower concentrations, reaching maximum values of approximately 130 ● 10-6 
cm/s (Figure 24). The Papp values for the apical to basal direction were very small for the 
lowest donor concentrations and gradually increased up to concentrations of about 70 – 
80µM and the remained more or less constant around 60 ● 10-6 cm/s. 
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Figure 24: The concentration dependency of the apparent permeability coefficient Papp of 
Quinidine. Results are given as mean of 3 wells with the standard deviation. (◊) Apical to 
basal permeation. (∗) Basal to apical permeation. 
Neuhoff et al. reported for transport of Quinidine at a concentration of 50µM under similar 
conditions (pH apical and basolateral 7.4) an ER of 4.0 with an Papp of 30.4 +/- 1.6 ● 10-6 
cm/s in the apical to basal direction and 122.3 +/- 8.7 ● 10-6 cm/s in the basal to apical 
direction [Neuhoff 2003] and Troutman et al. reported for transport of Quinidine 1µM an 
ER of 5.2 with an Papp of 20.8 +/- 0.32 ● 10-6 cm/s in the apical to basal direction and 109 
+/- 2.7 ● 10-6 cm/s in the basal to apical direction [Troutman 2003 B]. Korjamo et al. 
reported in their study for WT-Caco-2 cells Papp of ~18 ● 10-6 cm/s (apical to basal) and 
Papp of ~90 ● 10-6 cm/s (basal to apical) for Quinidine 1µM [Korjamo]. Our values for 
Quinidine 50µM were comparable to the reported ones with an ER of 2.20 and with an 
Papp of 47.9 +/- 2.2 ● 10-6 cm/s in the apical to basal direction and 105.3 +/- 1.6 ● 10-6 
cm/s in the basal to apical direction. For Quinidine 1µM we couldn’t detect any 
permeation in the apical to basal direction and in the basal to apical direction our 
estimated Papp was 76.3 +/- 14.2 ● 10-6 cm/s. 
For Verapamil no concentration dependent effect on the permeation behaviour was 
observed. The efflux ratio was over the whole concentration range tested (5 – 1000µM) 
around 1.3 – 1.4. The Papp for Verapamil in the basal to apical direction was in the range 
of 110 ● 10-6 cm/s for the apical to basal direction approximately 80 ● 10-6 cm/s (Figure 
25). The findings are consistent with the fact, that P-gp has only little effect on the overall 
permeation for high permeability compounds [Eytan 1996, 1999 and 2005]. 
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Figure 25: The concentration dependency of the apparent permeability coefficient Papp of 
Verapamil. Results are given as mean of 3 wells with the standard deviation. (◊) Apical to 
basal permeation. (∗) Basal to apical permeation. 
Verapamil is usually used as an inhibitor of P-glycoprotein in transport studies performed 
with Caco-2 cell monolayers. The transport of Verapamil itself and the contributions of 
passive diffusion and active, carrier-mediated efflux are less frequently the objective of 
studies. Some publications report active efflux of Verapamil in Caco-2 cells [Engman, 
Makhey] and other groups [Pauli-Magnus] didn’t measure P-glycoprotein-dependent 
transport. The measured efflux ratios for Verapamil are in the range of 1 – 2.5 [Engman, 
Shirasaka, Troutman 2003 B]. The mean value of Papp for Verapamil 5 – 1000µM 
measured with our cells was 83.2 +/- 8.2 ● 10-6 cm/s in the apical to basal direction and 
110.7 +/- 9.1 ● 10-6 cm/s in the basal to apical direction, resulting in a mean ER of 1.33. 
These values are comparable to the ones reported by Troutman et al., with Papp values of 
44.5 +/- 3.5 ● 10-6 cm/s (apical to basal, 0.1µM) and 117 +/- 1.2 ● 10-6 cm/s (basal to 
apical, 0.1µM) and the enantioselective analysis of Engman et al. yielded in the apical to 
basal direction Papp of 69 – 157 ● 10-6 cm/s (R-Verapamil, 2.5 – 80µM) and 85 – 143 ● 
10-6 cm/s (S-Verapamil, 2.5 – 80µM) with efflux ratios of around 2.0 for 8µM and 1.0 for 
80µM. On the other hand the values for the Papp of Pauli-Magnus et al. were 12.9 +/- 6.4 
● 10-6 cm/s (apical to basal, 5µM) and 11.9 +/- 1.3 ● 10-6 cm/s (basal to apical, 5µM) and 
Shirasaka et al. reported similar values, 12.9 +/- 1.10 ● 10-6 cm/s (apical to basal, 0.1µM) 
and 14.9 +/- 0.54 ● 10-6 cm/s (basal to apical, 0.1µM). The lower Papp values might be 
explained by the shorter culturing time before the transport experiments, Pauli-Magnus et 
al. performed experiments on day 7 after plating and Shirasaka et al. used the cells after 
5 days in culture. 
Digoxin showed the lowest permeability of all three compounds, not only in the apical to 
basal direction, with the Papp values being generally below 0.3 ● 10-6 cm/s or not showing 
any permeation at all, but also in the basal to apical direction. In this direction the Papp 
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was slightly below 30 ● 10-6 cm/s for concentrations above 20µM, and smaller but with 
more variation for lower concentrations (Figure 26). Neither the Papp values nor the ER 
(between 85 and 285, where calculable) indicated any concentration effects on the 
permeation of Digoxin, as for example saturation of the transporter. 
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Figure 26: The concentration dependency of the apparent permeability coefficient Papp of 
Digoxin. Results are given as mean of 3 wells with the standard deviation. (◊) Apical to 
basal permeation. (∗) Basal to apical permeation. 
Neuhoff et al. measured Papp values for Digoxin around 3.0 ● 10-6 cm/s in the apical to 
basal direction, independent of the concentration used (59nM and 625µM) and Papp in the 
basal to apical direction around 26 ● 10-6 cm/s for the lower and around 3 ● 10-6 cm/s for 
the higher concentration [Neuhoff 2006]. Troutman et al. reported similar Papp values for 
Quinidine 10µM with 2.18 +/- 0.10 ● 10-6 cm/s in the apical to basal direction and 44.1 +/- 
0.85 ● 10-6 cm/s in the basal to apical direction [Troutman 2003 B]. Papp b_a decreased 
as the concentration was increased above 50µM and the Papp a_b was concentration 
independent up to concentrations of 200µM. They measured efflux ratios ranging from 11 
to 7 in the concentration range tested [Troutman 2003 A]. The mean value of Papp for 
Digoxin measured with our cells was 0.19 +/- 0.08 ● 10-6 cm/s in the apical to basal 
direction (20 – 100µM) and 24.8 +/- 4.9 ● 10-6 cm/s in the basal to apical direction (2.5 – 
100µM), demonstrating similar permeation characteristics in the basal to apical direction, 
whereas the permeability in the apical to basal direction in our cells is significantly lower 
for Digoxin. 
For every transport experiment performed, mass balances were calculated by addition of 
the amount in solution after 3h and the amount withdrawn during the experiment. The 
intended donor amount provided the reference for calculation. One has to be aware that 
the intended donor concentration might have different from the effective used donor 
concentration. As we did not measure the initial concentration, we can just compare the 
intended concentrations with the calculated ones. The mass balances for experiments 
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performed with Verapamil yielded in the apical to basal direction recovery rates of 75 – 
104% with two thirds of the values between 90 and 100%, and in the basal to apical 
direction 77 – 103% again with two thirds of the values between 90 and 100%. The mean 
in the a_b direction was 91.79% +/- 9.34 and in the b_a direction 91.98% +/- 8.63 for a 
total of 15 different experiments with 3 wells each. For some of the experiments 
methanol extraction of the Transwell was performed after experiments (data not shown), 
but no substantial amounts of Verapamil were found to be adsorbed to the surface. 
Furthermore for the experiments with worse mass balances no trend could be observed, 
they were spread all over the tested concentration range. The mass balances for 
experiments performed with Quinidine yielded in the apical to basal direction recovery 
rates of 78 – 100% with most of the values between 95 and 100% and in the basal to 
apical direction 81 – 103% again with most of the values between 95 and 103%. The 
mean in the a_b direction was 94.88% +/- 5.19 and in the b_a direction 97.09% +/- 5.42 
for a total of 16 different experiments with 3 wells each. Generally there were in each 
transport direction only 2 experiments with recovery below 90%. The mass balances for 
experiments performed with Digoxin yielded in the apical to basal direction recovery rates 
of 80 – 116% with almost all of the values between 95 and 116% and in the basal to 
apical direction 75 – 110% with almost all of the values between 94 and 110%. The 
mean in the a_b direction was 101.76% +/- 12.17 and in the b_a direction 99.01% +/- 
12.74 for a total of 11 different experiments with 3 wells each. The lowest recovery was 
observed with the 2 smallest donor concentrations whereas for the values exceeding 
100% the most, no trend was observed. 
Taken together the best recovery in terms of consistency and variation was found for 
Quinidine followed by the Verapamil experiments and the worst results were found for 
Digoxin experiments with some variation and values exceeding 100% recovery. For the 
three chosen compounds there are no hints for adsorption to the surface of the Transwell 
plates, nor metabolism or substantial cellular accumulation in the concentration range 
tested. 
6.4.3.  Quanti f ication of  passive and carr ier-mediated transport 
parameters 
Permeation data were analysed using the theoretical model for the kinetics of cellular 
transport presented in chapter 6.3.9. As the experimental data didn’t indicate adsorption 
or metabolism, we could use this basic model and not the elsewhere described extended 
version [Blaser]. The concentration variables defined by the system of differential 
(Equation 85) to (Equation 90) were fitted to the experimental concentration data and 
optimal values of the parameters P and vk applicable to the different experimental 
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conditions were deduced. Numerical solution of the equations and least squares fit were 
performed using the software EASY-FIT (Prof. K. Schittkowski, University of Bayreuth, 
Germany). Concentration data of both compartments obtained from the apical-to-basal 
and the basal-to-apical direction of permeation were used simultaneously in the fitting. 
This provided a more stable regression analysis compared to the separate evaluation of 
each permeation direction. The drawn lines in (Figure 27) to (Figure 32) represent the 
representative best fits of Digoxin, Quinidine and Verapamil permeation. This is 
considered in all cases to be satisfactory. 
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Figure 27: Representative fit of Digoxin 50µM apical to basal transport across Caco-2 cell 
monolayers at 37°C (calculated with the model using  zero order efflux kinetics). 
Experimental points and model-based fitted curves. (◊) Apical concentration. (∗) Basal 
concentration. 
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Figure 28: Representative fit of Digoxin 50µM basal to apical transport across Caco-2 cell 
monolayers at 37°C (calculated with the model using  zero order efflux kinetics). 
Experimental points and model-based fitted curves. (◊) Apical concentration. (∗) Basal 
concentration. 
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Figure 29: Representative fit of Quinidine 50µM apical to basal transport across Caco-2 cell 
monolayers at 37°C (calculated with the model using  zero order efflux kinetics). 
Experimental points and model-based fitted curves. (◊) Apical concentration. (∗) Basal 
concentration. 
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Figure 30: Representative fit of Quinidine 50µM basal to apical transport across Caco-2 cell 
monolayers at 37°C (calculated with the model using  zero order efflux kinetics). 
Experimental points and model-based fitted curves. (◊) Apical concentration. (∗) Basal 
concentration. 
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Figure 31: Representative fit of Verapamil 50µM apical to basal transport across Caco-2 cell 
monolayers at 37°C (calculated with the model using  zero order efflux kinetics). 
Experimental points and model-based fitted curves. (◊) Apical concentration. (∗) Basal 
concentration. 
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Figure 32: Representative fit of Verapamil 50µM basal to apical transport across Caco-2 cell 
monolayers at 37°C (calculated with the model using  zero order efflux kinetics). 
Experimental points and model-based fitted curves. (◊) Apical concentration. (∗) Basal 
concentration. 
An estimate of the goodness of the fits is the final residual value (FRV). The Easy-Fit 
settings were equal for the three compounds. Therefore the estimated FRVs are 
comparable for the different concentrations of a substance as well as between the 
substances. The smaller the number of the FRV, the better is the fit. For Verapamil and 
Quinidine there was a trend for better fits for the higher concentrations, for Digoxin the 
fits were equally well among the whole concentration range tested. Generally the best fits 
were obtained for Verapamil data, with FRV values between 0.00182 (500µM) and 
0.0516 (7.5µM). Quinidine FRVs were basically in the same range and resulted between 
0.00287 (200µM) and 0.0592 (2.5µM) with two outliners of 0.218 (1µM) and 0.159 (5µM). 
The fits for Digoxin data were about one order of magnitude worse than the ones for the 
other two compounds. The values were in the range between 0.0145 (5µM) and 0.394 
(20µM). The experimental data for which fits were not as good as for the rest (some 
Quinidine concentrations and Digoxin in general) were generally those with poor apical to 
basal permeation, demonstrating that the chosen procedure with concomitant fittings of 
the apical to basal and basal to apical data was the right decision to obtain reasonable 
and consistent values for the kinetic parameters. 
The drug concentrations at time zero, CA (0) and CB (0), obtained from the best fit were in 
the case of Verapamil for most experiments smaller than the theoretical concentrations of 
the prepared solutions. In the b_a direction the model derived donor concentrations were 
usually 1 – 2% higher compared to the a_b concentration. For higher donor 
concentrations the consistency between the intended and the model derived donor 
concentrations was better than for the lower donor concentrations, with 95.92 – 103.38% 
for the concentration range between 150 – 1000µM and 81.43 – 93.72 % between 5 – 
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100µM. For the experiments with Quinidine, the drug concentrations at time zero, CA (0) 
and CB (0), obtained from the best fit were in most instances in quite good concordance 
with the theoretical concentrations of the prepared solutions. No trend for differences for 
the model-derived donor concentrations were for the two transport directions was 
observed. The estimated donor concentrations were in the range of 95.48 – 103.76% of 
the intended ones, with most values between 95 – 100%. Only the experiment with the 
worst fit (FRV) was an exception to this with the estimated donor amounts being 82.0, 
77.6, 99.82 and 90.3% of the intended ones. Again as with the recovery rates, Digoxin 
data showed the biggest variation among the set of compound chosen for this study. The 
drug concentrations at time zero, CA (0) and CB (0), obtained from the best fit were for the 
lower concentrations (0.5 – 5µM) between 83.20 – 100.62% and for the higher 
concentrations (10 – 100µM) between 98.17 – 112.68%, with most values between 105 – 
110%. 
The course of the drug mass in the cellular compartment yielded by the model based 
simulation was similar for Verapamil and for Quinidine ((Figure 33) and (Figure 34)), with 
an fast initial loading of the cells within the first few minutes, independent of the transport 
direction. For the apical to basal direction a small decrease of the mass in the cellular 
compartment follows within the next 60min after which the mass remains about constant. 
In the basal to apical direction the mass in the cellular compartment further rises to a 
small amount within the same time and remains then the same for the rest of the 
experiment. For Digoxin experiments the model simulation yielded in the apical to basal 
direction in a small initial binding to the cells with no change afterwards, whereas in the 
basal to apical direction the mass in the cellular compartment continuously increased 
over time (Figure 35). The medial drug mass over time, averaged for the a_b and b_a 
transport direction, in the cellular compartment yielded by the model-based simulation 
was 0.017 – 4.2nmol for Verapamil (5 – 1000µM), 0.0005 – 0.953nmol for Quinidine (1 – 
250µM) and 0.0002 – 0.047nmol for Digoxin (0.5 – 100µM). 
For all three compounds the resulting model derived mass of drug in the cellular 
compartment was directly proportional to the donor concentration over the whole range 
of tested concentrations with correlation coefficients of 0.99 and better. For a selected 
donor concentration of 100µM the model derived mass in the cell compartment was for 
Verapamil 0.37nmol, for Quinidine 0.38nmol and for Digoxin 0.047nmol. Generally for 
equal donor concentrations of Verapamil and Quinidine about the same drug in the 
cellular compartment resulted, whereas Digoxin mass was always about one order of 
magnitude lower. The similar cellular accumulation of Quinidine compared to Verapamil 
is, while having lower passive permeability in line with the stronger apical efflux of the 
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former compound ((Figure 36) and (Figure 37)). Hence, the different propensity of the 
two drugs to be apically effluxed can be quantitatively assessed with the present 
analysis. Digoxin masses in the cellular compartment were also coherent with the 
estimated kinetic parameters. Demonstrating only slightly higher passive than carrier-
mediated fluxes across Caco-2 cell monolayers it is not likely that in the apical to basal 
direction substantial amounts of Digoxin can accumulate whereas in the basal to apical 
direction more substance permeates across the cells resulting in higher cellular 
accumulation. 
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Figure 33: Calculated amounts of Quinidine in the cellular compartment during Quinidine 
50µM apical to basal and basal to apical transport at 37°C (calculated with the model using 
zero order efflux kinetics). 
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Figure 34: Calculated amounts of Verapamil in the cellular compartment during Verapamil 
50µM to basal and basal to apical transport at 37°C (c alculated with the model using zero 
order efflux kinetics). 
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Figure 35: Calculated amounts of Digoxin in the cellular compartment during Digoxin 50µM 
to basal and basal to apical transport at 37°C (cal culated with the model using zero order 
efflux kinetics). 
The fitting yielded in consistent values of the passive permeability coefficients for all 
three compounds used. The model derived permeability coefficients of Verapamil, 
Quinidine and Digoxin for the different donor concentrations used are displayed in 
(Figure 36). The passive permeability coefficient as modelled is independent of the 
transport direction and equal for the apical and the basal cell membrane. 
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Figure 36: Model derived permeability coefficient of Digoxin 0.5 – 100µM (◊), Quinidine 1 – 
200µM () and Verapamil 5 – 1000µM (∗) calculated with the model using zero order efflux 
kinetics. 
For the range tested no concentration dependency of the passive permeability was 
observed. This observation is valid for all three compounds used in the study. The two 
values for Quinidine, which are obviously different from the rest, are the ones for the 
concentrations whose fits were not as good as the rest (1& 5µM) as a result of poor 
permeation with acceptor concentrations around the limit of detection for the analytical 
method used. Nevertheless for Verapamil there appeared to be a trend for slightly lower 
permeability coefficients at higher donor concentrations compared to the lower donor 
concentrations. If this trend is systematic or just a side effect of the tighter fitting of the 
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experimental data of higher concentrations is unclear. According to diffusion theory there 
should not be a concentration dependency of the passive permeability coefficient. As 
there was no clear-cut concentration dependency of the permeability coefficient further 
discussion of the results will be based upon the mean of the values. The model derived 
medial passive permeability coefficients for the three drugs in Caco-2 cells at 37°C are 
given in (Table 15). 
Table 15: Model derived passive permeability coefficient of the compounds (calculated with 
the model using zero order efflux kinetics). Results are given as mean of n different 
concentrations and standard error of the mean. 
Digoxin 
(n=11)  
Quinidine 
(n=16)  
Verapamil 
(n=15) concentration 
range [µM] 0.5 – 100  1 – 200  5 – 1000 
P • 106 [cm/s] 25.532 +/- 0.827  
197.436 +/- 
6.161  
260.736 +/- 
6.201 
 
The rank order of passive permeability across Caco-2 cells was the following: Verapamil 
showed the highest permeability, followed by the slightly less permeable Quinidine and 
with one order of magnitude lower permeability Digoxin. For discussion of this rank order 
one has to keep in mind that both, Verapamil (molecular weight 454.60g/mol, logP 4.7, 
calculated by PubChem) and Quinidine (molecular weight 324.42g/mol, logP 2.6, 
calculated by PubChem) are ionisable compounds, with pKa values of 8.97 +/- 0.50 (ACD 
Software Solaris V8.14) for Verapamil and 9.28 +/- 0.70 (ACD Software Solaris V8.14) 
for Quinidine, whereas Digoxin (molecular weight 780.94g/mol, logP 2.2, calculated by 
PubChem) can be considered as neutral molecule in the relevant pH range for the 
transport studies. Verapamil can be expected to possess a higher permeability than 
Quinidine and Digoxin as its lipophilicity, expressed by the (calculated) logP is two orders 
of magnitude higher. Furthermore at pH 7.4 neither the degree of ionisation with the two 
pKa values being close to each other nor the molecular weight will be the crucial criterion 
for permeability differences between Verapamil and Quinidine. Digoxin with its high 
molecular weight is prone to have low permeability. This rank order is in agreement with 
the literature findings for Verapamil and Quinidine having high permeability and for 
Digoxin rather moderate to poor passive permeability [Varma]. The passive permeability 
coefficients for Verapamil and Quinidine were higher than the previously model estimated 
permeability for Indinavir (53 ● 10-6 cm/s), Saquinavir (89 ● 10-6 cm/s) and 
Amentoflavone (33.3 +/- 7.4 ● 10-6 cm/s) [Blaser, Kapitza] whereas Digoxin has the 
poorest permeability among these different compounds. 
Taken together the model estimated passive permeability coefficients were not 
concentration dependent and reflected the lipophilicity and molecular weight of the 
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different compounds. A reasonable rank order for the passive permeability of the 
Verapamil, Quinidine and Digoxin was obtained that was consistent with literature 
findings. 
Preliminary studies using the mathematical model with Michaelis-Menten kinetics for the 
apical efflux directly integrated to the equations used for fitting showed a high level 
correlation between vmax and K in the regression analysis, which meant that these 
parameters could not be deduced individually from each of these experiments [Kapitza]. 
Therefore all fittings in the present work were performed describing the carrier-mediated 
efflux by the global efflux / pump rate vk, which describes the amount of substance 
pumped out of the cell monolayer per time and area. The dependency of the apical pump 
rate vk, of Quinidine, Digoxin and Verapamil on the model-derived concentrations are 
displayed in (Figure 37). 
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Figure 37: Model derived efflux rate vk of Digoxin (0.5 – 100µM) (◊), Quinidine (1 – 200µM) 
() and Verapamil (5 – 1000µM) (∗) in Caco-2 cell monolayers depending on the estimated 
donor concentrations for nominal concentrations in the brackets (calculated with the 
model using zero order efflux kinetics). 
All three compounds used in the study are well known P-glycoprotein substrates, 
therefore the parameters vk can be regarded as an estimate of the mass efflux rate 
elicited by P-glycoprotein in Caco-2 cells. The model estimated values for the pump rate 
vk varied for the different compounds and concentrations, demonstrating clear 
concentration dependency of the efflux for all compounds. This concentration 
dependency that is the course of the plot was different for the three compounds. 
For Quinidine data biphasic behaviour was observed, with the first part showing a linear 
relationship for the increase of the apical efflux with concentration up to donor 
concentrations of about 20µM and at higher concentrations a flattening connected to 
each other with a curvature part, i.e. having the appearance of a hyperbola. This 
6. Publication part II: Individual transport of Digoxin, Quinidine and Verapamil in Caco-2 cells and 
the influence of binary mixtures on passive diffusion and active efflux 
David Blaser Page 128 of 194 University of Basel, 2007 
behaviour of the efflux rate for Quinidine was interpreted as a saturation of the carrier-
mediated transport. 
The pump rate of Digoxin showed almost perfect linear relationship for the dependency 
on the estimated donor concentration. As already indicated by the calculated Papp and 
efflux ratios for Digoxin (see chapter 6.4.2) it is most likely that the used concentrations 
are outside of the saturation range for Digoxin transport by P-glycoprotein. 
The behaviour of Verapamil efflux was the most ambiguous of the three P-glycoprotein 
substrates used. The plot of the pump rate depending on the estimated donor 
concentrations (Figure 37) might be regarded to have a sigmoidal or linear shape. But 
most probably also the used Verapamil concentrations are still not in the saturation range 
for its P-gp mediated efflux. 
The comparison of the estimated transport parameters with published results of other 
groups and the overall permeability Papp is not always conclusive. Troutman et al. 
determined for Verapamil, Quinidine and Digoxin the apparent permeability because of 
passive diffusion (PPD) across Caco-2 cell monolayers by measuring the transport in the 
presence of 1µM GW918 [Troutman 2003 A and B]. They stated, that the values in 
absorptive (a_b) and secretory (b_a) directions were not significantly different, supporting 
our assumption. For Verapamil (0.1µM) they determined a PPD of 86.3 +/- 3.47 ● 10-6 
cm/s, for Quinidine (1µM) a PPD of 55.9 +/- 0.99 ● 10-6 cm/s and for Digoxin (10µM) a PPD 
of 14.9 +/- 1.84 ● 10-6 cm/s. For both, Verapamil and Quinidine our model estimated 
passive permeability was more than three times higher than the values obtained by 
Troutman et al. after inhibition of P-glycoprotein with GW918. For Digoxin the difference 
is not as big but still our estimated passive permeability is about twice as theirs. This 
finding is somewhat puzzling, as the apparent permeability coefficient Papp obtained for 
the three compounds with our cells does not differ to the same degree from the Papp 
obtained by Troutman et al. (see chapter 6.4.2) as the passive permeability coefficient. It 
is generally valid for all three compounds that the Papp in the basal to apical direction was 
almost equal to the values calculated by Troutman et al. (see chapter 6.4.2). In the apical 
to basal direction the Papp obtained for Verapamil and Quinidine with our cells were about 
twice as big as their values. On the other hand, for Digoxin we measured in the apical to 
basal direction about tenfold lower Papp values than Troutman et al. For Verapamil and 
Quinidine the data indicate that both must have higher passive permeability in our cells 
compared to Troutman et al. and that otherwise the efflux activity in our cells must be 
lower for these two compounds. The higher passive permeability enables the better flux 
in the a_b direction and compensates in the b_a direction for the diminished carrier-
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mediated flux to result in an overall permeability that is comparable to Troutman et al. 
Contradictory to these interpretation are the findings for Digoxin, for what we found a 
slightly higher passive permeability. As Digoxin has about the same Papp in the basal to 
apical direction but a ten times lower Papp in the apical to basal direction, we would 
expect a higher efflux activity of our Caco-2 cells compared to Troutman et al. There are 
no obvious reasons for this behaviour. It is possible that the Papp in the apical to basal 
direction was underestimated as the permeated amounts were always close to the limit 
of detection of the analytical method used. 
These reflections indicate that the exact way of data analysis is crucial for the outcome of 
the kinetic analysis. By simple observation of the concentration-time profiles of the three 
compounds ((Figure 27) to (Figure 32)), it is neither possible to derive the quantitative 
contributions of the passive diffusion and the active efflux to the resulting permeation 
profile nor to elucidate their interplay. (Table 16) lists, among other data, the Papp values 
and the model-estimated values of passive permeability P of Digoxin, Quinidine and 
Verapamil, all estimated at a nominal donor concentration of 100µM. 
Table 16: The apparent permeability coefficients Papp, the model estimated passive 
permeability coefficients Pmodel, passive and active fluxes of 100µM Digoxin, Quinidine, and 
Verapamil across Caco-2 cell monolayers. Jpassive, model was calculated by Pmodel • C(0)model. 
∆C(15min) values denote the concentration differences between the apical and basal 
compartment 15min after the start of the experiment. Papp* are apparent permeability 
coefficients with the reference concentration ∆C(15min). All calculated values derived from 
the model using zero order efflux kinetics. 
Digoxin  Quinidine  Verapamil C(0) [µM] nominal / 
model estimated 100 / 109.31  100 / 96.64  100 / 84.53 
Papp•106 [cm/s] a_b 0.17 +/- 0.16  58.17 +/- 1.90  85.21 +/- 3.60 
Papp•106 [cm/s] b_a 30.35 +/- 0.71  84.65 +/- 2.98  96.29 +/- 10.59 
Pmodel•106 [cm/s] 27.61  199.77  291.33 
∆C(15min) [µM] a_b 105.99  73.64  49.60 
∆C(15min) [µM] b_a 88.12  61.81  44.54 
Papp*•106 [cm/s] a_b 0.16 +/- 0.15  78.99 +/- 2.58  171.79 +/- 7.25 
Papp*•106 [cm/s] b_a 34.45 +/- 0.81  136.95 +/- 4.82  216.19 +/- 23.78 
 
One should expect the values of the (model estimated) passive permeability to be in 
between the Papp in the apical to basal and basal to apical direction, as in the apical to 
basal direction the overall flux is reduced by the active efflux at the apical cell membrane, 
whereas in the basal to apical direction higher fluxes and therefore permeability 
coefficients should result because of this efflux. Only for Digoxin transport this hypothesis 
is true, for Quinidine and Verapamil the model estimated passive permeability coefficient 
is significantly higher than the values for Papp in the basal to apical direction. What is the 
reason for these discrepancies? 
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If we calculate the model estimated passive flux caused by concentration dependent 
diffusion across the cell monolayer, Jpassive, model = Pmodel • C(0)model, and compare these 
values to the model estimated active, carrier-mediated flux, Jactive, model, which is equal to 
our pump rate vk, we find for both, Quinidine and Verapamil the passive flux to be 
greater than the carrier-mediated efflux. For Quinidine 100µM the passive flux Jpassive, model 
is 19.3058 and the active flux Jactive, model 3.9794pmol/(cm2•s), for Verapamil 100µM we 
get for Jpassive, model 24.6261 and for Jactive, model 1.8816pmol/(cm2•s) and for Digoxin 100µM 
the Jpassive, model is 3.0180 and the Jpassive, model 2.9864pmol/(cm2•s). The values for the 
passive fluxes of Quinidine and Verapamil are about 10 times higher than their 
corresponding pump rates, meaning that for the overall permeation profile at the chosen 
donor concentration the passive diffusion is determinant. Contrarily, for Digoxin the 
passive flux is only slightly higher than the carrier-mediated component, explaining the 
poor permeability in the apical to basal direction. With one random exception for Digoxin 
and no exception for Verapamil, the calculated passive fluxes were always bigger than 
the active flux caused by carrier-mediated efflux. For Digoxin almost no net flux resulted 
explaining the poor permeability whereas for Verapamil always increasing net fluxes 
were calculated (Figure 38). For the two lowest concentrations of Quinidine the active 
part was bigger than passive one followed by an increasing importance of the passive 
flux. This behaviour resulted in biphasic net flux profile for Quinidine, with only low net 
flux for the lowest concentrations and for concentrations higher than the threshold of 
about 10µM an almost linear increase of the net flux with concentration (Figure 38). 
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Figure 38: The model derived concentration-dependent net fluxes of Digoxin (◊), Verapamil 
(∗) and Quinidine (). The net flux is the flux difference of the Jpassive, model (= Pmodel • 
C(0)model) and the Jactive, model (= efflux / pump rate vk) (calculated values derived form the 
model using zero order efflux kinetics). 
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To come back to the discrepancy between the model-estimated passive permeability and 
the Papp values, we have to keep in mind the mode by which the Papp value is calculated, 
namely the division by the donor concentration. From ((Figure 27) to (Figure 32)) it is 
known that in the case of Digoxin only poor permeation results in the first 15 minutes of 
the transport experiments, whereas for Quinidine and especially for Verapamil already 
substantial permeation has taken place (a_b and b_a direction). The results are the 
following, for Digoxin the sink conditions are most probably maintained, whereas for 
Quinidine and Verapamil strong deviations from the nominal donor concentration are 
observable with no maintenance of the sink conditions. These deviations were taken into 
account for a recalculation of the apparent permeability coefficients, yielding Papp*, by 
using the difference between the actual apical and basal concentration after 15min 
(∆C(15min)) as the reference (Table 16). Using this procedure, the underestimation of 
the permeability of Quinidine and Verapamil was partially corrected, resulting in higher 
values for Papp* than for Papp and an alignment yet not equalisation to our values for the 
passive permeability coefficient. For Digoxin the differences between the apparent 
permeability coefficients a_b and b_a and our model estimated passive permeability 
coefficient slightly increased. The Papp of Digoxin cannot become much greater, as the 
active flux generated by P-glycoprotein can only pump out of the cells what is delivered 
by passive influx. These observations demonstrate the importance of the knowledge of 
the passive permeability behaviour, the carrier-mediated efflux kinetics and their 
interplay, for the estimation of the overall permeation of a compound. For example, the 
concentration-time profiles of Quinidine and Verapamil may look similar ((Figure 29) to 
(Figure 32)) but the underlying contributions of passive diffusion and active efflux are 
different (Table 16) and may be, as in the case of the active efflux, concentration-
dependent. 
6.4.4.  Transport  of  binary mixtures of  compounds across Caco-2 
cel l  monolayers grown in Transwel l  plates 
The model was evaluated with respect to the ability to detect and quantify reductions of 
active efflux rate as estimated by the value of the pump rate vk. Further aspects were the 
influence of a concomitantly incubated substance on the passive permeability coefficient 
and the calculated amount of substance in the cellular compartment. The model derived 
kinetic parameters should allow a direct estimation of the effect of the co-incubated 
substance on the passive permeability and the active efflux whereas the use of the Papp 
and Efflux ratio does neither directly reveal which of these two fundamental properties 
was influenced nor to what extent. The same three compounds as used solitary, that is 
Digoxin, Quinidine, and Verapamil, were used in the same concentration range in 
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different combinations and concentrations to evaluate the permeation during concomitant 
incubation. To do so, a pair of compounds was added at the same time to the donor 
compartment and permeation was followed in both transport directions (apical to basal 
and basal to apical) for 3 hours. The resulting passive permeability coefficients P and the 
active efflux rates vk after concomitant incubation of Quinidine with Verapamil are 
displayed in (Figure 39) to (Figure 42). 
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Figure 39: Model estimated passive permeability coefficient P of Quinidine (Q) for transport 
experiments with concomitant incubation with Verapamil (VP). Numbers on the x-axis 
display nominal donor concentrations in [µM] (values derived form the model using zero 
order efflux kinetics). 
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Figure 40: Model estimated efflux rate vk of Quinidine (Q) for transport experiments with 
concomitant incubation with Verapamil (VP). Numbers on the x-axis display nominal donor 
concentrations in [µM] (values derived form the model using zero order efflux kinetics). 
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Figure 41: Model estimated passive permeability coefficient P of Verapamil (VP) for 
transport experiments with concomitant incubation with Quinidine (Q). Numbers on the x-
axis display nominal donor concentrations in [µM] (values derived form the model using 
zero order efflux kinetics). 
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Figure 42: Model estimated efflux rate vk of Verapamil (VP) for transport experiments with 
concomitant incubation with Quinidine (Q). Numbers on the x-axis display nominal donor 
concentrations in [µM] (values derived form the model using zero order efflux kinetics). 
The model estimated passive permeability coefficients of Quinidine are not strongly 
affected by the addition of Verapamil to the donor solution. All permeability coefficients 
were in the same range as the estimated values for Quinidine alone 1 – 200µM. The 
variations of the values didn’t show a clear Verapamil concentration dependency. Some 
of these values were higher other lower than the control. The other way round, the 
passive permeability of Verapamil was also not systematically affected by the addition of 
Quinidine and all calculated values were in the range of the permeability values derived 
form experiments with Verapamil alone. 
The apical efflux rate of Quinidine was influenced by the presence of Verapamil in terms 
of a reduction of the efflux rate. Verapamil reduced Quinidine efflux rate significantly, and 
the pump rate vk was greatest affected at the lower donor concentrations of Quinidine 
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i.e. 10, 20 and 50µM whereas at the higher Quinidine donor concentrations the effect 
was less pronounced. For the highest concentrations of Quinidine used in these 
experiments with concomitant incubation, i.e. 100µM, the effect of the second compound 
on the active efflux was barely detectable. The estimated values for the pump rate were 
fluctuating between 80 and 120% of the control with no clear-cut concentration 
dependency. It is more probable that these changes in the values of vk reflect differences 
in the intrinsic activity of P-glycoprotein for the different cells used in the experiments 
than effects of the co-incubated compound on the active efflux. Another reason for the 
reduced potency of Verapamil to diminish the efflux rate of higher Quinidine 
concentrations might also be, that at lower concentrations of Quinidine higher 
concentrations of Verapamil were used in each case whereas at higher Quinidine 
concentrations the respective Verapamil concentrations were smaller or equal to 
Quinidine concentrations. It is noteworthy that at the lower concentrations of Quinidine 
the addition of higher concentrations of Verapamil didn’t result in a steadily more 
pronounced reduction of the parameter vk. The pump rate of Quinidine was not further 
reduced and the effect level was the same, independent of the Verapamil concentration. 
This can be interpreted as an incomplete influence of Verapamil on Quinidine efflux, due 
to the fact that there might be a component in the efflux of Quinidine that cannot be 
influenced by Verapamil (e.g. due to different or not completely overlapping binding sites 
or other reasons). 
The effect of Quinidine on Verapamil efflux is more ambiguous. In the presence of 
Quinidine no reduction of the efflux rate of Verapamil was measured. At Verapamil 
concentrations of 5 and 25µM the variations of the pump rate are rather random than 
caused by Quinidine presence in the transport medium whereas for Verapamil 
concentrations bigger than 50µM efflux of Verapamil appears to be stimulated or 
activated by the presence of Quinidine as the efflux rate are enhanced compared to the 
control values. This phenomenon is observable at concentrations of Quinidine that are 
smaller or equal to the concentrations of Verapamil. As no higher concentrations were 
tested, we could only speculate about a possible reduction of Verapamil efflux in such 
experiments. Another interesting point is that Verapamil cannot reduce the efflux rate of 
Quinidine to more than a certain degree, even in increasing concentrations, whereas 
Verapamil itself demonstrates continuously increasing efflux rate in these experiments, 
again indicating that there is only a partial overlap in the binding sites of Verapamil and 
Quinidine. Finally, one has to be aware for the interpretation of Verapamil efflux, that 
already the values for the pump rate derived from single substance experiments with 
Verapamil didn’t show a clear concentration-dependent behaviour and there was obvious 
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saturation of Verapamil efflux in the range tested. The model-calculated amounts of 
substance in the cellular compartment of Quinidine for experiments in presence of 
Verapamil, demonstrate that in those experiments with a clear and sharp reduction of the 
efflux rate, Quinidine 10 & 20µM, the amount of substance in the cell is enhanced (Figure 
43). For the experiments with no or only a small reduction of the efflux rate, Quinidine 50 
& 100µM, the amount in the cellular compartment remains mainly unchanged compared 
to the control values. The amount of Verapamil in the cellular compartment remains 
mostly unaffected by the presence of Quinidine (Figure 44). 
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Figure 43: Model estimated amount in the cellular compartment (MCell) of Quinidine (Q) for 
transport experiments with concomitant incubation with Verapamil (VP). Numbers display 
nominal donor concentrations in [µM] (values derived form the model using zero order 
efflux kinetics). 
0.0
2
0.0
2 0.0
9
0.1
0
0.1
0
0.0
9 0.1
8
0.1
5
0.1
5
0.3
7
0.3
5
0.3
6
1.0
2
0.9
2
0.9
3
2.0
3
1.9
9
1.9
1
1.9
0
0.00
0.50
1.00
1.50
2.00
2.50
VP 
5
VP 
5
VP
25
VP
25
VP
25
VP
25
VP
50
VP
50
VP
50
VP
100
VP
100
VP
100
VP
250 
VP
250 
VP
250 
VP
500
VP
500
VP
500
VP
500
- Q
250
- Q 
10 
Q
100
Q
250
- Q 
50 
Q
100
- Q 
10 
Q
100
- Q 
10 
Q 
20 
-  Q   
1  
Q 
10
Q 
20
c
a
lc
u
la
te
d 
M
Ce
ll 
[n
m
o
l]
 
Figure 44: Model estimated amount in the cellular compartment (MCell) of Verapamil (VP) for 
transport experiments with concomitant incubation with Quinidine (Q). Numbers display 
nominal donor concentrations in [µM] (values derived form the model using zero order 
efflux kinetics). 
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The resulting passive permeability coefficients P and the active efflux rates vk after 
concomitant incubation of Quinidine with Digoxin are displayed in (Figure 45) to (Figure 
48). 
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Figure 45: Model estimated passive permeability coefficient P of Quinidine (Q) for transport 
experiments with concomitant incubation with Digoxin (D). Numbers on the x-axis display 
nominal donor concentrations in [µM] (values derived form the model using zero order 
efflux kinetics). 
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Figure 46: Model estimated efflux rate vk of Quinidine (Q) for transport experiments with 
concomitant incubation with Digoxin (D). Numbers on the x-axis display nominal donor 
concentrations in [µM] (values derived form the model using zero order efflux kinetics). 
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Figure 47: Model estimated passive permeability coefficient P of Digoxin (D) for transport 
experiments with concomitant incubation with Quinidine (Q). Numbers on the x-axis 
display nominal donor concentrations in [µM] (values derived form the model using zero 
order efflux kinetics). 
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Figure 48: Model estimated efflux rate vk of Digoxin (D) for transport experiments with 
concomitant incubation with Quinidine (Q). Numbers on the x-axis display nominal donor 
concentrations in [µM] (values derived form the model using zero order efflux kinetics). 
The model estimated passive permeability coefficients of Quinidine are affected by the 
addition of Digoxin to the donor solution. The concomitant incubation of Quinidine with 
Digoxin results in a systematic and concentration-dependent enhancement of the 
permeability coefficient of Quinidine whereas the same concentration of Digoxin, result in 
similar enhancement of Quinidine permeability, independent of the concentration of 
Quinidine. On the other hand the passive permeability of Digoxin is also affected by the 
addition of Quinidine, but the result is a reduction of the value of the permeability 
coefficient. This reduction is also dependent on the concentration of Quinidine, but after a 
certain level of reduction is obtained, higher concentrations do not further boost the 
reduction. There is an interaction between Quinidine and Digoxin on the level of the 
passive permeability, but the reasons for this interaction are not known. It is not likely that 
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this effect is an artefact of the parameter estimation procedure as not correlation 
between P and vk was observed in the fittings. We did not further investigate this finding. 
The model estimated apical efflux rate of Digoxin was strongly reduced by the presence 
of Quinidine. The reduction of Digoxin efflux was observed at all concentrations. Already 
a small concentration of Quinidine reduced Digoxin efflux, and a further increase in 
Quinidine concentration demonstrated a clear concentration-dependency of this effect, 
resulting in some cases in a reduction to less than 10% of the efflux activity of the 
control. The effect of Digoxin on the efflux rate of Quinidine was less pronounced, but 
measurable by the model parameter. The reduction of Quinidine efflux by Digoxin also 
appeared to be concentration-dependent. If comparable concentrations are considered 
(e.g. 50µM) the higher potency of Quinidine to reduce the efflux of Digoxin compared to 
the effect of Digoxin on Quinidine efflux is obvious. The model estimated amount of 
substance in the cellular compartment are in line with these findings ((Figure 49) and 
(Figure 50)). The amounts of Quinidine in the cellular compartment are only slightly 
higher in the presence of Digoxin compared to the control, whereas the calculated 
amounts for Digoxin were several-fold higher in presence of Quinidine, with higher 
concentrations of Quinidine resulting in higher amounts in the cell. 
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Figure 49: Model estimated amount in the cellular compartment (MCell) of Quinidine (Q) for 
transport experiments with concomitant incubation with Digoxin (D). Numbers display 
nominal donor concentrations in [µM] (values derived form the model using zero order 
efflux kinetics). 
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Figure 50: Model estimated amount in the cellular compartment (MCell) of Digoxin (D) for 
transport experiments with concomitant incubation with Quinidine (Q). Numbers display 
nominal donor concentrations in [µM] (values derived form the model using zero order 
efflux kinetics). 
The interaction of Verapamil transport with Digoxin transport was studied for two 
combinations and only data for Verapamil is available. Verapamil transport was studied 
at 5 and 25µM, both in combinations with 100µM of Digoxin. Digoxin didn’t influence 
Verapamil transport in a systematic manner. For Verapamil 5µM the resulting passive 
permeability coefficients P were 304.4 • 106cm/s (alone) and 315.8 • 106cm/s (in 
combination with Digoxin 100µM), the active efflux rates 0.34pmol/(s • cm2) (alone) and 
0.26pmol/(s • cm2) (in combination with Digoxin 100µM) and the calculated amount in the 
cellular compartment 17.1pmol (alone) and 17.5pmol (in combination with Digoxin 
100µM). For Verapamil 25µM the resulting passive permeability coefficients P were 
255.2 • 106cm/s (alone) and 304.2 • 106cm/s (in combination with Digoxin 100µM), the 
active efflux rates 0.82pmol/(s • cm2) (alone) and 0.98pmol/(s • cm2) (in combination with 
Digoxin 100µM) and the calculated amount in the cellular compartment 92.5pmol (alone) 
and 102.1 (in combination with Digoxin 100µM). The variations of these results are rather 
random than an effect of Digoxin on Verapamil transport. Further experiments would be 
necessary to fully explore the interaction of these two compounds. 
6.4.5.  Conclusion 
Taken together the results from single compound experiments, all compounds used 
showed asymmetrical transport across Caco-2 cell monolayers, the extent of which 
depended on the compound and the concentration used. The Papp values for all three 
compounds were comparable to previously reported ones. 
The model-estimated passive permeability coefficients were not concentration dependent 
and reflected among other possible reasons the lipophilicity and molecular weight of the 
different compounds. A reasonable rank order for the passive permeability of the 
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Verapamil, Quinidine and Digoxin was obtained that was consistent with literature 
findings. The model-derived permeability was severalfold higher for Verapamil and 
Quinidine than previously reported values for passive permeability across Caco-2 cells, 
whereas Digoxin passive permeability was in the same range as estimated by inhibition 
with GW918. Reasons for that discrepancy might be either differences in the 
experimental set-up, the kinetic analysis of the obtained transport data or even be based 
on differences in the properties of the cell membrane in presence of the P-gp inhibitor 
compared to the uninhibited situation, the mechanism of which could only be speculated 
about. It could be furthermore demonstrated that the calculation of the apparent 
permeability coefficient Papp is prone to result in erroneous estimates of the permeability if 
sink conditions are not strictly maintained. Our model estimated passive permeability 
coefficients were less susceptible to concentration-dependency and unaffected by the 
course of the concentration-time profiles with no necessity to maintain sink conditions. 
The estimated efflux rates reflected the different propensity of the compounds to efflux by 
P-glycoprotein. Different patterns of concentration-dependency of the net flux of 
compound across Caco-2 cell monolayers as estimated by our mathematical model were 
detected: Verapamil net flux was dominated by the passive flux over the whole 
concentration range tested and increased with rising concentrations. Digoxin net flux 
remained always low with no concentration dependent changes as the passive flux and 
the active flux were about in the same range. The behaviour of Quinidine net flux was 
biphasic, at low concentrations only small values for the net flux were calculated and 
after a certain concentration threshold was exceeded the net constantly became bigger. 
These findings demonstrate the importance of the knowledge of the exact quantitative 
contributions of simultaneous processes (e.g. passive diffusion and active efflux) to gain 
understanding of the overall permeation behaviour. For further studies the significance of 
the model could even be enhanced if the model-derived masses in the cellular 
compartment are verified by experimental results and the if model derived efflux rate 
could analysed in detail to derive information about the affinity and capacity of the 
transporter for different compounds and situations. The effects of binary combinations of 
compounds on the passive permeability and the active efflux were well reflected by the 
model-derived respective kinetic parameters and enable to study drug-drug interactions. 
Concluding, the present study demonstrates the utility of the proposed mathematical 
model for kinetic analysis of transport phenomena in confluent monolayers of Caco-2 
cells cultured in the Transwell system as the model-derived parameters are less 
susceptible to distorting effects than the conventional approach for data analysis. The 
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model provides a tool for the simple determination of the transport parameters by fitting 
of concentration-time profiles. 
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7 .  Ap p e n d i x  
7.1 .  Development  o f  an  opt ima l  procedure  for  TEER-
measurements  
The measurement of the transepithelial electrical resistance (TEER) of cultured cells on 
Transwell inserts was used as an instrument to determine the integrity and viability of the 
cell monolayer before and after transport experiments. To assure that the chosen 
measurement procedure was reliable and robust several preliminary tests were 
performed. STX-2 chopstick electrodes were compared to the Endohm chamber, the 
influence of the temperature and the influence of the washing step (D-PBS (without Ca2+ 
und Mg2+) vs. D-PBS (with Ca2+ und Mg2+) and the number of washing steps) of the cells 
on the course of the TEER values over time and the absolute values were studied. 
Furthermore the influence of shaking vs. non-shaking and the presence/absence of 
carbon dioxide were checked for. 
To do so, Caco-2 cells were grown on 6-well Transwell plates as described in the 
publication part and washed on the apical side with 3.5ml and on the basal side with 4ml 
D-PBS. 1600µl transport medium were added to the apical compartment and 2800µl 
transport medium were added to the basal compartment. One set of 6-well Transwell 
plates was then directly subject to a first TEER measurement and subsequently 
incubated (incubator or the incubator hood). TEER values were monitored for 7h. A 
second set of Transwell plates was first incubated for at least 60min in the incubator 
before the initial TEER measurement and then incubated (incubator or the incubator 
hood). TEER values were monitored for 7h. TEER values are displayed either as 
absolute values or relative to the initial value. To assure that the chosen procedure for 
the measurement of the TEER values was reliable and robust several preliminary tests 
were performed. 
The comparison of the STX-2 chopstick electrodes with the Endohm chamber showed, 
that the measurement with the Endohm chamber is much more reliable in terms of the 
values measured and results in stable and reproducible values for the TEER. A 
representative measurement of TEER values is shown in (Table 17). Values measured 
with the STX-2 electrode show a bigger variation in comparison to the values measured 
with the Endohm chamber. The values measured with the STX-2 chopstick electrode are 
more dependent on the handling of the electrode during the measurement, as there is no 
defined geometry as in the case of the Endohm chamber. The depth of the insertion into 
the solution, the angle in which the electrode is hold for measurement and the exact 
place of the monolayer to which the electrode is placed are only some of the reasons for 
higher variation of the measurements with the STX-2 electrode. The TEER 
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measurements are less time consuming with the Endohm chamber as it is only 
necessary to measure each well one time to get a reliable value. With the STX-2 
electrode at least 3 measurements in each of the 3 holes of the insert are necessary. 
With the STX-2 electrode only the resistance in close proximity to the electrode are 
measured, therefore not ruling out the possibility that small holes in the monolayer may 
be overlooked, especially in the centre of the monolayer. As the Endohm chamber 
measures the resistance of the whole monolayer, the possibility of detecting small 
changes in the monolayer is bigger. 
Table 17: Comparison of the measured TEER values of Caco-2 cell monolayers either 
measured with STX-2 electrodes (each well n = 9) or the Endohm chamber (each well n = 3). 
TEER values are displayed after subtraction of the TEER value of the blank polycarbonate 
membrane (457.64Ω*cm2 for STX-2 electrodes and 7Ω*cm2 for the Endohm chamber). The 
cell monolayers were in both experiments of passage 62 and 18 days post seeding. 
STX-2 chopstick 
electrodes TEER [Ω*cm
2] standard deviation [[Ω*cm2] 
standard deviation 
[%] 
well 1 455.20 26.77 5.88 
well 2 481.32 16.91 3.51 
well 3 454.16 44.96 9.90 
well 4 481.32 34.68 7.21 
well 5 447.89 55.81 12.46 
well 6 467.22 31.60 6.76 
Endohm chamber TEER [Ω*cm2] standard deviation [[Ω*cm2] 
standard deviation 
[%] 
well 1 491.20 0.00 0.00 
well 2 477.10 0.00 0.00 
well 3 425.40 0.00 0.00 
well 4 - - - 
well 5 463.00 0.00 0.00 
well 6 438.72 1.36 0.31 
 
The influence of the temperature during and the time needed for the measurements of 
the TEER values are two critical parameters that can strongly influence the values 
measured. Time is a critical parameter for all the single procedures during the TEER 
measurement, be it the removal of the culture medium, the washing of the cell monolayer 
or the addition of the transport medium. All these steps influence the exposure of the cell 
monolayer to the air and therefore, as described later, the TEER values. Furthermore the 
time needed for the measurement itself is also very important as during the 
measurement step the temperature may decrease. If there is no device or other way of 
keeping the Transwell plate and the transport medium during the measurement at 37°C, 
it is critical to perform this step as fast and standardised as possible, but still with all the 
cautiousness needed. (Figure 51) displays the course of the TEER of a Transwell plate 
with Caco-2 cell monolayers standing in the laminar flow bench at ambient temperature. 
The initial measurement (time = 0) was performed after equilibrating the Transwell plate 
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at 37°C for 60min. A reference sample of transport medium (approximately 30ml) in a 
bottle showed a decrease to 29.4°C after 15min at t he same place as the Transwell 
plate. 
Course of TEER values of Caco-2 cell monolayers 
depending on time standing at ambient temperature
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Figure 51: The course of TEER values with time of Caco-2 cell monolayers in Transwell 
standing in the laminar flow bench at ambient temperature. The cells were 15 days post 
seeding and the medium for measurement was transport medium including 0.5% ethanol 
(v/v). The measurement was performed with the STX-2 electrode. 
It is obvious from (Figure 51) that already small changes in the temperature of the 
transport medium may lead to an increase in the measured TEER values. A general 
tendency is that the TEER values become smaller at higher temperatures. 
All TEER measurements were performed in transport medium after the removal of the 
culture medium from the Transwell plates and a washing step with D-PBS. To investigate 
the influence of the washing step (D-PBS (without Ca2+ and Mg2+) vs. D-PBS (with Ca2+ 
and Mg2+) and the number of washing steps) of the cells on the TEER values and their 
course, several experiments were performed. In order to compare the effect of the type 
of D-PBS used, the cell monolayers were washed 1 or 3 times with each type of D-PBS 
after the removal of the culture medium and TEER values were immediately measured at 
37°C in the Endohm chamber. (Figure 52) shows that after washing the cells 3 times the 
TEER values were approximately 150Ω*cm2 lower if D-PBS (without Ca2+/Mg2+) was 
used instead of D-PBS (with Ca2+/Mg2+). With proceeding time of incubation the values 
rose again after usage of D-PBS (without Ca2+/Mg2+) and after approximately one hour 
the values were close to the ones after usage of D-PBS (with Ca2+/Mg2+). The TEER 
values after usage of D-PBS (with Ca2+/Mg2+) drop immediately after the initial 
measurement, rise again and stay with some variation constant after 60min (Figure 52). 
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Course of TEER values upon different washing 
procedures (3x) - absolute values
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Figure 52: Course of the absolute TEER values over 7h in the incubator hood at 37°C 
without shaking. The cells were washed 3 times with D-PBS. Group 1 was washed with D-
PBS (without Ca2+/Mg2+) and group 2 was washed with D-PBS (with Ca2+/Mg2+). Each group 
consisted of 3 wells. Transwell transport medium (including 0.5% Ethanol (v/v) was at 37°C 
and the reference solution in the Endohm chamber was at ambient temperature (25 – 30°C). 
The cell monolayers were of passage 65 and 20 days post seeding. 
If the Transwell plates were only washed once with D-PBS (without Ca2+/Mg2+) there 
were no differences to the values measured after one washing step D-PBS (with 
Ca2+/Mg2+) (Figure 53). Even the course of the TEER over 7h of incubation was the same 
in the 2 groups. In both groups there was an initial drop of the values just to rise again 
during the second half of the incubation time. Although there were no differences 
between the two groups if the cells were only washed once, D-PBS (with Ca2+/Mg2+) is 
recommended for the washing step, to rule out the possibility of affecting the TEER 
values by washing them with a calcium-free buffer after the removal of the culture 
medium. 
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Figure 53: Course of the absolute TEER values over 7h in the incubator hood at 37°C 
without shaking. The cells were washed 1 time with D-PBS. Group 1 was washed with D-
PBS (without Ca2+/Mg2+) and group 2 was washed with D-PBS (with Ca2+/Mg2+). Each group 
consisted of 3 wells. Transwell transport medium (including 0.5% Ethanol (v/v) was at 37°C 
and the reference solution in the Endohm chamber was at ambient temperature (25 – 30°C). 
The cell monolayers were of passage 65 and 21 days post seeding. 
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(Figure 53) shows an initial decrease in the measured TEER values with a subsequent 
recovery over the next hours (but not up to 100%). This decrease may be due to the 
exposition of the cell monolayer to the air during the removal of the culture medium and 
during the washing step. The same applies also if there would be a replacement of the 
solution in the apical and basal compartment after the initial TEER measurement. 
To further investigate the effect of the exposition of the cell monolayer to the air on the 
course of the TEER values a pre-incubation period before the initial measurement was 
introduced. After the removal of the culture medium and one washing step with D-PBS 
(with Ca2+/Mg2+), the transport medium was added to the apical and basal compartment. 
The cells were then incubated for at least 60min in the incubator at 37°C in an 
atmosphere of 8% CO2 and in equilibrium with distilled and autoclaved water. After this 
period the initial TEER measurement was performed. One Transwell plate was then 
subject to incubation in the incubator hood at 37°C  and 75rpm without a total 
replacement of the transport medium (500µl were withdrawn in each compartment and 
replaced), whereas on the second Transwell plate the transport medium was first totally 
exchanged again before the incubation in the incubator hood at 37°C and 75rpm. The 
course of the TEER values for the two groups is displayed in (Figure 54). 
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Figure 54: Course of the absolute TEER values over 7h in the incubator hood at 37°C and 
75rpm. Group 1 was directly subject to incubation after the initial TEER measurement 
whereas in group 2 the transport medium was replaced again completely after the initial 
TEER measurement. Each group consisted of 5 wells. The transport medium in the 
Transwells and the Endohm chamber was at 37°C for t he measurements. The cell 
monolayers of group 1 were of passage 60 and 21 days post seeding and the cell 
monolayers of group 2 were of passage 60 and 20 days post seeding. 
The TEER values of the cell monolayers in the Transwell plate with replacement of the 
transport medium after the initial TEER measurement showed an initial decrease down to 
80% of the initial values, followed by a continuous recovery back to 95% after 7h of 
incubation. By contrast the TEER values of the Transwell without replacement of the 
transport medium after the initial TEER measurement fluctuated between 97.5 and 
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102.5% of the initial TEER values. These results strongly indicate that the exposure of 
the cell monolayer to air is a stress factor to the cells and the tight junctions resulting in a 
loss of TEER. These results are in concordance with literature [Li]. 
The small initial decrease of the TEER value even without replacement of the transport 
medium may still be due to the stress cause by the removal of the culture medium and 
the following washing step. The time for pre-incubation may have not been long enough 
for a total recovery of the TEER values. But the standard error for the mean TEER values 
in this case is about the same range as the decrease itself. Therefore 60min pre-
incubation are regarded to be long enough to allow afterwards the detection of any 
changes in the TEER values caused by the medium or transported substances. The 
transport medium itself or the incubation in the incubator at 37°C and shaking at 75rpm 
don’t seem to affect the TEER for the incubation time of 7h. As in the experiments with 
Amentoflavone always 0.5% (v/v) Ethanol were included in the transport medium, it is 
necessary to know the effect of Ethanol on the TEER. It is known from literature [Ma], 
that Ethanol is able to modulate the tight junctions and therefore the TEER. Therefore the 
effect of the presence of 0.5% (v/v) in the transport medium was investigated. Ethanol 
(0.5% (v/v) was added to the transport medium after the initial TEER measurement 
(without exchange of the whole transport medium) and the TEER was followed for 5h 
(Figure 55). 
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Figure 55: Course of the %-TEER values over 5h in the incubator hood at 37°C and 75rpm 
in the presence of 0.5% (v/v) Ethanol in the transport medium. The Transwell was directly 
subject to incubation after the initial TEER measurement and addition of the Ethanol. Only 
1 well was measured. The transport medium in the Transwells and the Endohm chamber 
was at 37°C for the measurements. The cell monolaye rs were of passage 60 and 22 days 
post seeding. 
Within 1.5h after the addition of Ethanol the TEER decreases down to 87.5% of the initial 
value. Until the end of the incubation of 5h the value shows a recovery up to over 90%. 
Compared to the incubation without Ethanol the decrease appears to be more 
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pronounced and the recovery with time smaller. But two control experiments on the 
course of TEER performed with transport medium without Ethanol according to the 
“standard measurement procedure” described later revealed that an initial decrease of 
the TEER values of about 10% is normal (Figure 56). Therefore no effects were detected 
that could be attributed to the presence of Ethanol (0.5% (v/v) in the transport medium. 
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Figure 56: Course of the absolute TEER values over 7h in the incubator hood at 37°C and 
75rpm. Measurement in both groups was performed according the standard procedure. 
Each group consisted of 6 wells. The transport medium in the Transwells and the Endohm 
chamber was at 37°C for the measurements. The cell monolayers of group 1 were of 
passage 65 and 18 days post seeding and the cell monolayers of group 2 were of passage 
61 and 19 days post seeding. 
Further points that may affect the measured TEER values are the density of plating the 
cells. This influences the homogeneity of the values and the absolute values itself, 
because the TEER is depending on the time of confluence of the cells on the 
polycarbonate membrane and the confluence itself is depending on the density of plating. 
Therefore it is recommended to seed only 2 – 3 wells at a time followed by a 
rehomogenisation of the cell suspension. Taken all this together the factors affecting the 
most the measurement and the measured values are the type of the electrode use 
(Endohm chamber or STX-2-electrode), the temperature at which the measurement is 
performed, the way of washing the cells (D-PBS (with or without Ca2+/Mg2+)) and the 
exposition of the monolayer to air. 
The following protocol (“standard measurement procedure”) is recommended to allow a 
reproducible and meaningful TEER measurement. The Endohm chamber is preferentially 
used for the TEER measurements, whereas the geometry of the chamber should always 
be the same. The distance between the lower side of the electrode and the upper part of 
the case used for the present word was approximately 1.75cm. For resistance 
measurement, the Endohm chamber can be used directly without preincubation of the 
electrode. The chamber is filled with Ethanol 70% (v/v) and incubated for 15min for 
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sterilisation. After the removal of the Ethanol the chamber is washed several times with 
transport medium. At 37°C the resistance of a blank  Transwell plate with transport 
medium was 7Ω*cm2. For the measurements the Endohm chamber was filled with 4.6ml 
and the apical compartment of the Transwell with 1.6ml transport medium 37°C. It is 
necessary to strictly control the plating density of the cells used for transport experiments 
and to use always the same plating density. For the measurement itself the culture 
medium is withdrawn and the Transwell plate should be carefully washed 1 time with D-
PBS (with Mg2+/Ca2+) 37°C (apical compartment 3.5ml, basal compartment  4.0ml). After 
the D-PBS is withdrawn, the transport medium 37°C i s added (apical compartment 
1600µl and basal compartment 2800µl). The Transwell plate in incubated for 60min in 
the incubator 37°C in an atmosphere of 8% CO 2 and in equilibrium with distilled and 
autoclaved water. 4.6ml transport medium 37°C is ad ded to the Endohm chamber. The 
Transwell plate is taken out of the incubator and the TEER measurements are performed 
as fast and carefully as possible (1 measurement per well, the well is transferred to the 
chamber with tweezers). The volume necessary for the addition of the stock solution of 
the compound for the transport experiments is withdrawn. The cell monolayer should 
always be covered with transport medium. After the transport experiment the volume 
withdrawn for sampling is replaced in the apical compartment and the TEER measured 
again. One limitation of the TEER measurement procedure is, that the lowest TEER 
value for usage of the cell monolayers for transport studies was never checked for the 
permeability of a model compound to assess the paracellular permeability e.g. Mannitol. 
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7.2 .  De tec t ion  o f  Amentof lavone  phase  I I  metabol ism in 
Caco-2  ce l l  monolayers  us ing  enz ymat ica l  c leavage  
To further assure the formation of the Amentoflavone conjugates, a global enzymatical 
cleavage of the glucuronides and sulfates was performed with Succus helix pomatia 
(SHP). Caco-2 cells of passage 60 were grown for 19 days on a petri dish as described 
in the publication part (“Amentoflavone transport”). After removing the culture medium, 
cells were rinsed once with 15ml D-PBS (without Ca2+ und Mg2+) and 25ml of the 
transport medium with 10µM Amentoflavone (containing 1% ethanol (v/v)) were added. 
The petri dish was kept at 37°C in the incubation h ood and agitated for 7h on an orbital 
compact shaker at 50min−1. As a blank, transport medium with 1% ethanol (v/v) was 
incubated and treated the same way. At the end of the incubation 117µl of the respective 
samples were taken and combined with 13µl of a solution of Tween 80 0.1% (v/v), mixed 
and then analysed by HPLC-MS. The monolayer was checked with the inverted phase 
contrast microscope for morphological alterations. After the incubation the transport 
medium with Amentoflavone and the corresponding conjugates as well as the blank 
samples were centrifuged for 10min at 2000rpm. 117µl of the respective supernatant 
were taken and combined with 13µl of a solution of Tween 80 0.1% (v/v), mixed and then 
analysed by HPLC-MS. The supernatant was adjusted to pH 4.80 with acetic acid 50%. 
The blank was divided into two parts. One part was also adjusted to pH 4.80. The other 
half (7.00ml) was added with 175µl Amentoflavone solution 250µM and also adjusted to 
pH 4.80 (final Amentoflavone concentration approximately 6µM). Again 117µl of the 
respective solutions were taken and combined with 13µl of a solution of Tween 80 0.1% 
(v/v), mixed and then analysed by HPLC-MS. 2ml of the solutions of each subgroup 
adjusted to pH 4.80 were transferred to centrifuge tubes 15ml and added with either 
300µl SHP (at ambient temperature) or 300µl double distilled water (at ambient 
temperature). The tubes were incubated in the water bath for 60min at 55°C. After the 
addition of 2.3ml Methanol (at ambient temperature) the samples were vortexed for 10s 
and put for 20min in an ice-water-mixture. The samples were centrifuged for 10min at 
4500rpm, corresponding 3370g. 117µl of the respective supernatant were taken and 
combined with 13µl of a solution of Tween 80 0.1% (v/v), mixed and then analysed by 
HPLC-MS. During each step the molar concentration of Amentoflavone and the 
Amentoflavone conjugates was measured. During the enzymatical cleavage of the 
glucuronides and sulfates that was performed with Succus helix pomatia (SHP), the 
amount of Amentoflavone and the Amentoflavone conjugates was measured in each 
step (Table 18). 
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Table 18: Concentration of Amentoflavone (AF) during the treatment with SHP and water. 
sample concentration AF 
[µM] 
concentration AF 
conjugates [µM] 
samples after 7h incubation 
(n=3) 7.42 +/- 0.36 0.53 +/- 0.08 
samples after centrifugation 
(n=5) 6.24 +/- 0.31 0.51 +/- 0.08 
samples after adjustment to 
pH 4.8 (n=5) 4.16 +/- 0.19 0.39 +/- 0.08 
blank after addition of AF 
and adjustment to pH 4.8 
(n=5) 
4.18 +/- 0.25 0 
samples with AF and AF 
conjugates after treatment 
with SHP (n=5) 
0.86 +/- 0.15 0 
samples with AF and AF 
conjugates after treatment 
with H2O (n=5) 
1.84 +/- 0.10 0.20 +/- 0.08 
blank with AF after treatment 
with SHP (n=5) 0.70 +/- 0.14 0 
blank with AF after treatment 
with H2O (n=5) 1.80 +/- 0.12 0 
 
It is noteworthy that the concentrations of Amentoflavone in the samples incubated with 
SHP are less than half the ones compared with the samples incubated only with water. 
That may be explained by a possible binding to the proteins present in SHP. The 
concentrations of Amentoflavone in the samples that contained conjugates are higher 
than the one in the blank added with Amentoflavone. This is true for both the samples 
treated with SHP and the samples treated with water. But the samples had already 
before the incubation slightly higher concentrations of Amentoflavone than the blanks. 
The difference in Amentoflavone concentration between the samples and the blanks 
added with Amentoflavone is bigger for the samples that were treated with SHP than the 
ones treated with water, even though those show lower concentrations. The less 
pronounced decrease in Amentoflavone concentration after incubation with SHP in the 
samples that contained Amentoflavone conjugates in comparison with the blanks, could 
be explained by a liberation of previously conjugated Amentoflavone. The molar amount 
of Amentoflavone present in the final solutions after treatment with water in relation with 
the 2ml volume prior to the treatment result for the samples with Amentoflavone and 
Amentoflavone-conjugates in slightly higher concentrations than initially measured 
whereas the calculated concentrations of the blanks with Amentoflavone are slightly 
lower than initially measured. A possible explanation to these findings would be a 
cleavage of the conjugates because of the acidic milieu and the increased temperature. 
As there was no decrease in the concentration of the Amentoflavone conjugates during 
the treatment with water (see later) this explanation is not likely. A further explanation 
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would be an evaporation of the Methanol used or impreciseness during pipetting. It is 
furthermore remarkable that there is a decrease of about 2µM in the Amentoflavone 
concentrations after adjusting the pH to 4.80, compared to the concentrations after the 
centrifugation. This decrease cannot be explained as a dilution effect, as only about 2 – 3 
drops of acetic acid and sodium hydroxide were used. The decrease is most probably 
attributed to adsorption to the surface of the centrifugation tubes used. The samples 
were subject to several decanting steps until measured after the adjustment to pH 4.80 
whereas the measurement after the centrifugation was directly performed with samples 
from the centrifugation tubes used for centrifugation. After the incubation with SHP in 
samples with Amentoflavone conjugates neither the glucuronide nor the sulfate were 
detectable as monitored with UV or m/z 617 & m/z 713 ((Figure 58), (Figure 60) and 
(Figure 62)). In the UV chromatogram of the samples that contained Amentoflavone 
conjugates, new peaks appeared with slightly later retention than the metabolites 
((Figure 62) and (Figure 68)) (metabolites approximately 4.5, 4.8 & 5.6min; new peaks 
ca. 5.4 & 6.5min). These peaks were also detectable in the blank samples with added 
Amentoflavone and in the blank samples that consisted only of transport medium that 
were treated with SHP. As the AUC of these new peaks (Table 19) is in the same range 
for all subgroups treated with SHP, they were attributed to the presence of SHP. It has to 
be noted that the AUC of the new peaks is about 5 times bigger than the one in samples 
with Amentoflavone and Amentoflavone conjugates after treatment with H2O (AUC 
109.90 +/- 5.22 [mAU*s]). The chromatograms of the samples treated with H2O are 
shown in ((Figure 57), (Figure 59) and (Figure 61)) and the chromatograms of transport 
medium, treated with either H2O or SHP are shown in ((Figure 63) to (Figure 68)). 
Table 19: AUC of the newly detected peaks after treatment with SHP. 
sample total AUC 
[mAU*s] 
samples with AF and AF conjugates after 
treatment with SHP (n=5) 
626.38 +/- 17.01 
blank with AF after treatment with SHP (n=5) 625.92 +/- 5.37 
blank (without AF) after treatment with SHP (n=3) 578.55 +/- 0.64 
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Figure 57: m/z 617 corresponding to the sulfate conjugates in samples containing 
Amentoflavone and the Amentoflavone conjugates treated with H2O. 
 
Figure 58: m/z 617 corresponding to the sulfate conjugates in samples containing 
Amentoflavone and the Amentoflavone conjugates treated with SHP. 
 
Figure 59: m/z 713 corresponding to the glucuronide conjugates in samples containing 
Amentoflavone and the Amentoflavone conjugates treated with H2O. 
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Figure 60: m/z 713 corresponding to the glucuronide conjugates in samples containing 
Amentoflavone and the Amentoflavone conjugates treated with SHP. 
 
Figure 61: UV chromatogram with the peaks for the sulfate and glucuronide conjugates 
(retention 4.474 & 4.853min) and the Amentoflavone (retention 12.531min) in samples 
containing Amentoflavone and the Amentoflavone conjugates treated with H2O. 
 
Figure 62: UV chromatogram with the newly developed peaks (retention 5.4 & 6.5min) and 
the Amentoflavone (retention 12.503min) in samples containing Amentoflavone and the 
Amentoflavone conjugates treated with SHP. 
7. Appendix 
David Blaser Page 155 of 194 University of Basel, 2007 
 
Figure 63: m/z 617 corresponding to the sulfate conjugates in samples of pure transport 
medium treated with H2O. 
 
Figure 64: m/z 617 corresponding to the sulfate conjugates in samples of pure transport 
medium treated with SHP. 
 
Figure 65: m/z 713 corresponding to the glucuronide conjugates in samples of pure 
transport medium treated with H2O. 
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Figure 66: m/z 713 corresponding to the glucuronide conjugates in samples of pure 
transport medium treated with SHP. 
 
Figure 67: UV chromatogram of samples of pure transport medium treated with H2O. 
 
Figure 68: UV chromatogram with the newly developed peaks (retention 5.4 & 6.5min) in 
samples of pure transport medium treated with SHP. 
It cannot be ruled out that the conjugates are subject to protein binding as 
Amentoflavone itself is. A binding to the proteins present in SHP could also lead to a 
disappearance of the conjugates even though they were not cleaved. After the 
adjustment of the pH to 4.80 the concentration and therefore the amount of 
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Amentoflavone in the samples with Amentoflavone and Amentoflavone conjugates and 
the blanks with Amentoflavone was approximately the same (Table 18). On condition that 
the addition of SHP leads to a total cleavage of the Amentoflavone conjugates, the 
amount of Amentoflavone in the samples that contained the conjugates should be higher 
to the same amount in comparison to the blanks only containing Amentoflavone. The 
difference in the amount of Amentoflavone after SHP incubation is 0.736nmole. This is 
almost the same amount as the there were conjugates before the incubation (0.78nmole, 
Table 20). The conjugates were therefore no longer detectable because enzymatical 
cleavage rather than protein binding. 
Table 20: Concentration and amount of Amentoflavone and Amentoflavone conjugates 
during the processing with SHP or water. 
 AF in samples AF conjugates in samples AF in blank 
concentration after 
adjustment to pH 4.80 
[µM] 
4.16 +/- 0.19 0.39 +/- 0.08 4.18 +/- 0.25 
amount in 2ml after 
adjustment to pH 4.80 
[nmol] 
8.32 +/- 0.38 0.78 +/- 0.16 8.36 +/- 0.5 
concentration after 
incubation with H2O [µM] 1.84 +/- 0.10 0.20 +/- 0.08 1.80 +/- 0.12 
amount in 4.6ml after 
incubation with H2O 
[nmol] 
8.464 +/- 0.46 0.92 +/- 0.368 8.28 +/- 0.552 
concentration after 
incubation with SHP [µM] 0.86 +/- 0.15 0 0.70 +/- 0.14 
amount in 4.6ml after 
incubation with SHP 
[nmol] 
3.956 +/- 0.69 0 3.22 +/- 0.644 
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7.3 .  Amentof lavone  
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Figure 69: TEER values of Caco-2 cell monolayer used in the experiments with 
Amentoflavone and Vinblastine (individual or in combination). The grey columns display 
the absolute values before the experiments and the points connected with a line the TEER 
values after the experiment in % of the initial values. At least 3 wells were used per group. 
Numbers display concentrations in [µM]. TM = transport medium. 
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Figure 70: Mass balance of Amentoflavone transport at 37°C in Caco-2 cells grown in 
Transwell plates (individual transport and combination with Vinblastine). At least 3 wells 
were used per group. Numbers display concentrations in [µM]. 
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mass balance of Amentoflavone transport 
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Figure 71: Mass balance of Amentoflavone transport at 4°C in Caco-2 cells grown in 
Transwell plates (individual transport). At least 3 wells were used per group. Numbers 
display concentrations in [µM]. 
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Figure 72: Mass balance of Amentoflavone transport at 4 & 37°C in Transwell plates 
without cells (individual transport). At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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7.4 .  D igox in  
 
TEER Digoxin
0
100
200
300
400
500
600
0.5
 
a_
b
0.5
 
b_
a
1 
a_
b
1 
b_
a
2.
5 
a_
b
2.
5 
b_
a
5 
a_
b
5 
b_
a
10
 
a_
b
10
 
b_
a
20
 
a_
b
20
 
b_
a
35
 
a_
b
35
 
b_
a
50
 
a_
b
50
 
b_
a
65
 
a_
b
65
 
b_
a
80
 
a_
b
80
 
b_
a
10
0 
a_
b
10
0 
b_
a
nominal donor concentration C(0) [µM] and transport direction
TE
ER
 
be
fo
re
 
e
x
pe
rim
e
n
t 
[O
hm
*
c
m
2 ]
0
10
20
30
40
50
60
70
80
90
100
TE
ER
 
a
fte
r 
e
x
pe
rim
e
n
t [
%
 
o
f 
in
iti
a
l v
a
lu
e
]
 
Figure 73: TEER values of Caco-2 cell monolayer used in the experiments with Digoxin 
(individual transport). The grey columns display the absolute values before the 
experiments and the points connected with a line the TEER values after the experiment in 
% of the initial values. At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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Figure 74: TEER values of Caco-2 cell monolayer used in the experiments with 
combinations of Digoxin with Verapamil. The grey columns display the absolute values 
before the experiments and the points connected with a line the TEER values after the 
experiment in % of the initial values. At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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TEER Digoxin / Quinidine HCL combinations
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Figure 75: TEER values of Caco-2 cell monolayer used in the experiments with 
combinations of Digoxin with Quinidine. The grey columns display the absolute values 
before the experiments and the points connected with a line the TEER values after the 
experiment in % of the initial values. At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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Table 21: Model estimated kinetic parameters of Digoxin permeation across Caco-2 cell monolayers. 
 
nominal donor 
concentration 
[µM] 
0.5 1 2.5 5 10 20 35 50 65 80 100 
model derived 
C(0) a_b 0.437 0.887 2.433 5.031 10.855 19.888 34.36 56.339 71.159 85.154 110.971 
model derived 
C(0) b_a 0.416 0.859 2.377 4.986 10.801 20.243 34.388 55.771 70.73 85.794 107.639 
average model 
derived C(0) 0.427 0.873 2.405 5.009 10.828 20.066 34.374 56.055 70.945 85.474 109.305 
P ● 106 [cm/s] 24.373 18.867 27.215 23.33 27.92 28.658 25.306 25.969 26.694 24.916 27.609 
efflux rate vk 
[nmol/(s●cm2)] 0.000010179 0.000016258 0.000064992 0.00011678 0.00030307 0.00054787 0.00085304 0.00143825 0.00186169 0.00207638 0.00298635 
Jactive = vk 
[pmol/(s●cm2)] 0.010179 0.016258 0.064992 0.11678 0.30307 0.54787 0.85304 1.43825 1.86169 2.07638 2.98635 
Jpassive = P ● 
C(0) 
[pmol/(s●cm2)] 
0.010395085 0.016470891 0.065452075 0.116848305 0.30231776 0.575037099 0.869868444 1.455692295 1.893792483 2.129670184 3.017801745 
Jpassive - Jactive 
[pmol/(s●cm2)] 0.000216084 0.000212891 0.000460075 6.8305E-05 -0.00075224 0.027167099 0.016828444 0.017442295 0.032102483 0.053290184 0.031451745 
lowest MCell a_b 
[nmol] 0.000076 0.000103 0.000175 0.0001 2.7E-09 0.003 0.0026 0.0038 0.0057 0.0072 0.0112 
highest MCell 
a_b [nmol] 0.00009 0.00016 0.00021 0.000115 3.20E-09 0.0036 0.00305 0.00445 0.0066 0.0085 0.0132 
average MCell 
a_b [nmol] 0.000083 0.0001315 0.0001925 0.0001075 2.95E-09 0.0033 0.002825 0.004125 0.00615 0.00785 0.0122 
lowest MCell b_a 
 [nmol] 0 0 0 0 0 0.006 0.004 0.003 0.008 0.015 0 
highest MCell 
b_a [nmol] 0.00058 0.00098 0.00335 0.0067 0.0164 0.036 0.06 0.083 0.11 0.13 0.162 
average MCell 
b_a [nmol] 0.00029 0.00049 0.001675 0.00335 0.0082 0.021 0.032 0.043 0.059 0.0725 0.081 
average MCell 
a_b/b_a [nmol] 0.0001865 0.00031075 0.00093375 0.00172875 0.004100001 0.01215 0.0174125 0.0235625 0.032575 0.040175 0.0466 
FRV scaled 0.0596 0.0787 0.0195 0.0145 0.0185 0.394 0.0472 0.151 0.0448 0.0517 0.165 
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Table 22: Model estimated kinetic parameters of Digoxin permeation across Caco-2 cell monolayers in experiments with concomitant incubation 
with a second compound (Q = Quinidine). 
10 50 50 50 100 100 100 100 100 nominal donor 
concentration [µM] Q 250 Q 5 Q 50 Q 250 Q 1 Q 10 Q 50 Q 100 Q 250 
model derived C(0) 
a_b 10.765 48.707 48.02 68.34 71.195 91.104 139.853 134.636 132.278 
model derived C(0) 
b_a 8.734 45.929 44.767 65.831 80.633 81.889 136.787 131.707 126.515 
average model 
derived C(0) 9.750 47.318 46.394 67.086 75.914 86.497 138.320 133.172 129.397 
P ● 106 [cm/s] 14.63 20.37 11.331 12.4018 31.777 19.327 14.113 13.359 13.723 
efflux rate vk 
[nmol/(s●cm2)] 0.000025384 0.00086676 0.00018218 5.02209E-05 0.00215568 0.00084461 0.00043663 0.000082509 0.00015304 
Jactive = vk 
[pmol/(s●cm2)] 0.0254 0.8668 0.1822 0.0502 2.1557 0.8446 0.4366 0.0825 0.1530 
Jpassive = P ● C(0) 
[pmol/(s●cm2)] 0.1426 0.9639 0.5257 0.8320 2.4123 1.6717 1.9521 1.7790 1.7757 
Jpassive - Jactive 
[pmol/(s●cm2)] 0.1173 0.0971 0.3435 0.7818 0.2566 0.8271 1.5155 1.6965 1.6227 
average MCell a_b 
[nmol] 0.04025 0.0265 0.1445 0.2875 0.0143 0.2075 0.49 0.575 0.545 
average MCell b_a 
[nmol] 0.03575 0.04375 0.1465 0.305 0.1225 0.2175 0.5375 0.62 0.5725 
average MCell 
a_b/b_a [nmol] 0.038 0.035125 0.1455 0.29625 0.0684 0.2125 0.51375 0.5975 0.55875 
FRV scaled 0.0709 0.0766 0.0455 0.0471 0.026 0.0126 0.0169 0.0578 0.0116 
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Table 23: Apparent permeability coefficient Papp of Digoxin permeation in Caco-2 cell 
monolayers. Values were calculated from the permeated amount of substance after 15min. 
Values are displayed as mean of 3 measurements with the standard deviation (SD). 
Digoxin: 
nominal donor 
concentration [µM] 
Papp a_b ● 106 
[cm/s] SD 
Papp b_a ● 106 
[cm/s] SD 
Efflux 
Ratio 
0.5 ND  ND  - 
1 ND  ND  - 
2.5 ND  27.41 9.35 - 
5 ND  13.88 4.36 - 
10 ND  20.78 2.38 - 
20 0.17 0.05 28.14 1.03 166.39 
35 0.09 0.01 26.15 0.42 284.13 
50 ND  25.27 0.05 - 
65 0.31 0.02 26.87 1.74 85.33 
80 0.23 0.07 24.35 0.58 108.17 
100 0.17 0.16 30.35 0.71 177.47 
 
Table 24: Apparent permeability coefficient Papp of Digoxin permeation in Caco-2 cell 
monolayers in experiments with concomitant incubation with a second substance (Q = 
Quinidine). Values were calculated from the permeated amount of substance after 15min. 
Values are displayed as mean of 3 measurements with the standard deviation. 
Digoxin: 
nominal donor 
concentration [µM] 
 
Papp a_b ● 106 
[cm/s] SD 
Papp b_a ● 106 
[cm/s] SD 
Efflux 
Ratio 
10 Q 250 4.74 1.04 7.39 0.12 1.56 
50 Q 5 2.27 0.21 19.03 1.21 8.39 
50 Q 50 2.52 0.42 7.51 0.36 2.99 
50 Q 250 4.10 0.38 5.34 0.63 1.30 
100 Q 1 0.95 0.13 20.92 1.24 21.91 
100 Q 10 5.53 0.28 16.90 1.14 3.06 
100 Q 50 4.86 0.24 7.68 0.31 1.58 
100 Q 100 6.62 0.56 8.53 0.08 1.29 
100 Q 250 5.87 0.05 9.12 3.93 1.56 
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Figure 76: Mass balance of Digoxin transport apical to basal at 37°C in Caco-2 cells grown 
in Transwell plates (individual transport). At least 3 wells were used per group. Numbers 
display concentrations in [µM]. 
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Figure 77: Mass balance of Digoxin transport basal to apical at 37°C in Caco-2 cells grown 
in Transwell plates (individual transport). At least 3 wells were used per group. Numbers 
display concentrations in [µM]. 
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mass balance of Digoxin permeation 
(in presence of Quinidine HCl) apical to basal
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Figure 78: Mass balance of Digoxin transport apical to basal at 37°C in Caco-2 cells grown 
in Transwell plates (in presence of Quinidine). At least 3 wells were used per group. 
Numbers display concentrations in [µM]. 
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Figure 79: Mass balance of Digoxin transport basal to apical at 37°C in Caco-2 cells grown 
in Transwell plates (in presence of Quinidine). At least 3 wells were used per group. 
Numbers display concentrations in [µM]. 
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7.5 .  Quinid ine  
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Figure 80: TEER values of Caco-2 cell monolayer used in the experiments with Quinidine 
(individual transport). The grey columns display the absolute values before the 
experiments and the points connected with a line the TEER values after the experiment in 
% of the initial values. At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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Figure 81: TEER values of Caco-2 cell monolayer used in the experiments with 
combinations of Quinidine with Verapamil. The grey columns display the absolute values 
before the experiments and the points connected with a line the TEER values after the 
experiment in % of the initial values. At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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Table 25: Model estimated kinetic parameters of Quinidine permeation across Caco-2 cell monolayers. 
nominal donor 
concentration [µM] 1 2.5 5 7.5 10 20 30 40 50 65 65 80 80 100 150 200 
model derived C(0) 
a_b 0.82 2.492 4.991 7.69 10.08 19.889 29.156 38.789 48.581 63.608 64.037 78.764 77.555 96.166 145.789 194.402 
model derived C(0) 
b_a 0.776 2.387 4.515 7.345 9.79 19.989 29.784 38.835 48.919 66.159 64.802 80.684 77.009 97.115 154.458 201.366 
average model 
derived C(0) 0.80 2.44 4.75 7.52 9.94 19.94 29.47 38.81 48.75 64.88 64.42 79.72 77.28 96.64 150.12 197.88 
P ● 106 [cm/s] 265.57 208.78 147.668 169.15 182.91 184.65 194.14 195.17 206.74 187.49 195.73 197.2 198.67 199.77 215.259 210.075 
efflux rate vk 
[nmol/(s●cm2)] 0.0002 0.0005 0.0007 0.0011 0.0015 0.0021 0.0021 0.0022 0.0029 0.0019 0.0021 0.0023 0.0025 0.0040 0.0040 0.0053 
Jactive = vk 
[pmol/(s●cm2)] 0.2177 0.5202 0.6874 1.0580 1.4546 2.1360 2.0607 2.2153 2.941 1.8779 2.0883 2.2516 2.5278 3.9794 3.978177 5.2997 
Jpassive = P ● C(0) 
[pmol/(s●cm2)] 0.2119 0.5093 0.7019 1.2716 1.8172 3.6817 5.7213 7.5749 10.0786 12.1650 12.6088 15.7216 15.3536 19.3059 32.3154 41.5705 
Jpassive - Jactive 
[pmol/(s●cm2)] -0.0058 -0.0109 0.01452 0.2136 0.3626 1.5457 3.6606 5.3597 7.1376 10.2871 10.5205 13.4699 12.8258 15.3265 28.3373 36.2707 
lowest MCell a_b 
[nmol] 2.05E-10 2.60E-09 0.00113 0.0048 0.0072 0.028 0.062 0.092 0.116 0.18 0.17 0.225 0.22 0.26 0.58 0.76 
highest MCell a_b 
[nmol] 2.70E-10 3.30E-09 0.00155 0.0065 0.0096 0.038 0.085 0.125 0.158 0.245 0.245 0.31 0.295 0.35 0.425 0.575 
average MCell a_b 
[nmol] 2.375E-10 2.95E-09 0.00134 0.00565 0.0084 0.033 0.0735 0.1085 0.137 0.2125 0.2075 0.2675 0.2575 0.305 0.5025 0.6675 
lowest MCell b_a 
 [nmol] 0 0 0 0.0063 0.0105 0.043 0.095 0.135 0.175 0.275 0.27 0.34 0.32 0.375 0.67 0.86 
highest MCell b_a 
[nmol] 0.0019 0.006 0.0115 0.023 0.0325 0.0815 0.144 0.195 0.245 0.365 0.3505 0.45 0.4225 0.52 0.86 1.13 
average MCell b_a 
[nmol] 0.00095 0.003 0.00575 0.01465 0.0215 0.06225 0.1195 0.165 0.21 0.32 0.31025 0.395 0.37125 0.4475 0.765 0.995 
average MCell 
a_b/b_a [nmol] 0.000475 0.0015 0.003545 0.01015 0.01495 0.047625 0.0965 0.13675 0.1735 0.26625 0.25888 0.33125 0.31438 0.37625 0.63375 0.83125 
FRV scaled 0.218 0.0592 0.159 0.0521 0.0303 0.00959 0.00436 0.00759 0.00877 0.0053 0.00463 0.00457 0.00365 0.00851 0.00503 0.00287 
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Table 26: Model estimated kinetic parameters of Quinidine permeation across Caco-2 cell monolayers in experiments with concomitant incubation 
with a second compound (D = Digoxin / VP = Verapamil). 
10 10 10 10 10 20 20 50 50 50 100 100 100 100 nominal donor 
concentration [µM] VP 25 VP 100 VP 250 VP 500 D 100 VP 250 VP 500 VP 50 D 50 D 100 VP 25 VP 50 VP 100 D 100 
model derived C(0) a_b 10.375 9.673 9.423 9.778 9.061 19.046 18.894 49.923 46.251 48.715 100.529 98.214 101.544 96.024 
model derived C(0) b_a 10.058 9.749 9.68 9.692 9.149 19.377 18.892 49.6 47.859 48.28 99.613 98.362 99.588 95.482 
average model derived 
C(0) 10.217 9.711 9.552 9.735 9.105 19.212 18.893 49.762 47.055 48.498 100.071 98.288 100.566 95.753 
P ● 106 [cm/s] 178.45 197.75 179.28 204.65 262.33 205.57 231.03 180.87 230.05 299.03 196 190.67 201.59 304.13 
efflux rate vk 
[nmol/(s●cm2)] 0.0005 0.0006 0.0004 0.0004 0.0008 0.0009 0.0009 0.0026 0.0025 0.0022 0.0031 0.0047 0.0040 0.0032 
Jactive = vk 
[pmol/(s●cm2)] 0.5354 0.6060 0.4311 0.4430 0.8247 0.8592 0.9625 2.6101 2.5277 2.2929 3.1395 4.6732 4.0136 3.2376 
Jpassive = P ● C(0) 
[pmol/(s●cm2)] 1.8231 1.9204 1.7124 1.9923 2.3885 3.9493 4.3648 9.0004 10.8250 14.5022 19.6139 18.7406 20.2731 29.1214 
Jpassive - Jactive 
[pmol/(s●cm2)] 1.2878 1.3144 1.2813 1.5493 1.5638 3.0901 3.4023 6.3903 8.2973 12.2093 16.4744 14.0673 16.2595 25.8837 
average MCell a_b [nmol] 0.0295 0.02625 0.0278 0.0305 0.0235 0.059 0.0588 0.141 0.1395 0.162 0.33 0.295 0.3225 0.33 
average MCell b_a [nmol] 0.04275 0.04075 0.043 0.0445 0.037 0.089 0.0865 0.2125 0.2135 0.235 0.475 0.445 0.4625 0.4775 
average MCell a_b/b_a 
[nmol] 0.03613 0.0335 0.0354 0.0375 0.03025 0.074 0.0726 0.1768 0.1765 0.1985 0.4025 0.37 0.3925 0.4038 
FRV scaled 0.0218 0.0117 0.0258 0.0176 0.0461 0.017 0.0244 0.0165 0.0145 0.0457 0.0128 0.0131 0.0085 0.0319 
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Table 27: Apparent permeability coefficient Papp of Quinidine permeation in Caco-2 cell 
monolayers. Values were calculated from the permeated amount of substance after 15min. 
Values are displayed as mean of 3 measurements with the standard deviation (SD). ND = 
no permeation detected. * values calculated by drawing a straight line from zero to the 
concentration after 30min. 
Quinidine: 
nominal donor 
concentration [µM] 
Papp a_b ● 106 
[cm/s] SD 
Papp b_a ● 106 
[cm/s] SD 
Efflux 
Ratio 
1 ND  76.27 14.18 - 
2.5 ND  133.65 5.86 - 
5 3.92*  100.68 1.25 25.69 
7.5 9.45*  128.21 2.84 13.57 
10 13.25 3.10 131.74 3.94 9.94 
20 22.84 0.60 122.15 8.20 5.35 
30 41.59 0.77 111.72 5.73 2.69 
40 48.80 3.39 97.28 3.98 1.99 
50 47.93 2.17 105.29 1.58 2.20 
65 56.96 1.28 88.33 9.28 1.55 
65 60.27 3.79 89.79 0.41 1.49 
80 61.73 0.99 90.18 4.04 1.46 
80 61.39 0.77 88.60 1.98 1.44 
100 58.17 1.90 84.65 2.98 1.46 
150 68.02 2.49 92.10 4.84 1.35 
200 73.49 1.97 95.13 2.41 1.29 
 
Table 28: Apparent permeability coefficient of Quinidine permeation in Caco-2 cell 
monolayers in experiments with concomitant incubation with a second substance (D = 
Digoxin / VP = Verapamil). Values were calculated from the permeated amount of 
substance after 15min. Values are displayed as mean of 3 measurements with the standard 
deviation. 
Quinidine: 
nominal donor 
concentration [µM] 
 
Papp a_b ● 106 
[cm/s] SD 
Papp b_a ● 106 
[cm/s] SD 
Efflux 
Ratio 
10 VP 25 47.98 5.39 83.65 6.89 1.74 
10 VP 100 42.56 2.21 103.57 3.28 2.43 
10 VP 250 36.39 2.29 59.64 4.90 1.64 
10 VP 500 65.42 3.68 77.14 0.51 1.18 
10 D 100 77.61 4.84 102.12 9.16 1.32 
20 VP 250 51.29 1.97 85.77 5.18 1.67 
20 VP 500 68.08 5.80 86.32 3.00 1.27 
50 VP 50 44.41 2.58 73.84 3.13 1.66 
50 D 50 55.75 3.72 99.45 9.56 1.78 
50 D 100 86.66 1.60 126.16 13.38 1.46 
100 VP 25 62.05 4.61 96.63 12.88 1.56 
100 VP 50 52.43 1.90 81.79 1.36 1.56 
100 VP 100 63.79 2.68 88.56 1.15 1.39 
100 D 100 92.24 4.30 113.59 6.43 1.23 
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mass balance of Quinidine HCl permeation 
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Figure 82: Mass balance of Quinidine transport apical to basal at 37°C in Caco-2 cells 
grown in Transwell plates (individual transport). At least 3 wells were used per group. 
Numbers display concentrations in [µM]. 
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Figure 83: Mass balance of Quinidine transport basal to apical at 37°C in Caco-2 cells 
grown in Transwell plates (individual transport). At least 3 wells were used per group. 
Numbers display concentrations in [µM]. 
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mass balance of Quinidine HCl permeation 
(in presence of Digxoin or Verapamil HCl) 
apical to basal
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Figure 84: Mass balance of Quinidine transport apical to basal at 37°C in Caco-2 cells 
grown in Transwell plates (in presence of Digoxin or Verapamil). At least 3 wells were used 
per group. Numbers display concentrations in [µM]. 
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Figure 85: Mass balance of Quinidine transport basal to apical at 37°C in Caco-2 cells 
grown in Transwell plates (in presence of Digoxin or Verapamil). At least 3 wells were used 
per group. Numbers display concentrations in [µM]. 
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7.6 .  Verapami l  
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Figure 86: TEER values of Caco-2 cell monolayer used in the experiments with Verapamil 
(individual transport). The grey columns display the absolute values before the 
experiments and the points connected with a line the TEER values after the experiment in 
% of the initial values. At least 3 wells were used per group. Numbers display 
concentrations in [µM]. 
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Table 29: Model estimated kinetic parameters of Verapamil permeation across Caco-2 cell monolayers. 
 
nominal donor 
concentration 
[µM] 
5 7.5 12.5 25 50 75 100 150 200 250 500 500 750 1000 1000 
model derived 
C(0) a_b 4.455 6.494 10.346 22.417 40.717 67.787 85.517 150.206 191.834 240.571 513.388 502.722 739.104 
972.1066
56 
1004.638
2 
model derived 
C(0) b_a 4.686 6.481 11.09 22.571 44.025 68.998 83.539 147.834 196.51 241.695 485.841 505.258 749.668 
1033.776
53 
990.1536
6 
average model 
derived C(0) 4.57 6.49 10.72 22.49 42.37 68.39 84.53 149.02 194.17 241.13 499.61 503.99 744.39 1002.94 997.40 
P ● 106 [cm/s] 304.36 265.51 261.2 255.24 293.29 275.47 291.33 262.19 274.93 242.54 242.35 240.42 251.11 220.46 230.64 
efflux rate vk 
[nmol/(s●cm2)] 0.0003 0.0004 0.0006 0.0008 0.0013 0.0018 0.0019 0.0050 0.0063 0.0066 0.0194 0.02204 0.0149 0.0305 0.0347 
Jactive = vk 
[pmol/(s●cm2)] 0.3398 0.4366 0.5815 0.8220 1.2812 1.7873 1.8816 5.0343 6.2889 6.5946 19.3616 22.0412 14.8549 30.4763 34.6934 
Jpassive = P ● C(0) 
[pmol/(s●cm2)] 1.3911 1.7225 2.7995 5.7414 12.4270 18.8401 24.6255 39.0716 53.3837 58.4844 121.0815 121.1692 186.9228 221.1085 230.0394 
Jpassive - Jactive 
[pmol/(s●cm2)] 1.0513 1.2859 2.2180 4.9194 11.1458 17.0528 22.7440 34.0373 47.0948 51.8898 101.720 99.1281 172.0678 190.6322 195.3460 
lowest MCell a_b 
[nmol] 0.0112 0.0163 0.0275 0.065 0.123 0.21 0.27 0.445 0.575 0.72 1.45 1.375 2.3 2.8 2.85 
highest MCell a_b 
[nmol] 0.015 0.022 0.037 0.087 0.165 0.275 0.355 0.595 0.77 0.95 1.975 1.875 3.1 3.8 3.85 
average MCell a_b 
[nmol] 0.0131 0.0192 0.0323 0.076 0.144 0.2425 0.3125 0.52 0.6725 0.835 1.7125 1.625 2.7 3.3 3.35 
lowest MCell b_a 
 [nmol] 0.0175 0.024 0.0435 0.093 0.2 0.305 0.375 0.635 0.85 1.05 2 2 3.4 4.4 4.1 
highest MCell b_a 
[nmol] 0.0245 0.0335 0.0595 0.125 0.25 0.39 0.48 0.82 1.1 1.35 2.7 2.75 4.3 5.8 5.5 
average MCell b_a 
[nmol] 0.021 0.0288 0.0515 0.109 0.225 0.3475 0.4275 0.7275 0.975 1.2 2.35 2.375 3.85 5.1 4.8 
average MCell 
a_b/b_a [nmol] 0.0171 0.0240 0.0419 0.0925 0.1845 0.295 0.37 0.6238 0.8238 1.0175 2.03125 2 3.275 4.2 4.075 
FRV scaled 0.0275 0.0516 0.031 0.0187 0.0108 0.00659 0.00822 0.00493 0.00327 0.00941 0.0054 0.00182 0.00399 0.00376 0.00372 
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Table 30: Model estimated kinetic parameters of Verapamil permeation across Caco-2 cell monolayers in experiments with concomitant incubation 
with a second compound (D = Digoxin / Q = Quinidine). 
5 5 25 25 25 25 50 50 100 100 250 250 500 500 500 nominal donor 
concentration 
[µM] Q 250 D 100 Q 10 Q 100 Q 250 D 100 Q 50 Q 100 Q 10 Q 100 Q 10 Q 20 Q 1 Q 10 Q 20 
model derived 
C(0) a_b 4.0769 4.235 25.025 27.77 23.19 23.514 44.886 43.524 89.795 90.352 239.714 234.459 489.216 496.188 491.491 
model derived 
C(0) b_a 4.239 4.56 25.004 24.459 23.464 25.131 45.702 44.289 91.666 91.782 242.34 244.248 488.637 499.504 499.155 
average model 
derived C(0) 4.158 4.398 25.015 26.115 23.327 24.323 45.294 43.907 90.731 91.067 241.027 239.354 488.927 497.846 495.323 
P ● 106 [cm/s] 303.46 315.75 242.87 256.94 293.69 304.15 251.71 259.4 244.04 251.39 260.69 270.47 249.34 268.84 306.8 
efflux rate vk 
[nmol/(s●cm2)] 0.0002 0.0003 0.0013 0.0009 0.0012 0.0010 0.0031 0.0029 0.0051 0.0044 0.0145 0.0131 0.0210 0.0309 0.0342 
Jactive = vk 
[pmol/(s●cm2)] 0.2312 0.2567 1.2543 0.9204 1.2185 0.9836 3.1433 2.8812 5.1196 4.4458 14.4820 13.1392 21.0418 30.9411 34.2095 
Jpassive = P ● 
C(0) 
[pmol/(s●cm2)] 
1.2618 1.3885 6.0753 6.7099 6.8509 7.3977 11.4010 11.3893 22.1419 22.8933 62.8333 64.7379 121.9089 133.8409 151.9651 
Jpassive - Jactive 
[pmol/(s●cm2)] 1.0306 1.1319 4.8210 5.7894 5.6324 6.4141 8.2576 8.5081 17.0223 18.4476 48.3514 51.5988 100.8671 102.8999 117.7556 
average MCell 
a_b [nmol] 0.0131 0.0135 0.0788 0.08 0.0758 0.0803 0.1335 0.129 0.275 0.2875 0.73 0.7325 1.625 1.51 1.5 
average MCell 
b_a [nmol] 0.0203 0.0215 0.1135 0.119 0.1118 0.124 0.168 0.1658 0.415 0.43 1.1025 1.135 2.35 2.3 2.3 
average MCell 
a_b/b_a [nmol] 0.0167 0.0175 0.0961 0.0995 0.0938 0.1021 0.1508 0.1474 0.345 0.3588 0.9163 0.9338 1.9875 1.905 1.9 
FRV scaled 0.0226 0.024 0.0324 0.02 0.017 0.0115 0.0253 0.0233 0.0152 0.0142 0.0171 0.0138 0.00657 0.0158 0.0234 
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Table 31: Apparent permeability coefficient Papp of Verapamil permeation in Caco-2 cell 
monolayers. Values were calculated from the permeated amount of substance after 15min. 
Values are displayed as mean of 3 measurements with the standard deviation (SD). 
Verapamil: 
nominal donor 
concentration [µM] 
Papp a_b ● 106 
[cm/s] SD 
Papp b_a ● 106 
[cm/s] SD 
Efflux 
Ratio 
5 60.34 16.63 132.02 4.40 2.19 
7.5 93.67 3.83 118.75 6.44 1.27 
12.5 82.73 1.68 123.81 5.68 1.50 
25 84.44 11.80 102.96 10.24 1.22 
50 82.63 5.84 110.75 5.16 1.34 
75 88.84 10.04 108.85 3.26 1.23 
100 85.21 3.60 96.29 10.59 1.13 
150 86.54 1.82 110.42 9.83 1.28 
200 92.31 4.79 112.26 5.99 1.22 
250 73.65 11.94 99.96 0.77 1.36 
500 84.69 10.87 106.67 2.11 1.26 
500 81.10 2.99 111.93 2.38 1.38 
750 89.29 6.39 113.09 4.29 1.27 
1000 77.13 3.91 103.23 4.56 1.34 
1000 85.40 5.27 109.39 6.56 1.28 
 
Table 32: Apparent permeability coefficient Papp of Verapamil permeation in Caco-2 cell 
monolayers in experiments with concomitant incubation with a second substance (D = 
Digoxin / Q = Quinidine). Values were calculated from the permeated amount of substance 
after 15min. Values are displayed as mean of 3 measurements with the standard deviation. 
 
Verapamil: 
nominal donor 
concentration [µM] 
 
Papp a_b ● 106 
[cm/s] SD 
Papp b_a ● 106 
[cm/s] SD 
Efflux 
Ratio 
5 Q 250 70.51 5.84 99.96 6.08 1.42 
5 D 100 93.77 10.50 94.27 13.68 1.01 
25 Q 10 70.96 8.55 98.37 7.33 1.39 
25 Q 100 79.16 8.35 103.57 5.44 1.31 
25 Q 250 83.44 5.28 107.76 4.18 1.29 
25 D 100 84.64 10.14 121.81 7.28 1.44 
50 Q 50 60.55 2.70 93.21 3.36 1.54 
50 Q 100 62.61 0.22 99.75 3.88 1.59 
100 Q 10 66.71 1.90 90.09 2.21 1.35 
100 Q 100 70.18 3.95 93.25 1.96 1.33 
250 Q 10 74.75 5.09 103.37 7.37 1.38 
250 Q 20 75.60 2.91 104.52 5.95 1.38 
500 Q 1 80.42 4.70 100.52 3.90 1.25 
500 Q 10 79.95 5.52 105.43 1.35 1.32 
500 Q 20 90.07 5.31 118.40 5.18 1.31 
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mass balance of Verapamil HCl permeation 
apical to basal
0.00
20.00
40.00
60.00
80.00
100.00
5 7.5 12
.
5 25 50 75 10
0
15
0
20
0
25
0
50
0
50
0
75
0
10
00
10
00
nominal donor concentration C(0) [µM]
re
c
o
v
e
ry
 
[%
 
o
f 
do
n
o
r 
a
m
o
u
n
t]
withdrawn
in solution
 
Figure 87: Mass balance of Verapamil transport apical to basal at 37°C in Caco-2 cells 
grown in Transwell plates (individual transport). At least 3 wells were used per group. 
Numbers display concentrations in [µM]. 
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Figure 88: Mass balance of Verapamil transport basal to apical at 37°C in Caco-2 cells 
grown in Transwell plates (individual transport). At least 3 wells were used per group. 
Numbers display concentrations in [µM]. 
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mass balance of Verapamil HCl permeation 
(in presence of Quinidine HCl or Digoxin) 
apical to basal
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Figure 89: Mass balance of Verapamil transport apical to basal at 37°C in Caco-2 cells 
grown in Transwell plates (in presence of Digoxin or Quinidine). At least 3 wells were used 
per group. Numbers display concentrations in [µM]. 
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Figure 90: Mass balance of Verapamil transport basal to apical at 37°C in Caco-2 cells 
grown in Transwell plates (in presence of Digoxin or Quinidine). At least 3 wells were used 
per group. Numbers display concentrations in [µM]. 
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